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MODIFICATION OF BEHAVIOR OF ELASTIN-LIKE POLYPEPTIDES BY 
CHANGING MOLECULAR ARCHITECTURE 
 
ALI GHOORCHIAN 
 
ABSTRACT 
Elastin-like polypeptides (ELP) are environmentally responsive polymers that exhibit 
phase separation in response to external stimuli such as temperature, pH, light, and ionic 
strength. It has been shown that the sequence of the pentapeptide, its length, and the 
solution concentration are very important in the transition of the molecules from soluble 
to insoluble, but there has not been any detailed study of the effect of molecular 
architecture on the behavior of ELPs. 
In this study we designed, synthesized and characterized ELPs with different 
architectures and chemical identities to probe the effect of molecular design on the 
microscopic and macroscopic behavior of ELP molecules and to compare them to the 
linear ELP molecules. These new architectures also helped us better understand the 
theory of folding and aggregation of ELPs. The design was based on constructing three-
armed star molecules by tagging a trimer forming oligomerization domain to the ELP 
chains. ELPs were chosen to have different chemical identities by changing the 
pentapetide sequence. The molecules were synthesized by molecular biology techniques 
and characterized by different methods. 
Our results show that capping the three ELP chains forces the chains to fold into more 
extended rod-like constructs prior to aggregation. A mathematical model was developed 
vii 
 
to predict the behavior of ELP chains at the transition temperature and it was shown that 
there is a difference between N- and C- terminal capping ELPs seem to fold at lower 
temperatures when their N-termini are held together.  It was also shown that the 
constructs with both their ends capped can be designed such that they fold into a stable 
unit at much lower temperatures than the linear constructs without necessarily 
aggregation at higher temperatures.  
The trimer constructs were also used to make micellar aggregates that were 
characterized by dynamic and static light scattering. It was shown that the size of the 
micelles can be controlled by adjusting salt concentration or by making mixtures of linear 
and trimer constructs. The micelles were also crosslinked into responsive stable nano-
particles.    
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Chapter I 
Background 
 
 
1-1. Introduction 
In nature there are many macromolecule-based systems with fundamental importance 
for living organisms that exhibit changes in structure and behavior in response to changes 
in their environment. Many biological systems function on the basis of some feedback 
communication with their surroundings which induce specific changes in the 
conformation of proteins, polypeptides, or nucleic acids. These changes in the 
conformation would then translate into changes in the function of the macromolecules 
and ultimately affect the living organisms. In essence many of the biologically related 
functions can be considered as responsive to environmental changes. The response can be 
a change in solubility, secondary structure, or even intermolecular association and can be 
triggered by a variety of natural stimuli including temperature and pH variations, among 
many other physiologically-induced changes. Understanding these biological responses 
and what induces them, their response to environmental stimuli, and the pathway of 
transition from one state to another has been the subject of countless studies and theories 
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throughout many decades. This understanding would help to provide us tools to utilize 
these environmentally-induced changes in designing new and improve biologically-
inspired materials. 
The most commonly studied responsive macromolecules are the ones that exhibit 
lower critical solution temperature (LCST) and transition from soluble to insoluble in 
response to environmental stimuli.
1.1, 1.2
 LCST is a temperature below which, a mixture 
components remain soluble and do not show any immiscibility for any composition. The 
best known representative of these materials is poly(N-isopropylacrylamide) (PNIPAA) 
which has an LCST of 32˚C and has been studied for many years as a “smart” polymer 
for a variety of applications.
1.1, 1.3-6
  
The other common family of responsive macromolecules consists of peptide-based 
responsive molecules. The building blocks of these materials are usually naturally 
occurring amino acids and there is interest in them because of the advantages they offer 
in biologically-related applications. These soft, hydrated materials have many advantages 
over traditional chemically synthesized polymers. One major advantage of these 
materials is the possibility of precise control over the chemical identity and length 
together with their monodisperse distribution in the solution.
1.7
 Many of these materials 
have been shown to be biodegradable and generally biocompatible.
1.8-10
 Also the ability 
to add short peptide motifs and tags such as RGD, IKVAV, and GHK to the polypeptide 
makes these materials very attractive for bio-interface and cell attachment 
applications
1.11-13
. These materials have also shown potential to be used as self-
assembling units that can be used in designing 3D functional hydrogels. 1.14, 1.15 Even 
their obvious shortcoming of being limited to naturally occurring amino acid residues is 
3 
 
becoming less of a restriction by the development of more artificial amino acids that can 
be used in making peptide-based materials.
1.16-18
. 
Elastin-like polypeptides are a group of peptide-based materials which also have the 
LCST characteristics of responsive polymers and go through a transition in response to 
external stimuli.
1.19
 These polypeptides have similar characteristic of the elastin which 
makes them great candidates for many potential applications in which the flexibility and 
resilience of elastin is desired. The elastin-based materials are especially interesting since 
elastin and its unique characteristics have become the center of many material-related 
investigations and innovations in recent years because of its ability to repeatedly and 
reversibly go through stress cycles without failing.
1.20, 1.21
 Elastin-like polypeptides are 
designed based on observed repetitive sequences in mammalian elastin proteins
1.22
 with 
the most common being the pentapeptide Val-Pro-Gly-Xaa-Gly, in short VPGXG, in 
which Xaa can be any of the natural or synthetic amino acids except for proline.
1.23
 They 
are soluble below their lower critical transition temperature (LCST) and become 
insoluble and aggregate above their phase transition temperature.
1.23
 The protein-rich 
liquid phase from this phase separation is a coacervate and has been shown to have about 
40% protein content.
1.7
 In addition to VPGXG , there are other sequences that have 
shown to have the characteristics of elastin-like polypeptides, including LGGVG
1.24
, 
GXGGX
1.25
, APGVGV
1.26
, AVGVP
1.27
, KGGVG
1.28
, LGAGGAG
1.29
, but most of the 
studies have focused on VPGXG as the representative of this family of peptide-based 
materials. 
In this chapter we first look at different viewpoints on the theory of phase transition 
and aggregation of elastin-like polypeptides and the much debated origin of their 
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elasticity. In this aspect the role of water is especially of interest and the structural studies 
of these materials will be discussed. We will then present the synthesis and 
characterization methods of these materials and summarizes the work that has been done 
to utilize these biologically inspired materials in different medical and non-medical 
applications. 
1-2. Theory of Transition 
From macroscopic point of view the transition of elastin-like polypeptides from 
soluble to insoluble in response to environmental stimuli can be easily observed and 
quantified using UV-vis spectroscopy (Figure 1-1). 
The transition temperature depends on the chemical identity, chain length, 
concentration, and architecture of the ELP in the solution
1.7, 1.30, 1.31
 and sometimes a 
combination of these factors can be utilized to design a specific ELP molecule with a 
known transition temperature for a particular application. The environmental stimuli to 
trigger this phase change are diverse and ELP molecules can be designed to respond to 
temperature, pH, ionic strength, light, and other stimuli.
1.7, 1.32, 1.33
  
 
a)       b)    
 
0
0.2
0.4
0.6
0.8
1
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35 40 45 50
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Figure 1-1. a) Transition of an ELP solution from soluble (left) to insoluble suspension of aggregates 
(middle), and finally phase separation (right). The phase separation happens after keeping the solution 
above the transition temperature for extended period of time. b) UV absorbance measurement of the 
(GVGVP)40 solution from below to above the transition temperature. 
  
The extensive studies by Urry showed that there is a predictable relationship between 
the hydrophobicity of the X residue in (VPGXG) and the temperature at which the ELP 
solution goes through the transition.
1.7
 This hydrophobicity scale has been shown to be a 
very accurate first estimate that can be used prior to designing and synthesizing new ELP 
molecules to predict their transition temperatures.  
As much as it is a straight forward to observe and measure the transition temperature 
of elastin-like polypeptides, it is difficult and problematic to have a full picture of this 
transition at the molecular level. Early work by Urry
1.34
 showed that a cyclic 
polypentapeptide of (VPGVG)3 in its crystalline state consists of three type II β-turns 
joined by Val-Gly-Val bridges. Based on this observation and using the (VPGVG) as the 
representative elastin-like polypeptide, they then employed circular dichroism (CD), 
NMR and dielectric relaxation studies to probe the transition of unordered polypeptides at 
low temperatures to more ordered structures at temperatures above the transition 
temperature.
1.19, 1.35
 They suggested that this transition is in agreement with their 
proposed phase diagram for ELP molecules
1.36
 and the change at molecular level is 
ultimately accompanied with the phase change in solution. But later studies showed that 
this molecular structure change is a gradual process that starts at temperatures well below 
the transition temperature.
1.37
 Urry and Cabello later suggested that the ordering of 
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polypeptides is actually the main contributor to the LCST behavior of ELPs.
1.38
 They 
studied the thermal behavior of ELP molecules using temperature modulated differential 
scanning calorimeter (TMDSC) in different salt concentrations and suggested that the 
process of inverse transition temperature (ITT) in ELPs is inherently different from LCST 
of the other macromolecules and the process of folding and aggregation leads to an 
increase in the order of the chains. 
Based on Urry’s  model for ELP transition, the chains in the random conformation 
below their transition temperature start to form type II β-turn conformation as they 
approach their transition temperature and then at the transition temperature they fold in to 
a so called a β-spiral which is a helical arrangement of β turns.1.36 These folded constructs 
would then be stabilized by making trimers called twisted filament (Figure 1-2). 
 
   
Figure 1-2. The formation of twisted filaments from folded ELP chains as suggested by Urry. The β-spiral 
formation from β-turns is believed to be precursor of ELP aggregation. (with permission from reference 
1.39
).  Copyright 1997 American Chemical Society. 
  
Numerous groups have studied different ELP sequences to probe this theory and an 
array of results has been reported. Many of the experimental studies, mostly using CD 
7 
 
spectroscopy and IR measurements, have suggested the existence of more ordered state 
of the polypeptides at higher temperatures that might be made of mainly β turns. In a 
study using infrared spectroscopy and computational methods on a 59 kDa ELP of 150 
pentapeptide repeats of (VPGXG), Serrano et al. suggested that their results are 
consistent with β-spiral model of Urry.1.40 This is one of the few works which combines 
experimental data along with a mathematical model to study this transition. They also 
showed that increasing temperature to those of higher than the transition temperature 
affects the packing of the β-spiral strands to β-sheet structure. This is consistant with 
Urry’s observation that heating up the ELP solution to temperatures well above their 
transition temperature causes more water to be expelled from the coacervate.
1.36
 Other 
studies by Arkin using (VPGXG) as the model molecule and employing multicanonical 
Monte Carlo simulations show good agreement to the Urry model.
1.41, 1.42
 Nicolini et 
al.
1.43
 characterized temperature and pressure induced inverse transition temperature of a 
single pentapeptide using DSC, CD, and FTIR showing the existence of type II β-turns 
and a change from unfolded to folded structure by increasing the temperature. They also 
showed that at high pressure the population of ordered structures decreases and more 
random coil is observed. 
Despite the existence of the experimental and molecular simulation results pointing 
towards the existence of ordered structure for ELPs there are also many investigations 
showing less or no order for these constructs either below or above the transition 
temperature. Li et al.
1.44
 conducted one of the most detailed simulation studies of ELP 
molecules using (GVGVP)18 as their template in a temperature range of 7˚C to 42˚C. 
Their starting point was the proposed β-spiral model and they showed that when the ELP 
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goes through the transition more turns can be observed above the transition temperature. 
But their simulations indicate that above Tt the ELP monomer can be described as a 
compact and amorphous structure which contains disordered β strands and fluctuating 
turns. It is noticeable that in this simulation a single chain was studied and the effect of 
other chains on the conformational behavior of the ELP chain was not taken into 
consideration. Yao et al. studied the structure of a (GVGVP)3 by using 1D NMR and 
their results suggested only a small fraction of the overall structure consists of type II β-
strands.
1.45
 Later, Krukau et al. used a GVG(VPGVG)3 as a molecular model to study the 
conformational transition of the ELPs by employing molecular simulations in water at 
temperatures between 7˚C to 167˚C and their results suggest that the breaking of 
hydrogen bonds of clustering water plays a very important role in the transition 
temperature but there is no folding of the ELP molecule upon reaching to the transition 
temperature.
1.46
 They suggested the existence of a random distribution of structured 
elements on the peptide chains even above the transition temperature. They also 
challenged the idea of having ELP chains in random coil below the transition temperature 
as they found a rigid conformation below the transition temperature. They suggest that 
the minimum of CD spectra at 195 nm which is used as an indication for the existence of 
random structure might be contributed to the presence of ordered polyproline II (PPII) 
structure. This idea has been challenged by the fact that increasing temperature causes the 
198 nm minimum to disappear while another characteristic peak of PPII conformation at 
212 nm remains almost the same in most of the CD spectra of ELP molecules at different 
temperatures. This is an indication that these two peaks represent two different species 
and so they most probably cannot be interpreted as PPII secondary structure.
1.47
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Some researchers used elastin-like polypeptide sequences other than VPGVG to study 
the conformational change of the chains through the transition. One such molecule was 
(LGGVG)n which was studied by some groups. Martino et al. 
1.48
 first studied this ELP 
using CD spectroscopy and transmission electron microscopy. They suggested that the 
sequence XGGXG can better represent elastin molecules as it illustrates what they called 
“sliding β-turn”.1.24 They showed that a simultaneous presence of different conformations 
can be observed for this construct which includes type II β-turns, type I β-turns, and 
unordered structure and makes this ELP a structurally heterogeneous biopolymer. Using 
TEM they also observed twisted-rope aggregates which are in agreement to the Urry’s 
theory. Although it should be noted that their studies were done in organic solvents (TFE 
and HFIP) and it has been shown elsewhere that organic solvents and specifically TFE 
(trifluoroethanol) can promote the type II β-turn conformation for ELPs.1.49 Kumashiro 
group later studied this polypeptide using 1D and 2D NMR and concluded that the best 
scenario for describing the conformation of these polypeptides is what they call a 
“conformational ensemble”, in which a number of different conformations coexist.1.24, 1.50 
They also confirmed the existence of type II β-turn structure in water and type I β-turn in 
TFE.
1.51
 This heterogeneity in conformation was also reported by Ahmed et al.
1.52
 who 
studied VPGXG as their model molecule and did a range of UV-resonance raman 
(UVRR) studies on linear and cyclic elastin. They suggested that there is an ensemble 
population of polypeptides especially for linear constructs which mostly includes type III 
β-turns and disordered β-strands and some type II β-turns. For the cyclic polypeptides at 
low temperatures they found that most of the population is unordered strands of type II 
and type III β-turns, but an increase in type II β-turns at temperatures above the transition 
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temperature was observed. However, their UVRR does not show any difference in 
population of type II β-turns for linear or cyclic constructs. The possible difference 
between the population of the turns is especially interesting considering the fact that most 
of the structural studies by Urry were done on cyclic short chains. Bochicchio et al. also 
used CD spectroscopy on elastin, abductin, and resiline proteins and showed the very 
close equilibrium between PPII, unordered, and β-turn conformations.1.49 These different 
results from different systems and the possibility of having a number of different 
conformations coexisting might explain the very different and sometimes contradictory 
results that have been reported, especially using molecular dynamic simulations, since 
these simulations are based on a series of initial boundary conditions which could be 
significantly different from one solution condition to another. 
1-3. Role of Water 
Although there are numerous viewpoints on the molecular changes in ELP molecules 
when they go through their transition, there is very little doubt about the importance of 
water in this process. These mostly hydrophobic polypeptides are surrounded by water 
molecules which are called the water of hydrophobic hydration. Water of hydrophobic 
hydration was first studied by Frank
1.53
 who described these water molecules as 
“icebergs” surrounding the hydrophobic molecules. The idea of ice-like water molecules 
later evolved to more dynamic water molecules which have a relaxation frequency 
somewhat lower than that of the bulk water. In work done by Urry et al.
1.39
 they observed 
a temperature dependent relaxation of about 5 GHz, which is just below the frequency of 
bulk water, for two long ELP molecules. This first hydration shell covers most of the 
surface of the biomolecule at lower temperatures and increasing the temperature causes 
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this water network to break into small water clusters that cannot cover all of the area on 
the surface of the molecule and are less ordered.1.54 This results in more exposed 
hydrophobic residues to the bulk water which drives the aggregation of the molecules as 
they approach the transition temperature. The fact that the transition of biomolecules 
from soluble to insoluble correlates with the reordering of waters around the molecules 
was used to relate the transition temperature of ELPs to the water of hydrophobic 
hydration.
1.7
 It has been suggested that even the thermal characteristics of the water of 
hydrophobic hydration is different from that of the bulk water.
1.55
 Oleinikova et al. 
studied the heat capacity (Cp) of water molecules around hydrophilic and hydrophobic 
residues in both hydration shell and bulk water using molecular simulations.
1.56
 They 
showed that the Cp value of the water surrounding the biomolecule is actually higher than 
that of the bulk water but it starts to decrease when the temperature starts to elevate. It 
eventually approaches that of the bulk water at high temperatures and at these high 
temperatures the Cp is actually affected by the interaction of hydrophobic hydration water 
with the bulk water which means that the two species of the water molecules become 
more and more alike.   
Since the change in the structure of water is accompanied with phase separation of 
these biomolecules and considering that the transition temperature is the line between the 
miscibility and immiscibility of the solution components, the Gibbs free energy should be 
zero at this point and so  
   
  
  
          (1-1) 
Urry used this concept to develop the Tt-based hyrophobicity scale that can be used to 
predict the transition temperature of different ELP solutions based on their chemical 
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identity.
1.7, 1.57
 Also based on his theory, the folding of ELP molecules to more ordered 
constructs upon reaching to the transition temperature causes these chains to have more 
positive entropy. This entropy would be then compensated by the less ordered water 
molecules negative entropy at the transition.
1.7, 1.39
  
The water of hydrophobic hydration and its role in the transition of ELPs has been 
subject to many studies and experiments using different methods. Cabello et al. used 
scanning calorimetry to study poly(VPGVG) with the aim of better understanding the 
mechanism of protein folding and assembly.
1.58
 Their experiments were aimed at 
studying the clathrate-like structure of water molecules surrounding the hydrophobic 
moieties of the polypeptide chain from conditions of water deficiency to excess of water. 
This work was done based on using polypeptides with molecular weights of above 15 
kDa and their results indicated that there are a maximum of 170 water molecules per 
pentapeptide. They also confirmed that these clusters of water are distributed in a non-
homogeneous fashion with a broad range of energy distribution. The water molecules and 
their role in the structural stability of the polypeptide by making hydrogen bonds was 
investigated by changing the aqueous environment from water to D2O by Cho et al.
1.47
 
They measured the critical solution temperature of five different ELP molecules with 
different lengths and chemical identity. Using CD spectroscopy, ATR/FTIR, and DSC 
measurements they found β-turn structures in both water and D2O solutions but the 
highest content of these β-turns were observed for less hydrophobic and shorter 
polypeptides (Figure 1-3). They also studied the difference between the LCST of the ELP 
molecules in water and heavy water and compared it to that of the 
polyisopropylacrylamide (PNIPAA). Base on their experiments there is a considerable 
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difference between ΔLCST and enthalpic cost of ELP and PNIPAA when the solvent is 
changed from water to D2O. They suggested that this difference is mainly attributed to 
the different phase transition mechanisms in the two and the fact that hydrogen bonding 
plays a very important role in the ELP transition and restructuring above the transition 
temperature while there is minimal change in hydrogen bonding upon the hydrophobic 
collapse of PNIPAA molecules and unlike ELP molecules PNIPAA remains unstructured 
upon transition.  
 
 
 
Figure 1-3. CD spectra of ELPs with different lengths and chemical identity. The minimum around 197 
nm is less negative for longer hydrophilic constructs which is an indication of higher β structure at the same 
temperature. Reprinted with permission from reference 
1.47
). Copyright 2009 American Chemical Society.  
 
Since the water of hydrophobic hydration affects the transition of the elastin-like 
polypeptides trough changes induced by the hydrogen bonding of water molecules with 
different amino acid residues, the effect of water on the structural transition of ELP 
molecules also depends on the chemical identity of the polypeptide. This was 
investigated for poly(GVGVP) and poly(AVGVP) using FTIR and raman spectroscopy in 
solution and in the solid state.
1.27
 It was suggested that below the transition temperature 
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for both polymers, water molecules make hydrogen bonds with a part of the amide 
groups and the rest of these groups interact with each other to form a β-sheet-like 
structure consisting of β-turns. But the difference between the two polypentapeptides is 
that the water is more structured around poly(AVGVP) molecules. Also, this polypeptide 
makes a more compact structure above the transition temperature and shows more 
resistance to rehydration which makes it more difficult to dissolve back into solution and, 
consequently, a hysteresis between heating and cooling UV spectra was observed. This 
mostly was attributed to the direct bonds between the amide groups and expulsion of 
water molecules from the spaces in between them, which makes it harder for the water to 
penetrate back in to the molecular structure below the transition temperature. On the 
other hand, poly(GVGVP) retains more water molecules on its amide groups above the 
transition temperature and consequently behaves reversibly when it goes through the 
transition temperature. This difference in the hydration shows how the chemical identity 
of a polypeptide can affect the structure of water around the molecule, which in turn 
changes the LCST behavior of the ELP molecule. Also from their studies, and in 
contradiction to the general belief that the transition of these biomolecules is mainly 
related to the restructuring of the water molecules around the hydrophobic moieties, they 
concluded that the restructuring of the biomolecule itself, for instance the decrease in β-
sheet structure, is the more important factor in the transition. Their observation is in 
agreement with some other published data suggested that the interaction of water 
molecules with charged or polar moieties can be more influential in the transition than the 
interacting waters of hydrophobic hydration.
1.59
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Not only the identity of the polypeptide affects the water structure around the 
molecule, but also the characteristics of the aqueous solvent can make a difference as to 
how the water molecules arrange around the biopolymer. This was studied specifically by 
having different salts and salt concentrations in the solution. Salts in general affect the 
solubility of proteins following the well-known Hofmeister series.
1.60
 In contradiction to 
traditional belief that these salts cause changes in hydrogen bonding among the bulk 
water molecules, more recent investigations suggest that the ions in fact interact with the 
biomolecules itself which results in an interfacial change between these molecules and 
their surrounding water molecules.
1.61
 This different interaction then causes the water 
molecule clusters around the biomolecule to arrange differently and so in the case of ELP 
molecules these interfacial waters affect the transition temperature of the polypeptides. 
Cho et al. investigated the effect of Hofmeister anions on the transition temperature of a 
(VPGVG)120 and another construct with the same repeat number but more hydrophilic 
overall nature. They used 11 different sodium salts of the Hofmeister anions.
1.62
 Their 
results suggest that the hydrogen bonding of water molecules to the amide backbone 
becomes weak in the presence of the kosmotropic anions but in the case of chaotropic 
anions it is the hydrophobic hydration of the biomolecules which is being weakened and 
results in a lower transition temperature. In this case, they observed a strong correlation 
between the Tt of the ELP and the surface tension of the anions. Interestingly they found 
out a parallel but weaker salt-in effect even in the presence of chaotropic anions caused 
by direct binding of anions to amides. This latter effect actually works in the opposite 
direction with regard to the transition temperature of ELPs but has a smaller overall 
effect.   
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In short, water structure around the ELP molecules, is mostly believed to have a direct 
impact on the transition temperature, stability and structure of these molecules both 
below and above the transition temperatures and many factors including the chemical 
identity of the molecule, temperature, solvent, and salts affect the structure and stability 
of the water of hydrophobic hydration molecules. 
1-4. Structural Studies 
Structural studies of elastin-like polypeptides have proven to be a challenging task 
considering their non-crystalline structure and the fact that they go into large aggregates 
upon their transition. Consequently, there is no high-resolution NMR or X-ray 
crystallography of ELPs and most of the studies are based on interpretation of data from 
CD spectroscopy, IR, solid state NMR, or NMR studies of these molecules at 
temperatures below their transition temperatures. But the very nature of the transition and 
structural change has not been really resolved. Here we review some of the attempts to 
get a better understanding of the structure of elastin-like polypeptides below and above 
their transition temperatures. 
The early work to probe the dynamic behavior and conformation transformation of 
these biomolecules come from Urry’s research group over the course of three decades.1.7, 
1.35, 1.36, 1.63-65
 Using the model ELP sequence (VPGVG)n they first showed the physical 
transformation of the ELP from low temperatures to temperatures above its transition and 
based on that he proposed that these molecules which are highly hydrated below their 
transition temperature, start to lose water above Tt and make a coacervate of about 37% 
polypeptide but then at even higher temperature there is a denaturation process that ends 
up losing more water to the point that the coacervate consists of about 68% protein.
1.64
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They further studied this physical phenomena using UV and CD spectroscopy and came 
to the conclusion that these polypeptides consists of type II β-turn conformations which 
upon heating to the transition temperature form what they called a twisted filament (super 
coiled).
1.34
 They also showed that increasing temperature from below to above the 
transition temperature results in an increase in the ordered structure while keeping the 
solution at high temperature (around 80˚C) leads to disruption of the structure.1.64 These 
observations were also accompanied by his observations of filament structure of cyclic 
(GVGVP)2 and (GVGVP)3 constructs.
1.34
 Much more recently, Karle and Urry 
successfully crystallized and studied another cyclic ELP sequence (APGVGV)2. When it 
goes through its transition at 60˚C, this ELP crystallizes out of the solution. They used x-
ray crystallography to show the existence of type II β-turn at both ends of the 
construct.
1.26
 They showed that because of the hydrogen bonds among the residues of this 
molecule it forms an extended β-sheet.  
Other researchers tried to probe the molecular structure of ELPs using IR or CD 
spectrometry
1.27, 1.40, 1.52, 1.66
 and also raman spectroscopy.
1.67
 Nicolini et al. used a 
combination of differential scanning calorimeter (DSC), CD and FTIR to study a short 
chemically synthesized polypeptide consisting of eight amino acids GVGVPGVG at high 
and low temperature and pressure.
1.43
 The temperature ranged from 2 to 120˚C and the 
pressure up to about 10 bars. They showed that even this very short pentapeptide goes 
through the folding transition at about 36˚C but then by heating up to very high 
temperature a denaturing was reported which they believe is a consequence of highly 
mobile chains that cause the hydrogen bonds to break. This is in agreement with Urry’s 
observation for much longer polypentapeptides at temperatures around 80˚C. The high 
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pressure study of the polypeptide revealed that the high pressure destabilizes the folded 
construct. They also suggest that folding is driven by the increase in the entropy of water 
at higher temperature.  
Some groups also tried to probe the structural behavior of ELP constructs up to the 
transition temperature or in the solid state using NMR. Yao and Hong studied a model 
ELP consisting of three repeats of site-specific labeled VPGVG using solid state NMR in 
their attempts to better understand the structure of ELP and the source of its elasticity.
1.45
 
They claimed that this peptide resembles the structure of longer VPGVG-based ELPs and 
therefore their results are valid even for long ELP constructs. They observed two types of 
compact and extended conformations. The compact conformation is reported to be about 
one third of all the conformational population. By conformational search for Pro-Gly pair 
they suggested that the compact structure is probably a type II β-turn structure although it 
is also possible for it to be a previously unclassified turn with Pro7 torsion angels of (-
70˚, 20±20˚) and Gly torsion angels of (-100±20˚, -20±20˚). They proposed that the 
extended conformation was an unordered β-strand. For the origin of elasticity based on 
their NMR studies, they offered that entropic elasticity is the result of hydrophobic 
hydration molecules and not the conformational entropy of the polypeptides. Kurkova et 
al. studied the structure of two synthetic ELP molecules, poly(GVGVP) and 
poly(AVGVP) in water and D2O at different temperatures using 
1
H, 
2
H, 
13
C and 
15
N 
NMR spectroscopy.
1.68
 They assigned the signals by implementing COSY, NOESY, 
HXCORR, HSQC, HMBC and SSLR INEPT techniques and reported four different 
states for the molecular conformations of the two polypeptides based on their 
environmental temperature. In the first state they observed an extended and more random 
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and hydrated polypeptide chain conformation for both polypentapeptides. This state is 
reported to continue up to temperatures of about 300 K. In the second state they reported 
a more coiled and globular but still disordered state. This state persisted to temperatures 
close to the transition temperatures of the polypeptides. The difference between the two 
polypeptides was reported to be the broadness of the temperature intervals for each of 
them. For poly(AVGVP) they reported a rather narrow temperature region of about 3 
degrees and it mostly behaves like a sudden change from the first state to the third one 
while for the other polypeptide this window was broader and overlapping with the next 
region. From temperatures of 303 to 313 K they observed a tightly coiled and compact 
state. The final state was an aggregated conformation for both constructs. Interestingly, 
they reported the simultaneous existence of second through fourth states in both 
polypeptides at all the temperatures above 299 K. This coexistence of different states of 
the polypeptides is very similar to previously discussed results and can explain the 
difficulties involving prediction or simulation of ELP behavior. They also suggested that 
only in the case of the poly(AVGVG) were β-turns observed in the second state and these 
turns were stabilized by hydrogen bonding between Ala carbonyl and Val group. The 
mixture of different conformations at a given temperature has also been observed in other 
NMR studies of ELP constructs
1.24, 1.50, 1.51
. In another attempt to understand the structure 
of the ELP molecules, Gross et al. used a construct containing six repeats of GVGVP 
with a cysteine residue at the N-terminus.
1.69
 Based on DSC, CD, UV, IR and NMR 
spectroscopy data they suggest that this construct does not contain β-spiral 
conformations; rather an anti-parallel β-sheet is proposed to be the main component of 
the conformation of this ELP construct.  
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Other researchers tried to probe the role of individual residues, especially the Proline, 
in the structural conformation of ELP constructs. One of the first studies of this nature 
was done by Kim et al. in which they studied three ELP molecules based on the VPGVG 
sequence.
1.70
, they incorporated (2S)-proline in the first polypeptide, (2S,4S)-4-
fluoroproline in the second, and (2S,4R)-4-fluoroproline in the third. They suggested that 
the substitutions of the proline in the polypeptide sequence have very noticeable effect on 
the transition and self-assembly of ELP molecules. The third construct showed a lower 
transition temperature and higher content of type II β-turns but the effect of the 
substitution in the second polypeptide showed an opposite trend. They concluded that the 
stereoelectronic effect can affect the self-assembly and the stability of the β-turn and it is 
directly related to the presence of the proline residue. They also confirmed their 
experimental results by employing density function theory and modeling the three 
different possible turns. The effect of proline on self-assembly of ELPs was also 
confirmed by more recent work
1.71
 where they studied the effect of proline number and 
spacing on the self-assembly and structure of elastin-like polypeptides. They observed 
that the spacing between the proline residues and the reversible self-assembly of the 
polypeptides are inversely proportional. They suggest the strong presence of β-sheet 
structures in proline-poor constructs which then lead to amyloid-like, irreversible 
aggregation of these molecules at higher temperatures. Glaves et al. studied the role of 
proline using point mutated ELP constructs.
1.72
 This work is a continuation of their 
previous work in which, by using molecular simulations and experimental data, they 
showed that there might actually be a folding process involved in the transition of the 
ELP molecules which cause the ordering of the polypeptides upon reaching their 
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transition temperature.
1.73-75
 Their results are very similar to the other reports on the role 
of the proline in the structural transition of ELP in that mutation of this proline 
completely altered the behavior of ELP. Their NMR studies and molecular dynamic 
simulations showed an unstructured conformation for these mutated ELPs while the wild 
type was observed to have the β-turn structure. In their work they also emphasized the 
importance of the proline cis or trans isomers for the stability of the polypeptides in the 
solution. Their results suggest a correlation between the increase in the population of the 
type II β-turn and the inverse temperature transition with cis to trans equilibrium in the 
solution at different temperatures. They suggested that high temperature lowers the Gibbs 
free energy barrier between the two isomers causes more prolines to go from their cis to 
trans conformation which then results in unstable polypeptides and ends up forming 
aggregates. This peptidyl-prolyl isomerization, they believe, can play an important role in 
aggregation and elastomeric behavior of ELPs. Interestingly their simulations showed 
very different conformations of polypeptides depending on which of the two 
isomerization forms of the prolines was used. This can add another critical parameter in 
performing molecular simulations for these systems and might explain some of the 
inconsistent results from different MD simulations. The proline isomerization was also 
studied by Valiaev et al. by force inducing the cis to trans isomerization of an ELP 
consisting of 180 repeats of pentapeptides.
1.33
 In this study they employed single 
molecular force spectroscopy method using AFM to characterize the molecular 
elongation and isomerization of ELP constructs as a result of external force. Their results 
confirmed the conformational change of the molecules due to the cis to trans 
isomerization of the proline residue.   
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Nevertheless the actual structure of the ELP molecules and their pathway towards the 
aggregation is not yet clear but it is certain that both chemical nature of the ELP molecule 
and the environment can affect the process of phase transition in macroscopic and 
microscopic levels. 
1-5. Synthesis. 
In general two methods of synthesizing elastin-like polypeptides have been used, 
chemical synthesis and biosynthesis. 
1-5-1. Chemical Synthesis. 
This is the traditional method of synthesizing any polypeptide sequence in which solid 
state chemistry is employed to add the amino acids together in the desired sequence. 
Specifically Fmoc solid state chemistry
1.76
 or Boc protected solid state chemistry
1.77
 have 
been used for ELP construction. In his early works Urry used Boc-protected solid state 
synthesis to make different lengths of ELP molecules.
1.36
 But solid state chemistry is not 
limited only to earlier works in the field of ELPs. Recent work by Ohgo et al. employed 
solid state chemistry to synthesis short sequences of ELP molecules
1.24
. The obvious 
shortcomings of this method are the difficulty of making long polypeptide sequences. In 
recent years, especially for making long ELP molecules, almost every group is using the 
more precise and predictable method of genetically engineered polypeptide synthesis. 
1-5-2. Genetically Engineered Polypeptides. 
Advances in molecular biology and gene manipulation in the past few decades have 
enabled researchers to design and synthesize almost any conceivable sequences in their 
laboratories with very high precision. For elastin-like polypeptides, the highly repetitive 
nature of these biopolymers made them even better candidates to be made by genetic 
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engineering. There are generally two approaches in genetically synthesizing 
polypeptides, concatemerization and directional ligation. 
In concatemerization, a double stranded DNA sequence with two well-defined 
identical sticky ends is constructed using two single stranded forward and reversed 
sequence DNAs. The existence of the same sticky ends on both sides of the gene causes 
the ligation process to result in a random distribution of different lengths of the gene. The 
ligated DNA sequences with different lengths would then be used as the insert into a 
vector DNA digested at the same recognition cut sites as the two sticky ends of the 
annealed insert. The genes should then be separated based on their molecular weight. 
This is a random process and would result in a range of gene sequences with different 
molecular weights. This process can be specifically useful if different lengths of the gene 
is needed at once but there would be little to no control over what fraction of the end 
product would have a specific molecular weight.
1.78
  
The other gene engineering approach in synthesizing ELP molecules is recursive 
directional ligation (RDL) which become the most popular method of constructing these 
constructs soon after the method was shown to be applicable to silk elastin-like proteins 
by Cappello et al.
1.79
. This method then was further developed by Meyer and Chilkoti to 
become a seamless and very flexible method of synthesizing ELP molecules.
1.80
 Based on 
this method, a double stranded DNA sequence with two different sticky ends is inserted 
in to a linear vector which is doubly digested with the same two restriction enzymes of 
the insert DNA sequence. This plasmid is then amplified in vivo in a host bacterial cell. 
For the next step, two populations of the same plasmid would be used such that one 
population is cut at both sides of the insert and the other population is cut only at one side 
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such that it provides proper sticky ends for the insert DNA to be ligated to this linear 
plasmid. The result of the ligation of these two pieces of DNA would be a plasmid DNA 
of twice the size of the original DNA sequence. In theory this process can be repeated as 
many times as desired to result in long DNA sequences. We also used this approach in 
our lab to construct different lengths and sequences and architectures of ELP molecules 
(Figure 1-4). 
There are many advantages of using this method over other synthesizing processes for 
ELP molecules and the most important one is the absolute control over the chemical 
identity and length of the genes and also the mono-dispersity of the final polypeptide 
from the expression of these genes. The main limitations of this method is that it is 
usually time consuming and expensive to scale up. Also the use of RDL method has 
shown to be problematic for very repetitive sequences like (VPGVG)n and usually longer 
sequences have been synthesized by interrupting the repetitive sequence by substituting 
the second Val residue in some of the pentapeptides. Recently, McDaniel et al. reported a 
modified RDL method that might overcome this limitation over a large range of 
molecular weights.
1.81
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Figure 1-4. Schematic diagram of recursive directional ligation method used in our lab for ELP gene 
sysnthesis. 
 
1-6. Characterization 
Elastin-like polypeptides are characterized based on their molecular, physical, thermal, 
structural and rheological characteristics using many different techniques.
1.82
  
1-6-1. Biophysical properties. Most of the common techniques in characterizing 
proteins are also used in characterizing elastin-like polypeptides. Molecular weight of the 
constructs can be determined by mass spectroscopy and their concentration and purity is 
often characterized by electrophoresis-based methods like SDS-PAGE. The transition 
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temperature of the constructs are measured mostly by UV-vis spectroscopy although 
some analysts also have used differential scanning calorimetery (DSC) to measure the 
transition temperature and study the thermal behavior and of the molecules.
1.57
 Surface 
plasmon spectroscopy has been used for studying the surface behavior of ELPs.
1.83
 
1-6-2. Structural properties. The most well-known techniques in structural studies of 
proteins in general are nuclear magnetic resonance (NMR) and X-ray crystallography and 
although they have proved to be the most powerful techniques for this purpose their use 
for ELP molecules has been limited by the aggregation of the constructs above the 
transition temperature. Circular dichroism (CD) spectroscopy in which the absorption of 
left- and right-handed circularly polarized light is measured to determine unordered, 
alpha and beta conformations. 
Hydrodynamic radius of ELP-based particles has been studied using dynamic light 
scattering (DLS) in which a beam of light passes through the aqueous sample. The light is 
scattered by the particles in different directions and part of it passes through a detector. 
The Brownian motions of the particles results in constantly changing measured intensity 
that fluctuates with time. The intensity-time correlation function would then be analyzed 
using Stokes-Einstein equation to calculate the hydrodynamic radius. 
1-6-3. Rheological properties. The rheological properties of ELP solutions or ELP-
based hydrogels can be estimated by measuring elastic, viscoelastic and dynamic 
modules together with dynamic viscosity as a function of stress strain, time and 
temperature. 
 
 
27 
 
1-7. ELP-based Materials 
Because of the favorable characteristics of elastin-like polypeptides, including 
environmental responsiveness, general biocompatibility, biodegradability, and tunable 
behavior, they have been interesting candidates for developing new materials. Many of 
these materials are finding their ways into practical applications, but there are also many 
examples of materials based on these responsive biopolymers which are developed as 
proof of concept or towards the final goal of medical or biological applications. In this 
section, we present some of the work that has been done in the material world based on 
elastin-like polypeptides and then in the next section we present studies that have been 
done to use these materials in specific applications. 
Most of the ELP-based materials can be categorized into three major groups: 
hydrogels, particles, and surface modifications. However, there are others forms in which 
these materials are being used including fibers or microfluidic devices that will be 
discussed later in this chapter.  
1-7-1. Hydrogels 
Hydrogels are three-dimensional networks of hydrophilic polymer chins which are 
solvated in water. Typically the mass fraction of water in this network is much higher 
than that of the polymer. The polymer chains in this network are held together by some 
kind of crosslinking between them. The crosslinking can be based on physical bonds such 
as hydrogen bonds, electrostatic forces, hydrophobic interactions, and/or chain 
entanglements or covalent bonds. Many of proposed applications of hydrogels are in the 
field of biomedical engineering and for that reason a great deal of effort has been made to 
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make biocompatible and biodegradable hydrogels that can be used in physiological 
conditions. 
Hydrogels are also one of the most studied and most interesting classes of ELP-based 
materials. In fact they are the first set of materials that were made based on using elastin-
like polypeptide when Urry applied γ-irradiation to an ELP coacervate and showed that 
the resulting gel has the responsive behavior of the ELP solutions as well.
1.36
 In his 
experiments he used 20 Mrad radiation at temperatures above the transition temperature 
of the ELP to crosslink the coacervate and showed that the resulting gel has considerable 
elastomeric characteristics. Use of γ-irradiation was a starting point in making hydrogels 
from ELP solutions and although it has also been used in more recent studies
1.84, 1.85
, the 
random nature of this approach and practical problems of employing it, during the past 
three decades many other approaches have been introduced for ELP crosslinking.   
Chemical crosslinking at specific sites along the backbone structure of the ELP has 
been shown to be a very effective way of making ELP-based hydrogels especially for 
those constructs containing lysine residue.
1.86-92
  
Another possible approach in crosslinking ELP constructs has shown to be enzymatic 
crosslinking. In this approach, transglutaminase (tTG) which is shown to be a more 
biocompatible substitute for the harsh chemical crosslinkers is used together with ELP 
molecules which contain both glutamine and lysine residues in their primary 
sequence.
1.93-96
 In this approach tTG facilitates the formation of a covalent bond between 
lysine and glutamine residues of biopolymer chains. The concept of using tTG as an 
enzymatic crosslinker has also been shown to work for other networks consisting of 
collagen or poly ethylene glycol (PEG).
1.97, 1.98
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Although most of the hydrogels are formed based on covalent crosslinking of the 
chains
1.85, 1.89, 1.92, 1.99, 1.100
, sometimes the polypeptide chains are designed such that a part 
of the chain can act as the crosslinker itself. This physical crosslinking has the advantage 
of eliminating the potentially toxic crosslinking agents.
1.78
 These constructs are usually 
based on a tri-block copolymer in which the end-blocks have lower transition temperature 
than the mid-block and increasing the temperature above the transition temperature of the 
end-blocks results in self-assembly of these blocks while the mid-blocks are still 
soluble.
1.101-103
 Recent studies have shown that some of these self-assembling tri-block 
copolymers can be extremely biostable in vivo and consequently very useful in 
biomedical applications.
1.104
 In an approach by Ma et al. aromatic-aromatic interactions 
of conjugated moieties to elastin-like polypeptides was used for self-assembly of 
polypeptide chains.
1.105
 In this study they showed the effectiveness of aromatic 
interactions between aromatic groups of fluorenyl, pyrenyl and napthyl for physical 
crosslinking of different ELP molecules into gels with controllable characteristics.   
Recently Sallach et al. reported a new approach in which they developed an ELP tri-
block copolymer capable of both chemical and physical crosslinking.
1.106
 Their system 
included rigid domains followed by a covalent crosslinking site and the elastomeric 
domain.  
Making these hydrogels by any of these different crosslinking techniques is only the 
first step in having a practically useful material. The next step is to tune the 
characteristics of these gels for specific applications. The advantage of chemical 
crosslinking of ELP hydrogels is the ability to control the mechanical properties and 
transition temperatures of the gel by designing the crosslinking density from the gene 
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level. Girotti et al. synthesized a fairly long ELP containing VPGIG and VPGKG as the 
main ELP sequences and REDV peptide sequence as a cell recognition sequence and 
finally VGVAPG for enzymatic hydrolysis of the scaffold.
1.107
 They chose this 
biopolymer sequence to tune the desired mechanical and bioactive properties and they 
showed the potential of such highly tunable design of ELP-based hydrogels. In more 
recent work, this group used the same polypeptide sequence and developed a salt 
leaching/gas-foaming technique to make highly porous hydrogels for which the porosity 
was controlled by the amount of sodium hydrogen carbonate salt incorporated into the gel 
during the crosslinking.
1.108
 This approach enabled them to fabricate three dimensional 
hydrogels with controllable pore size and functional moieties that can be used as a tissue 
engineering scaffold. The fabrication and control of porous hydrogels has also been 
studied by Annabi et al. using high pressure CO2 and chemical crosslinking.
1.109
 Their 
results showed that the change of processing pressure from 30 bar to 150 bar can lead to a 
60% increase in gel porosity and the resulting gel has highly interconnected pores and a 
good permeability. 
Trabbik-Carlson et al. synthesized a number of ELP sequences using the generic 
sequence of VPGXG and chemically crosslinked lysine residues of the polypeptides 
using tris-succinimidyl aminotriacetate (TSAT). 1.92 They also showed that the swelling 
characteristics and the material mechanical properties depend on the molecular weight of 
the ELP, solution concentration and the number and spacing of the lysine residues in the 
ELP sequence which all can be controlled very precisely. The crosslinking was done in a 
non-aqueous environment to prevent any conformational change of the chains while 
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crosslinking. This approach has been used by other researchers as well and the effect of 
solvent on the gel structure has been characterized
1.87, 1.88
.   
Many of these crosslinked hydrogels cannot be used as injectable scaffolds and so Lim 
et al. developed a method for rapid and potentially in vivo crosslinking of ELP so that the 
ELP aqueous solution along with the viable cell can be directly injected into a defect site 
and immediately crosslinked in the presence of hydroxymethyl phosphines.
1.110
 Their 
approach has the advantage of producing water as the only byproduct which makes it 
ideal from biocompatibility point of view. Having the same concept of injectable liquid 
scaffold for in vivo gel formation in mind, Barbosa et al. developed a system based on 
incorporation of an osteoconductive-containing ELP sequence, in chitosan-based systems 
to improve bioactivity of the these systems in bone tissue engineering.
1.111
 In their system 
the gel was physically crosslinked by the interaction between chitosan and β-
glycerophosphate and also chemically crosslinked using genipin. The transition 
temperature was tuned to 35˚C. The system showed an apparent improvement of 
mechanical properties when studied in vitro in simulated body fluid and they showed that 
the gels have the ability of inducing calcium phosphate precipitation.  
This last example shows that not only can ELP molecules be designed so that resulting 
hydrogels have suitable mechanical and biological characteristics for a specific 
application, but they also can be a part of hybrid systems in which a non-ELP system is 
modified by using ELP molecules to improve their characteristics.
1.112-114
 One good 
example of this combination is the use of ELP molecules in conjugation with collagen. In 
a work by Garcia et al., ELP chains are enzymatically crosslinked with collagen to give 
better mechanical strength to the collagen tissue-engineered implants.
1.96
 The ELP in this 
32 
 
study had the same sequence as the one used by Girroti earlier
1.107
 and the crosslinking 
was done using transglutaminase. The introduction of ELP into collagen scaffold was 
shown to be effective in improving collagen mechanical characteristics. The modulus and 
degradation temperature of the gel was shown to be affected by the ELP content of the 
gel and they were successful in growing certain line of cells on this new platform. A 
more detailed study of the characteristics of hydrogels containing ELP and collagen-
derived peptides was done by Morihara et al. 1.115 In this work they chemically co-
polymerized collagen model peptide (PPG)10 and the pentapeptide (VPGVG) in different 
molar ratios using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride 
(EDC) and 1-hydroxybenzotriazole (HOBt) in an organic solvent at room temperature. 
Their results showed that high content of (VPGVG) in the hydrogel showed a sol-gel 
transition at temperatures above the transition temperature but at concentration between 
58 to 82% of (VPGVG) in the hydrogel, a reversible transition from clear to cloudy 
suspension was observed instead. They suggested that in this hydrogel, ELP molecules 
act as the crosslinking nodes and their aggregation leads to the formation of the gel 
especially at high ELP concentration.  
Although in most of the cases, the functionality of ELP-based hydrogels is 
incorporated into their gene sequence such that the final product has certain 
characteristics, there have been examples of modifying the ELP hydrogel after the gel 
formation.
1.116, 1.117
 This approach can sometimes be beneficial especially if a certain 
ligand cannot be produced in the bacterial systems or certain spacer needs to be added to 
the molecules after the bio-production of the polypeptides. Kaufmann et al. developed a 
system containing repeats of VPGXG in which X was chosen as V, K, E and I.
1.14
 They 
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then crosslinked the resulting coacervate above its transition temperature by 
bis(sulfosuccinimidyl)suberate in N,N-dimethylformamide (DMF). This hydrogel was 
modified by protecting lysine residues and then linear and cyclic RGD sequences were 
ligated to the gel. The conjugation efficiencies were shown to be between 25 to 65% and 
they also showed a clear difference in cell adhesion efficiency depending on the use of 
linear or cyclic RGD.    
1-7-2. Particles and Micellar Systems 
A very attractive area of research in ELP-based materials has been the use of them as 
building blocks for responsive micelles and nano- and micro-scale particles. The 
responsiveness and small size of these particles and their tunable properties together with 
their general biocompatibility and non-toxicity have been exploited especially in targeted 
drug delivery applications.  
The first crosslinked particles based on elastin-like polypeptides were developed by 
Urry by γ-irradiation of small droplets of (VPGVG)n.
1.118
 Although early Urry’s 
experiment showed the possibility of formation of responsive particles and drug loading 
and unloading by using ELP molecules, it was not until more recently that particles of 
more biologically appropriate and controlled size were developed. A recent study of 
nano-particles formed by γ-irradiation of (VPGVG)251 aggregates, showed the effect of 
heating rate of the ELP solution on the size distribution of the final particles.
1.119 
Based 
on this study, heat shocking the solution before irradiation can lead to the formation of 
particles as small as 150 nm in diameter. Osborn et al. showed the possibility of making 
use of coacervate droplets of ELP to make crosslinked particles with micron-size 
diameters.
1.120
 Ge et al. even showed the possibility of making these droplets in vivo in 
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E.coli and tobacco cells.
1.121
 Herrero-Vanrell et al. developed a system in which the sizes 
of the particles were controlled to be about 300 to 400 nm and the drug was encapsulated 
in them by a novel electrospray technique.
1.122
 The advantage of their system was their 
ability to control the size of these particles by changing the chemical identity and length 
of the polypeptides. But even these particles are too big for some drug delivery 
applications for which particles below between the sizes of 10 to 200 nm in diameter are 
expected to be the most effective ones because of long-term circulation.
1.123
 For smaller 
sizes, other researchers have developed systems of amphiphilic block copolymers to 
make micellar particles with smaller sizes.
1.124-127
  
Micelles are self-assembled aggregates of surfactant-like molecules with a hydrophilic 
head group and hydrophobic tails. Micelles are formed when the concentration of 
monomers exceed a certain limit, called critical micelle concentration at a constant 
temperature. The driving force behind the self-assembly is the hydrophobic effect. At low 
concentrations the hydrophobic tails are solvated by water molecules and as the monomer 
concentration increases, the entropy penalty of keeping these molecules soluble in the 
more ordered network of water molecules gets larger to the point that aggregation of the 
hydrophobic tails becomes energetically favorable. In other word, the monomer free 
energy comprises a hydrophobic term (g) from the hydrophobic tail and electro-static 
energy (g
’
) from the hydrophilic (charged) head group. As the difference between the two 
energies (g
’
-g) approaches zero the components in the system become immiscible and 
start to aggregate into micelles with different geometries.
1.128
   
The geometry of the micelles is affected mainly by the size of the head group and the 
length of the hydrophobic tail and the way in which the molecules pack into the micelle. 
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The packing of the monomers into the micelle is characterized by what is known as 
packing factor. Whatever the shape of the micelles, the hydrophobic core of the micelle 
should satisfy two criterion, first V/ν=A/a0=N in which V is the total volume of the 
micelle, ν is the volume of a single hydrophobic chain, A is the total surface area of the 
micelle, a0 is head group area, and N is the aggregation number and then, the farthest 
distance from the interior to the hydrocarbon-water interface cannot exceed the maximum 
length of the hydrocarbon chain (lc) .
1.128
 For these conditions to be true for a spherical 
micelles with radius of R, 
  
 
              (1-2) 
Considering the fact that the radius of this sphere cannot be larger than lc, the spherical 
micelles can only exist if  
 
    
 
 
 
        (1-3) 
With the same concept it can easily be shown that for packing factor of 1/2 the 
micelles take the geometry of a cylinder while bilayer structure is expected for packing 
factor of about 1. For values in between, a transition from one state to another is 
expected. For instance, for packing factor of about 0.38 and 0.44, globule shape and 
toroid shape micelles are expected respectively.
1.128, 1.129
  
Write et al. developed an ABA block copolymer consisting of hydrophobic and 
hydrophilic ELP molecules and successfully encapsulated small drug molecules in the 
particles ranging from 50 to 90 nm in diameter.
1.130
 In another study
1.131
 six different ELP 
block copolymers with different lengths and hydrophilic to hydrophobic ratios were 
studied and a two-step aggregation process was observed in which the block copolymers 
go into micelles when hydrophilic to hydrophobic ratios were between 1:2 to 2:1. The 
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micelle sizes were controlled by the ELP length and the hydrophobic content of the 
chains. In addition to temperature triggered micelle formation, it has been shown that 
block copolymers can be designed such that formation of nano-particles can be a result of 
both pH and temperature and in fact same construct can produce different size of particles 
depending on the environmental stimuli that is applied.
1.132, 1.133  
In addition to using hydrophilic and hydrophobic ELP blocks to make micellar 
particles, other researchers used a hydrophilic head group fused to the hydrophobic ELP 
chain to induce the self-assembly of micelles. In a recent study particles with less that 
100 nm diameter were obtained by adding different lengths of polyaspartic acid to the C-
terminus of an ELP chain
1.134
 and the size of the particles were controlled by changing 
the length of the polyaspartic acid. More recently, Ghoorchian et al. successfully made 
size-controlled micellar particles as small as 20 nm in diameter using the fusion of a 
negatively charged trimer forming oligomerization domain called foldon to the C-
terminal of (GVGVP)40 (Figure 1-5 ).
1.135
 The size of the particles is controlled just by 
adjusting the salt concentration of the solution.   
 
Figure 1-5. Micelle formation of three-armed star elastin-like polypeptide molecules. Below the 
transition temperature the molecules are as random coil in the solution. Above the transition temperature at 
low salt concentration the charged head groups decorate the exterior of micelles consisting of aggregated 
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ELP molecules. Reprinted with permission from reference
1.135
. Copyright 2010 American Chemical 
Society. 
 
In a different approach and instead of using fused blocks of ELP molecules, Kolbe et 
al. used separate chains of positively and negatively charged ELPs and deposited them on 
CaCO3 micro particles by employing a layer-by-layer technique.
1.136
 The core was then 
dissolved and a hollow capsule with layered shell was obtained. 
The concept of using inorganic nano-particles as the basis for ELP assembly was also 
studied by Huang et al. by developing optically responsive assemblies of gold nanorods 
and ELP molecules.
1.32
 In this approach, optically responsive gold nanorods generate heat 
when exposed to near IR light. This heat then induces the aggregation of ELP molecules 
which are covalently bonded to the surface of these nanorods, which results in a 
detectable optical response. 
1-7-3. Surface modifications 
Biological surface modification has been an interesting multi-disciplinary area of 
research for many years and involves the study and modification of surfaces which act as 
interface between biological environments and synthetic materials. There are many 
applications of these modified surfaces including medical implants, biosensing, tissue 
engineering, and biomimetic materials.
1.78, 1.137
 The surface modifications can be either 
static, in which the biological receptors are fixed permanently on the surface or in more 
recent approaches, dynamic, in which the surface modifiers can be switched between two 
different modes. 
Elastin-like polypeptides have been shown to be interesting candidates to be used as 
surface modifiers considering their controllable responsive nature and the possibility of 
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attaching different functional domains and recognition sequences to them. Other stimuli-
responsive polymers like poly(N-isopropylacrylamide) have also been used in surface 
modification and they are proven to be useful in certain applications
1.138, 1.139
, but the 
advantages of ELP-based materials make them more attractive for biological applications 
in which more flexibility in design and application is needed. The change of 
hydrophobicity in ELP molecules can be used as a way to change the characteristics of 
the surface while the possibility of adding almost any peptide sequence to them or even 
chemical conjugation of non-peptide molecules to these constructs can be a way of 
functionalizing the surfaces. Early work using ELP molecules for biological surface 
modification was done by the Chilkoti group.
1.140
 In their work polypentapeptides based 
on VPGXG sequence were covalently attached to a glass surface and the possibility of 
enhancing or preventing the attachment of proteins to the surface was observed. They 
later used ELP-thioredoxin fusion protein and selectively immobilized it on a 
hydrophobically treated surface just by increasing the temperature.
1.141
    
The fact that a surface can be patterned using ELP-tagged proteins and can then be 
activated to interact with other proteins or cells near the surface has practical 
applications.
1.142
 Chilkoti group showed that it is possible to use ELP inverse transition 
behavior to immobilize ELP-fused proteins directly from cell lysate without any 
processing of the lysate.
1.143
 The surface patterning is not limited only to 2D surfaces but 
even 3D microstructures have been shown to have the potential of being patterned using 
ELP molecules.
1.144
 Martin et al. showed that changing the temperature changes the 
dimensions of the micropatterned scaffold but the topography stays the same. This of 
course can be useful in cell culturing.  
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Although the characteristics of ELP molecules make them very interesting base 
material for developing biologically active surfaces, this aspect of ELP-based materials 
has not been explored as much as hydrogels or nano-particles but even from the existing 
experimental results it is evident that ELPs can provide a platform that can be easily 
tuned to capture very different target molecules.
1.145
 This especially can be useful in 
developing ELP-based sensors or capturing systems.
1.146
 As an example Valiaev et al. 
developed a sensing system by modifying the cantilever tip of an AFM that can detect 
biomolecules based on the changes that they induce on the local environment,1.147 which 
shows the flexibility and possibilities of developing novel systems for biomolecule 
detection.  
1-8. Applications 
1-8-1. Drug Delivery 
The idea of delivering drug to specific organs without exposing healthy tissues to the 
adverse effects of it is not new and goes back to more than a century ago when in 1906 
Paul Ehrlich suggested the use of a drug carrier to “the organ in question”.1.148 The drug 
carrier can attach or encapsulate the drug and guide it towards the point of interest. 
Attaching the drug to a high molecular weight carrier is especially useful to prolong the 
circulation time of the drug in the body before drug clearance and mostly relies on the 
enhanced permeability and retention effect (EPR).
1.149-153
 EPR effect is the result of rapid 
growth of tumor vasculature which makes the tumors much more porous than healthy 
tissues and enables macromolecules to penetrate them.
1.154
 In addition to the EPR effect, 
attaching macromolecules to small drugs can increase the circulation time just based on 
the higher apparent molecular weight.
1.155
 An example of this approach is the conjugation 
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of polyethylene glycol (PEG) to adenosine deaminase (ADA) which leads to longer 
biological half-life of the compound.
1.156, 1.157
 Although this is one of the easier 
approaches in targeting cancerous tissues it is not always the best one especially 
considering the fact that the drug is still circulating all through the body and there is 
always some penetration to the healthy tissues along with the possibility of the clearance 
of the drug from the body. Even when the drug reaches the cancerous tissues the 
heterogeneity of the tumors makes the effective and complete delivery of the drug much 
more complex since the cancer cells only occupy up to one tenth of the total tumor 
volume.
1.158
 As a result, other approaches to facilitate the delivery of the carrier to the 
target, like ligand-mediated targeting
1.159, 1.160
, temperature mediated targeting
1.161, 1.162
, 
and pH-mediated targeting
1.163
 have been widely investigated.  
One way to overcome some of the difficulties related to delivering polymer-drug 
conjugates to the tumor site is the encapsulation of the drug in a carrier and then release 
of it at the specific destination.
1.164
 For any carrier to be used for drug delivery, it should 
be stable in the physiological conditions and be able to keep the drug encapsulated or 
attached to it for as long as needed for the delivery. There should also be a way of 
releasing the drug at the site and most importantly it should be biocompatible and 
selective towards the target cells
1.165
 and be able to overcome different transport 
barriers.
1.166, 1.167
 Of course different applications need different release rates and 
mechanisms. In general the drug can be released from the particle either by slow, 
constant diffusion, by bolus initiated by external stimuli, or a combination of them.
1.164, 
1.168, 1.169 A good example of using polymeric particles for slow release of drug is the 
well-known Norplant which consists of small silicone capsules that release contraceptive 
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drug during a five-year period. Liposomes and micelles have shown to have good 
potentials for drug loading and targeted delivery using external stimuli.
1.168, 1.170
 The 
stimulation by which the drug is released might also be different from one case to 
another. Early studies used magnetic beads in the particles to control the release of the 
drug by applying a magnetic field.
1.171
 Ultrasound and electric current have also been 
used as external stimuli for controlled release of the drugs.
1.172-175
 However, many of the 
recent works are leaning towards designing responsive particles which can be stimulated 
by more physiologically controllable stimuli such as temperature and pH.
1.176-179
 Even 
when the carrier is delivered to the specific site, the problem of it diffusing into the cell to 
deliver the drug can reduce the efficiency of the system. For that matter, in some studies a 
cell penetrating domain is added to the carrier to enhance the targeting and overcome the 
poor pharmacokinetic parameters related to most of the particle-based delivery 
systems.
1.180, 1.181  
A different approach to deliver drugs, instead of systemic delivery, is to use a drug 
depot and locally administrate the drug in form of a gel to the specific site without 
exposing the other organs to the drug.
1.182, 1.183
 The biggest limitations of this approach 
are that the exact site of the tumor should be known and the implantation might be very 
invasive.
1.82
 
The tunable responsive behavior of elastin-like polypeptides, their general 
biocompatibility and biodegradability and the possibility of designing them to respond to 
many different environmental stimuli have attracted great attention to develop drug 
delivery systems from early studies by Urry
1.184
 to much more recent advancements in 
this field.
1.117, 1.122, 1.127, 1.161, 1.185-189
 The fact that hydrophobicity along with the size and 
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molecular weight of the carriers have shown to be effective in the success of drug 
delivery system and these parameters are well under control in ELP-based materials, is 
also a good reason to use them in targeted drug delivery.
1.123, 1.190, 1.191
 
Just like any other macromolecule with high molecular weight, an ELP with transition 
temperature above the body temperature which is conjugated to a hydrophobic drug can 
be used to deliver the drug solely based on EPR effect
1.192
 and the molecular weight of 
ELP has shown to have direct effect on the drug accumulation in the tumor.
1.191
 In this 
approach the ELP can be designed to be very hydrophilic and thus stay soluble while the 
hydrophobic drug molecules might come together and make an even higher molecular 
weight soluble micelle-like drug carrier. This simple attachment of ELP molecules to 
certain therapeutics or antibodies has been shown to be useful in attacking some 
inflammatory diseases.
1.193, 1.194
 Although this ELP-drug conjugation can enhance the 
drug delivery yield and has all the characteristics of polymeric delivery systems, it does 
not utilize most of the ELP advantages including its tunable transition from soluble 
molecules to insoluble aggregates. Noticeably it has been shown that the conjugation 
might affect where the drug will end up to be in the cell and while the free drug mostly 
accumulate in the nucleus the conjugated drug might disperse in cytoplasm of the 
cell.
1.195
 In a controlled study using 
14
C-labeled ELP conjugated to doxorubicin, Liu et al. 
showed that the use of an ELP with a very high transition temperature can slightly 
increase the uptake of the drug in the cells, but it is still much less effective than using an 
ELP construct which also has the capability of responding to local hyperthermia.
1.196
 For 
that reason many researchers have tried to exploit the temperature responsiveness of the 
ELPs in designing drug delivery vehicles.
1.186, 1.197-199
 In fact when the ELP is designed 
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such that its transition temperature is just slightly above the body temperature, mild 
hyperthermia can be applied to the site of the tumor and that causes the aggregation of 
ELP-drug conjugate molecules at the site. This accumulation of high molecular weight 
particles facilitates the penetration of the drug to the cancerous cells. 
In addition to increasing the drug uptake, the delivery systems based on mild thermal 
treatment of ELP-drug conjugates have been shown to be effective in inhibition of 
proliferation of cancer cells
1.187
 and was helpful in overcoming the drug resistance to 
some extent.
1.185
 This might be a result of different cytotoxicity mechanism of the 
conjugated drugs. Another advantage of using mild hyperthermia for ELP-conjugated 
drugs has been shown in the systems in which targeting ligands (RGD, NGR) are used to 
increase the uptake of the drug in the cells. In these cases the existence of binding ligand 
can sometimes increase both specific and non-specific binding but use of external 
stimulus to trigger tumor-specific multivalency has shown to be effective in reducing the 
non-specific binding.
1.131, 1.200, 1.201
 
Another approach for delivering drugs to the site of interest using ELP-based materials 
is by designing systems based on hydrophobic-hydrophilic ELP block copolymers that 
assembles into micellar particles and encapsulate the drugs and releases it at the target 
site in response to external stimuli.
1.131, 1.202
 These micelles usually have a very narrow 
size distribution and thus a better control over their retention in the blood stream can be 
achieved.
1.78
 The micelles can also be designed such that they respond to different 
environmental stimuli. It has been shown that the drug can be released either by the 
dissociation of drug carriers at the target cells or by the aggregation of monomers or 
micelles at higher temperatures at the site of interest.
1.203, 1.204
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The possibility of loading drugs in the ELP-based micelles has been verified in a 
number of studies.
1.122, 1.130, 1.205, 1.206
 Kim et al. studied a series of different block 
copolymers that have the capability of self-assembling into micelles and can also be 
crosslinked to responsive nano-particles.
1.207
 It has been shown that ELP-based nano-
particles can be used in gene delivery applications.
1.208, 1.209
 
Although the use of an environmentally responsive system improves the drug delivery 
yield especially when it is accompanied with targeting ligands, similar to any other 
systemic drug delivery systems, the penetration of the drug into the cell which is the last 
transportation barrier can still be challenging.
1.210, 1.211
 This is where cell penetrating 
peptides (CPP) can be added to the ELP-based systems.
1.181
 In general, CPPs are short 
peptides that can effectively penetrate into the cell membranes and enter the 
cytoplasm.
1.212
 They are either amphipathic helical peptides with high lysine content or 
argentine-rich peptides, such as Antp or TAT.
1.213
 Meanwhile, it has been shown that 
attaching these peptides to macromolecules or nano-particles facilitates their transport 
through the cell membranes as well.
1.214
 In a study by Bidwell et al. a therapeutic peptide 
was attached to a 59.1 kDa ELP carrier and then four different CPPs were added to the N 
terminal of the ELP to study the possible improvement of the cellular uptake of the 
drug.
1.180
Their results showed that the existence of the CPP clearly increases the drug 
accumulation in the cells and there is also a difference between different CPPs in their 
ability to penetrate into the cells.  
A third approach in using ELP-based materials for drug delivery is by intratumoral 
injection of ELP solutions that are designed to form a gel in situ at the body temperature. 
This approach can be used for both delivering drug to cancerous tumors which are 
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accessible to the surgeon and their position is well known and also for delivering 
antibiotics to the sites which are susceptible to infection especially in orthopedic 
applications.
1.215
 In this approach the transition temperature of the ELP-drug conjugate is 
usually lower than the body temperature. Early work on localized drug delivery were 
done using charged ELP constructs coupled with ionic drugs.
1.216
 Later hybrid materials 
consisting of both elastin-like polypeptides and silk-like polypeptides were used to make 
use of the physical properties of the silk along with solubility and tunable properties of 
ELPs.
1.79, 1.217
 It has also been shown that triblock ELP copolymers with the ability to 
make physical crosslinking can go through gelation and might be used as injectable 
gels.
1.217  
Liu et al. developed a system in which two different ELP constructs with molecular 
weight of about 50kDa but different transition temperatures were labeled with a 
fluorescent die and then injected to a tumor.
1.218
 One ELP construct was designed to 
undergo a sol-gel transition at the body temperature and the other one was designed to 
stay soluble before and after the injection. Their results show a clear difference between 
the diffusion of the drug in these two cases such that the drug had a much longer 
retention time when entrapped in the gel. 
The increase in retention time was quantified earlier in another work and was shown 
to be 25-fold longer than a soluble protein with the same molecular weight.
1.219
 In 
addition to longer retention time and half-life of the drug in the tumor, this method was 
more effective in slowing the growth of the tumor in mice.
1.197, 1.218
   
 
 
46 
 
1-8-2. Tissue engineering 
Elastin-derived materials have long been sought for their potential to be used in tissue 
engineering applications primarily because of their elastic characteristics and general 
biocompatibility. Elastin in tissue engineering can originate from naturally occurring 
matrices like the elastin in autografts, allografts, xenografts, and decellularized 
extracellular matrices or from synthetic sources like elastin-like polypeptides, silk elastin-
like polypeptides and their hybrid molecules
1.220
 and they have been used in a range of 
applications like skin substitutes and wound healing
1.221, 1.222
, vascular grafts
1.223-225
, 
bladder reconstruction
1.226
, intervertebral restoration
1.227
, liver tissue repair
1.228, 1.229
 and 
artificial extra cellular matrices.
1.230
 Recent advances in gene manipulation and protein 
engineering provided strong tools for engineering elastin-like polypeptides with higher 
control over their functionality and mechanical characteristics for tissue engineering.
1.188, 
1.231
 
Early works by Urry group showed the possibility of adding cell recognition sequence 
(RGD) to elastin-like polypeptide and the functionality of these sequences in vitro.
1.232, 
1.233
 The resulting polypeptide was shown to be non-toxic to bovine aortic endothelial 
cells. Later, Betre et al. showed the possibility of using un-crosslinked ELPs as injectable 
tissue engineering scaffolds and the ability of ELP to promote chondrogenesis in 
vitro.
1.223
 Below 35˚C the soluble ELPs allow the incorporation of cells within the 
solution but upon injection, a gel-like matrix forms that would serve as the scaffold for 
the growth of the cells. They later showed that the ELP aggregates can promote the 
cartilage tissue growth and accumulation.
1.223, 1.234
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Although the use of un-crosslinked ELP has shown to be feasible for tissue 
engineering, in many cases it is necessary to use a prefabricated scaffold that can provide 
a suitable growth environment for the cells or to prevent the platelet coagulation.
1.235
 For 
that reason crosslinked materials in the form of gels
1.236
, films
1.89
, and fibers
1.237
 have 
been produced using different crosslinking methods. 
Vascular grafts and blood vessels have been synthesized for decades and are one of 
the commonly used biomaterials,1.224, 1.238, 1.239 but most of the current commercially 
available synthetic biomaterials including polyethylene teraphthalate and expanded 
polytetrafluoroethylene show thrombogenicity as a result of protein adsorption and 
platelet activation
1.240
 and immunogenic response leading to chronic inflammation
1.241
 in 
addition to the general lack of elasticity for arterial applications.
1.242
 In this case, ELPs 
are good candidates to be used in making small diameter vascular grafts considering their 
tunable characteristics
1.100, 1.243-246
 and their relative biocompatibility.
1.184
 To exploit some 
of these characteristics and to overcome the shortcomings of other synthetic materials the 
Tirrell group developed a system based on ELP molecules containing RGD and CS5 to 
be used as artificial extra cellular matrix and studied endothelial cell adhesion for 
vascular graft applications.
1.91, 1.247
 Their results showed that RGD is a better choice to 
enhance the cell adhesion and in later work, they showed that the density of RGD also 
affects the cell adhesion and higher density of this peptide sequence results in more 
robust cell adhesion and spreading.
1.230
 Joen et al. showed the possibility of stimulating 
fibroblasts and neuroblasts on RGD-containing ELP matrix.
1.248
 Caves et al developed a 
system of artificial extra cellular matrix composed of ELP protein matrix reinforced with 
synthetic collagen fibers.
1.249
 In their experiments ELP sequence was chosen to be a block 
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copolymer consisting of two hydrophobic ends and a hydrophilic mid-block and 
additional crosslinking domains. The collagen microfibers were produced using wet 
spinning technique and then embedded within a thin film of crosslinked ELP.
1.250
 The 
reinforced thin film was then rolled into small diameter vascular grafts. The combination 
of collagen and ELP was shown to be effective and they were successful in controlling 
the collagen fiber orientations while the structural resilience of ELP made the material 
stronger.  
More recently, the same group showed that the collagen reinforced ELP matrix which 
has a tailored mechanical behavior can also be used in soft tissue repair in vivo.
1.251
 To 
combine the strength and elasticity in a single material, Wise et al. used a different 
method to synthesize vascular grafts with tailored mechanical properties.
1.252
 They 
synthesized an elastin/polycaprolactone hybrid material by electrospinning the 
recombinant human tropoelastin in combination with polycapolactate and showed that the 
resulting material has enhanced endothelial cell interactions along with low 
thrombogenicity while keeping up with the mechanical properties of internal mammary 
artery. In some applications, instead of using ELP to synthesize the material for arterial 
vessels, elastin-like polypeptides have been used to produce a biocompatible, 
thromboresistant coating that can be used on top of conventional materials to make small 
diameter grafts.
1.225, 1.235, 1.253
 A study by Srokowski et al. showed the effectiveness of 
using three different ELP sequences in coating small tubular surfaces and their positive 
effect on reducing fibrinogen adsorption and platelet adhesion in contact with flowing 
blood.
1.142
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The other important area in which elastin-like polypeptides have been explored in 
tissue engineering applications is cartilage or soft tissue repair.
1.223 Early studies used un-
crosslinked ELP solutions with transition temperatures just below the body temperature 
for injection to the defect site
1.254
 The aggregated ELP has shear modulus about three 
orders of magnitude higher than that of the soluble ones,
1.223 but this shear modulus is 
still at least four orders of magnitude lower than the natural cartilage.
1.255
 and for that 
reason in most of the tissue repair applications, some kind of crosslinking has been 
implemented and hydrogels have been widely used in tissue engineering applications.
1.256
 
One logical approach to the crosslinking of ELP in cartilage tissue repair would be to 
modify the ELP such that it goes through crosslinking in the body without adding any 
extra component. This was done by enzymatic crosslinking of ELP solution containing 
lysine and glutamine by making use of the tissue transglutaminase.
1.257
 McHale et al. 
showed that this hydrogel has at least two orders of magnitude larger force moduli in 
comparison to non crosslinked gel.
1.95
 An improved system with much faster reaction 
time was later developed by Lim et al.
1.110
 and in vivo experiments showed the possibility 
of using this technique to repair cartilage tissue in big animals.
1.258
 The same group also 
used physical crosslinking of block copolymers as another approach for developing 
cartilage repairing systems.
1.259
 In fact physical crosslinking or self-assembling of 
modularly designed biomaterials for tissue engineering is an effective way of developing 
materials for tissue engineering platforms.
1.260
 The modular design of ELP construct has 
also been used by Heilshorn group to develop 3D artificial extra cellular matrices that has 
the potential to be used in regenerative theraputics. 1.261-263 In all of these cases, the choice 
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of the crosslinking method has shown to be effective on the cell viability and growth and 
for that reason the crosslinking should be tailored to the specific application.
1.264
 
Other than synthetic ELPs, naturally occurring elastin-like polypeptides obtained from 
human tropoelastin gene has also been used in regenerative applications.
1.265
 Some 
studies have shown the biocompatibility of ELP matrix based on exons 20-21-24 in 
reconstruction of rabbit osteochondral defects.
1.183
 
In addition to cartilage tissue regeneration, ELPs have been used to treat chronic 
wounds. These are the wounds that do not go through the healing process in the normal 
healing time of up to 12 weeks
1.266
 and are mainly associated with poor dermal or 
epidermal remodeling. These include wounds from autoimmune disease, arterial and 
diabetic foot ulcers, and dicubitus wounds.
1.267
 In many of these cases, natural elastin, 
which has been shown to be effective in dermal wound healing,
1.220
 or a combination of 
elastin and collagen is used for dressing the chronic wounds.
1.267-269
 These can be in the 
forms of collagen scaffolds coated with elastin
1.270
, collagen/elastin membranes
1.271
 and 
also some commercially available collagen/elastin dressings like Matriderm.
1.272
 Koria et 
al. developed a system based on ELP fused to the keratinocyte growth factor (KGF).
1.222
 
KGF has also been shown to be effective in reepithelialization and wound healing.
1.273
 
The fusion protein was shown to go in to submicron-size particles above the transition 
temperature of ELP and enhance the healing of wounds in diabetic mice by improving 
dermal and epidermal regeneration. Interestingly the use of ELP resulted in significant 
granule formation in vivo.  
Apart from soft tissue engineering, ELPs have been used in bone reconstruction and 
mechanical characteristic enhancement of biomineralized composites.
1.274
 Wang et al. 
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developed an ELP system including well-defined charged distribution and used it to 
construct ELP-hydroxyapatite (HAP) composites. The HAP-ELPs were then incorporated 
into calcium phosphate cements (CPC) which resulted in a mechanically robust 
material.
1.10
   
1-8-3. Purification 
The need for recombinant proteins for medical and industrial applications and the 
difficulties involved in most of the purification processes like cellulose binding 
domains
1.275
, thioredoxin
1.276
, and affinity-based chromatography, including high cost, the 
need for specialized equipment, and hurdles towards scale-up of the bench-top 
procedures
1.277
 have made a good case for scientists to look into other means of 
purifications that can be customized to the system of interest. Elastin-like polypeptides 
have proven to maintain their thermal transition characteristics even after fusing to other 
protein domains including their environmental responsiveness
1.278
 and was first used by 
Meyer and Chilkoti as a fusion tag for protein purification.
1.279
 In their work, different 
lengths of ELP genes were fused to the C-terminus of E. coli thioredoxin and they 
purified the protein by both metal affinity chromatography and inverse transition cycling. 
In the case of ELP-fused protein, the ELP was then cleaved by using thrombin. Their 
results proved the possibility of purifying thioredoxin with very high yield by exploiting 
the inverse transition cycling of the tagged ELP. More recently they showed that lower 
molecular weight anionic ELP tags as small as 4.3 kDa, dramatically increase the 
recovery of the protein.
1.277
 It has also been shown that in principle this purification 
technique is a general procedure and can be modified to fit many systems including green 
fluorescent protein, blue fluorescent protein, and chloroamphenicol acetyltransferase,
1.280
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or even to purify plasmid DNA
1.281
 or antibodies
1.282, 1.283
. The process can be used to 
recover very dilute protein samples as well,
1.284, 1.285
 although the fusion order can make a 
considerable difference in the expression and activity of the target protein such that short 
ELP tags fused to the C-terminus of the desired protein lead to the highest level of 
expression, purification, and activity of the protein.
1.286
 
One important step in using ELP tags to purify a target protein is the final cleavage of 
the ELP from the protein. This is usually done by designing a cleavage site between the 
two polypeptides and applying protease digestion after the purification by inverse 
temperature cycling. Protein splicing elements have long been studied in systems dealing 
with fusion proteins and have been used along with chromatographic columns to purify 
recombinant proteins. Maybe the most well-known example among them are inteins.
1.287, 
1.288
 In addition to inteins, many other self-cleaving tags including Sortase A (SrtA)
1.289
, 
N-Terminal protease
1.290
, FrpC module
1.291
, and cysteine protease domain (CPD)
1.292
 have 
been used in developing protein purification systems, but inteins still remain the main 
self-cleaving tags. A recent review of self-cleaving fusion tags is published by Li.
1.293
 
In the case of ELPs, inteins have also been engineered to construct self-cleaving 
purification systems.
1.294-296
 In a study by Banki et al. the intein-mediated self-cleavage of 
ELP from the target protein was achieved by lowering the pH to 6 during the cold 
centrifugations.
1.297
 Self-cleavage has also been shown to be possible by small 
temperature shifts during the purification
1.279, 1.294
 or even addition of reducing agents like 
DTT.
1.295
 Although these self-cleaving ELP-tagged systems are not yet commercialized, 
they have shown great potential towards industrial use especially that they can be used 
without the need for additional steps such as chromatography
1.298
 and it has been shown 
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that the whole process of purification and cleavage can be done at temperatures as low as 
the room temperature by salt substitution which makes it even more economically 
attractive for industrial processes.
1.299
  
One issue with many of these self-cleaving systems is the need for purification of the 
protease after being used to make it reusable again and make the process cost-effective. 
This process should be done usually by conventional affinity column processes which 
make it less attractive for commercial-scale production. Very recently, Lan et al. 
developed a system in which an ELP-tagged protease was used along with a cleavable 
ELP-tagged target protein (Figure 1-6).
1.300
 This procedure allows for a single-step 
purification of the protein and removal of the tag while the protease can be reused 
immediately for another purification. 
 
Figure 1-6. Use of ELP tags for protein purification. ELP molecules were tagged to the target protein and 
mixed with another ELP tagged protease. The enzyme cut the target protein and then pellet out of the 
solution together with the ELP molecules detached from the target protein. Reprinted with permission from 
from Reference 
1.300
. Copyright 2011 Elsevier.     
 
In some cases, the addition of ELP to the target protein not only creates an improved 
pathway to purify the protein, it can also help increasing the expression of the protein as 
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well. Hu et al. showed the effect of ELP fusion on the expression yield of antimicrobial 
peptides and used the same tag for purification of the peptides.
1.301
 The effectiveness of 
ELP tags in expression of proteins has also been shown in plant-derived proteins.
1.193, 
1.302, 1.303
 Plants are especially interesting in scaling up the processes to industry with low 
cost and high versatility.
1.304
 Floss et al. showed the possibility of using transgenic plants 
as bioreactors for ELP fusion proteins.
1.305
 They also used transgenic tobacco plants and 
expressed and purified (HIV)-neutralizing antibodies with and without tagged ELP in the 
plant seeds.
1.306
 Their results showed the enhancement of accumulation of protein in the 
presence of ELP while making the purification much easier.  
The ELP fused proteins have also been shown to have the capability of being used as 
heavy metal removal and purification. In a study done by Lao et al. Cadmium 
contaminants were successfully removed and washed from the soil with a very high yield 
using a phytochelation molecule genetically fused to an ELP.
1.307
 In a different study, 
MerR which is a bacterial metalloregulatory protein and binds to mercury, was fused to 
(VPGVG)n of various lengths and was shown to be extremely effective in reducing the 
mercury level of water to as low as drinking water. 1.308 
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Chapter II 
Molecular Architecture Influences the Thermally Induced Aggregation 
Behavior of Elastin-Like Polypeptides   
(Modified from publication with N.B. Holland, Biomacromolecules 2011, 12, 4022-4029)   
2-1. Abstract 
Elastin-like polypeptides are thermally responsive polymers that exhibit phase 
separation above a transition temperature.  The effect of molecular architecture on the 
temperature responsive behavior of elastin-like polypeptide solutions was investigated by 
characterization of solutions of two families of three-armed star polypeptides and linear 
polypeptides.  These biosynthesized polypeptides have precise lengths and amino acid 
sequences. Transition temperatures were measured as a function of molecular weight and 
solution concentration and compared to their linear counterparts.  Like their linear 
counterparts, the transition temperature is linearly related to log concentration.  A 
mathematical relationship was used to fit the transition temperature data of different 
polypeptide lengths to a volume-based concentration using the polymer coil volume.  The 
results of this model suggest that the linear ELP is in a random coil conformation at the 
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transition temperature while the three-armed ELP is in a compact extended coil 
conformation, consistent with different pathways for aggregation.  
 
2-2. Introduction 
Elastin-like polypeptides are environmentally responsive biopolymers which are based 
on peptide sequences originally found in nature
2.1
  consisting of repeats of the 
pentapeptide (GβGαP) in which α can be any of the 20 naturally occurring amino acids 
while β can be any of those amino acids except for proline.2.2  An important characteristic 
of these polypeptides is their LCST (lower critical solution temperature) behavior, 
resulting in phase separation of the soluble polypeptides into a protein rich coacervate 
and a protein lean phase above what has been referred to as an inverse transition 
temperature.
2.3
  This phase separation is reversible and the transition temperature can be 
modified by changing the chemical identity and length of ELP molecules as well as their 
concentration in solution.
2.2, 2.4
  Phase separation can also be triggered by other stimuli, 
including pH, ionic strength, and light.
2.3, 2.5-7
 The reversible phase separation has been 
the subject of many studies in the past three decades and numerous applications have 
been proposed for these materials based on these characteristics, such as drug delivery
2.8
 , 
tissue engineering
2.9, 2.10
, surface engineering
2.11
 , and microfluidic devices.
2.12 
 
One interesting aspect of these materials is the dependency of their transition 
temperature on the sequence, length, and concentration in the solution.
2.4, 2.13
 These 
characteristics have been exploited to modify the transition temperature of ELP solutions 
to make them suitable for different potential applications. Although length and 
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concentration dependency of the transition temperature in linear ELPs have been 
thoroughly described, the role of molecular architecture has not yet been investigated. 
To study the effect of molecular architecture on ELP behavior, in conjuction with 
length and concentration, we present here the characterization of polypeptides designed 
by adding a trimer forming oligomerization domain to the C-terminal of the linear ELP 
molecules.  
The trimer construct was chosen in an attempt to induce polypeptide association based 
on the most widely accepted theory of ELP folding and aggregation. According to this 
theory
2.3, 2.14
, heating up the ELP sample causes the unordered polypeptide chains to go 
through a gradual transition to more ordered, and more hydrophobic folded structure 
mainly consisting of β turns.  At the transition temperature these “ordered” hydrophobic 
constructs are stabilized by other chains, presumably as twisted filaments of three chains, 
which then aggregate and phase separate. The association of three chains as a twisted 
filament has been supported by a recent study in which combining ELP with a trimer 
forming α-helical coiled coil motif resulted in the ends of the ELP chains coming into 
close proximity above the transition temperature.
2.15
 It has also been shown that ELP 
molecules fused to a self-assembling domain go through similar conformational transition 
as they approach their transition temperature.
2.16
 Based on this mechanism, the 
aggregation of the ELP exhibits significant concentration dependence since it proceeds 
only after associating as a twisted filament.
2.14
 Consequently, alterations in the geometry 
of the ELP that encourage the formation of twisted filaments could potentially affect the 
overall folding and aggregation of the chains. It should be noted that even in the absence 
of specific stoichiometric interactions, a high local concentration caused by close 
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proximity of the chains might help the chain-chain interactions and consequently the 
aggregation of the molecules.   
As described previously,
2.17
 the trimer forming foldon domain, which is a part of the 
bacteriophage T4 fibritin protein, can be added as a fusion protein to either termini of 
ELP chains to form a three-armed ELP. Here we report on the characterization of 
different lengths of such three-armed star-like elastin-like polypeptides and the 
dependency of their aggregation temperatures on length and concentration, as compared 
to linear counterparts and we also study the effect of ELP/foldon fusion order in the 
molecular behavior of these constructs. The study of these different architectures 
provides new data used to improve the model for predicting the transition characteristics 
of ELP solutions. 
2-3 Materials and Methods: 
2-3-1.Gene Design and Preparation 
The design and synthesis of elastin like-polypeptides with and without the foldon 
trimerization domain were done using the recursive directional ligation technique as 
explained in detail elsewhere.
2.4, 2.17
 The final sequences of the linear ELP, ELP-foldon 
and foldon-ELP genes are MGH(GVGVP)nGWP, MGH(GVGVP)nGWP-
GYIPEAPRDGQAYVRKDGEWVLLSTFL and 
MGHGVGYIPEAPRDGQAYVRKDGEWVLLSTFLGP-(GVGVP)nGWP respectively 
in which n is the number of the pentapeptide repeats and was chosen to be 20, 40, or 60. 
For longer linear ELP constructs, a cysteine residue was introduced at the C terminal end 
of the ELP sequence resulting in a sequence of MGH(GVGVP)nGWPC where n was 20, 
40, or 60. Disulfide bond formation between two chains makes a linear ELP chain with 
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twice the length of the expressed polypeptide. The transition temperature of ELP-cys 
dimers (in non-reducing conditions) is in agreement with that of a linear ELP of twice the 
length and so can be used interchangeably (Figure 2-1). The polypeptides are referred to 
as (GVGVP)n, (GVGVP)n-foldon and foldon-(GVGVP)n where n is the total number of 
pentapeptide repeats.  The genes were prepared in pET20b vectors and transformed into 
BL21(DE3) expression strain of E. coli. 
 
Figure 2-1. UV absorbance curves of (GVGVP)80 and (GVGVP)40Cys in non reducing conditions both at 
25 µM 
 
2-3-2. Protein Expression and Purification.  
Expression of polypeptides were started using 20 ml of overnight starter culture from 
frozen stock which was then added to 1 L of LB medium in a 2 L Erlenmeyer flask 
supplemented with 0.1 mg/ml of ampicilin and shaken at 37ºC to OD600 above 0.9. Then 
the culture was induced by adding 0.1 mM IPTG. The cells were harvested at least 5 
hours after the induction by centrifugation for 20 min at 3000g. The cells were then 
frozen overnight and later lysed by sonication in phosphate buffer saline, pH 7.4 (PBS) 
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supplemented with 2 mM EDTA. The lysed cells were then centrifuged at 4ºC for 20 min 
at 20,000g to separate the soluble cell compounds, including ELP, from the insoluble 
cell lysate. The soluble fraction was then heated up to at least 40ºC for the ELP to 
precipitate out of solution. Centrifugation at about 40ºC and 15000g was then used to 
separate the soluble impurities from the insoluble ELP. The final pellet was then 
resuspended in PBS and the cold and hot cycles were repeated at least two more times to 
purify the ELP or ELP-foldon proteins. Protein samples were diluted using PBS to their 
final concentrations. 
2-3-3. Protein Characterization.  
Gel electrophoresis using a 4-20% gradient Tris-HEPES-SDS gel (Thermo Scientific) 
confirmed the purity and molecular weight of all the samples, and also confirmed the 
formation of the ELP-foldon trimers. The samples were prepared in loading buffer 
containing 0.1% SDS and heated to boiling temperature for 5 min and then cooled to 
ambient temperature prior to loading on the gel. The molecular weights of the 
polypeptides were additionally confirmed by ion spray quadrupole/time-of-flight mass 
spectrometry (AB/Sciex). The concentrations of the purified proteins were determined 
based on UV absorbance at 280 nm measured on a Biomate3 (Thermo Scientific) using 
calculated extinction coefficients.
2.18
 Folding of the foldon domains were additionally 
confirmed by a 228 nm peak in circular dichroism spectra obtained on an Aviv 215 CD 
spectropolarimeter. 
Transition temperatures of ELP and ELP-foldon constructs were obtained using UV 
absorbance of solutions at 350 nm measured on a Shimatzu 1800 UV-vis 
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spectrophotometer equipped with a temperature controlled sample holder unit. The 
spectra were obtained at 0.1ºC steps with a temperature ramp of 1ºC/min. 
2-4. Results and Discussion 
2-4-1. Protein Expression 
ELP constructs with and without foldon were expressed and purified with yields 
between 100 and 200 mg/L of culture. As has been shown previously for (GVGVP)40-
foldon,
2.17
 each of the ELP molecules containing foldon, fold as a trimer, as illustrated by 
SDS-PAGE (Figure 2-2). The trimers in this study include (GVGVP)20-foldon, 
(GVGVP)40-foldon, (GVGVP)60-foldon, foldon-(GVGVP)20, and foldon-(GVGVP)40 
while the linear constructs are (GVGVP)40, (GVGVP)80, and (GVGVP)160.  
 
Figure 2-2. SDS-PAGE of (GVGVP)20-foldon, (GVGVP)40-foldon and (GVGVP)60-foldon. When samples 
were loaded after about 5 minutes of boiling, the foldon domain was disrupted and the polypeptides 
appeared as monomers on the gel (lanes 2, 4, 6 from left), theoretical molecular weights of 11.9 kD, 20.1 
kD, and 28.3 kD, respectively. But when the samples were loaded with no prior heating, the foldon domain 
remained as a trimer and bands with three times the molecular weight of the monomeric ELP-foldon 
constructs were observed on the gel (lanes 3, 5, 7 from left). 
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2-4-2. Transition Temperature Determination 
The transition temperature at which the ELP molecules aggregate, producing a turbid 
solution is commonly measured using UV-vis spectroscopy. This transition temperature 
can be measured as the cloud point (Tc), i.e. the onset of turbidity determined from 
intersection of the tangent lines of zero absorbance and the highest slope of the curve on a 
UV absorbance spectrum.
2.19
 Since this transition is rather sharp, many groups working 
with ELPs have defined the transition temperature (Tt) for a constantly warmed sample as 
the temperature at the mid-point between the baseline and maximum in the absorbance 
versus temperature curve, which is comparable to the point of the highest slope of the 
curve.
2.3
 For high molecular weight ELP molecules or for high concentration solutions, 
there is a rapid change in turbidity, i.e. nearly infinite slope, which results in nearly 
identical values to a cloud point measurement. However, for short chains and/or low 
concentration solutions there can be a considerable difference between the two values due 
to a smaller slope in the turbidity curve. A comparison between (GVGVP)60-foldon and 
(GVGVP)20-foldon at 25 μM shows a clear difference between the two spectra (Figure 2-
3a). For the shorter ELP chains using the midpoint as the transition temperature results in 
a significantly higher Tt, particularly at lower concentrations. This method of 
measurement is not adequate for identifying the transition temperature of these samples 
since the resulting temperature does not represent the point at which the ELP molecules 
start to phase separate and is dependent on the heating rate of the sample. Since some of 
our samples are relatively low molecular weight, we use the cloud point (Tc) to most 
accurately reflect the transition temperature of the ELP solutions (Figure 2-3b).  
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a       b 
 
Figure 2-3. a) UV absorbance of (GVGVP)60-foldon and (GVGVP)20-foldon at 25 µM concentration in 
PBS as a function of temperature. In order to determine the transition temperature for ELP solutions, the 
samples were warmed at a rate of 1˚C/min and the UV absorbance at 350 nm was recorded. As is observed 
for the (GVGVP)60, the curve is quite sharp, and the mid-point of the curve (Tt) is nearly equivalent to the 
onset of turbidity (Tc).  For the lower molecular weight (GVGVP)20-foldon, the slope of the curve is 
smaller, resulting in different values for Tt and Tc.  b) The concentration dependency of the transition 
temperatures of ELP-foldon constructs using both Tc and Tt. For high molecular weight constructs the 
values are essentially identical but for shorter chains a considerable deviation in the values is observed. 
 
This was not a concern for many previously published studies since the measurements 
were made using higher molecular weight constructs and medium to high solution 
concentrations for which the values from the mid-point and the onset of turbidity are 
essentially equivalent (Figure 2-3b). For these studies, we are able to directly compare 
our data to those of previous studies. Meanwhile, the use of cloud point as the transition 
temperature gives us the flexibility to include a much wider range of data in the study of 
the length and configuration of ELP constructs.  
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2-4-3. Modeling the Transition Temperatures 
It has been shown for linear ELP constructs that the transition temperature decreases 
with increasing concentration of the ELP solution and increasing molecular weight. 
However, at high concentration the transition temperature reaches a minimum for ELP 
constructs containing same pentapeptide sequence regardless of their length.
2.2, 2.4
 Based 
on the phase diagram originally presented by Urry
2.3
, Meyer and Chilkoti developed a 
model to predict the transition temperatures of ELP solutions as a function of 
concentration and length for different linear elastin-like polypeptides.
2.20
 This model 
predicts a so-called critical point where the transition temperatures for all lengths 
converge, i.e. the temperature and concentration at which the transition temperature 
reaches a minimum. Our experimental data for linear and trimer ELPs are first analyzed 
using this model in order to compare the results to those of previously reported linear 
ELP constructs.  
The model was originally developed using measurements of ELP solutions with 
concentrations mostly below 2 mg/ml.  Since the critical point occurs at much higher 
concentrations, it was determined by extrapolation. In this model the transition 
temperature (Tt), is a linear function of the logarithm of concentration (C) following the 
equation 

Tt Tcr Kc ln C Ccr ,                                                                    (2-1) 
in which 

Kc  kt L ,                                                                                      (2-2) 
where Ccr is the critical concentration, kt is a constant with the unit of ˚C, and L is the 
number of pentapeptide repeats.  
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We have previously reported that transition temperatures of (GVGVP)40-foldon also 
exhibits linear dependency on the natural logarithm of the concentration at low 
concentration values,
2.17
 but here with a broader range of sizes of ELP-foldon, we find 
that the data can be fit to the model. The molar concentration of the trimers, i.e. 1/3 the 
concentration of the ELP-foldon monomers, was used, and the total number of 
pentapeptides in the trimers were used for L. To fit the experimental data, the transition 
temperatures (Tc) were measured at different concentrations (C) and the first estimate of 
the critical concentration (Ccr) and critical temperature (Tcr) were obtained from the 
intersection of plots of transition temperature vs. natural logarithm of concentration. 
Subsequently, the transition temperature for all different concentrations of either linear or 
trimer constructs were then fit to the equation using least square analysis to determine the 
critical parameters along with kt. The model is able to fit our experimental data for both 
linear and trimer constructs (Figures 2-4a and 2-4b, respectively). The calculated 
parameters from the fit for linear constructs are in good agreement with previously 
reported values (Table 2-1). Based on this analysis, the critical temperature is about 2˚C 
lower and the critical concentration is one order of magnitude larger for the ELP-foldon 
constructs compared to the linear critical values. It is also interesting to note that the kt 
value is observed to be about 1.5 times larger for the trimers than the linear ELP. 
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a      b 
  
c      d 
  
Figure 2-4. Transition temperatures versus log concentration for linear and trimer ELPs. The fit of our 
experimental data for linear ELP constructs to the Meyer and Chilkoti model2.4 (a) results in good 
agreement with the previously reported data. The ELP-foldon data (b) can also be fit well with this model, 
but results in a lower critical transition temperature than found in the linear fit. The critical concentration is 
about one order of magnitude larger than that of the linear fit. The same data is fit using modified model 
based on volumetric concentrations (c, d). The common critical transition temperature calculated by this 
approach is 23.0˚C, which is close to the reported experimental critical transition temperature for high 
molecular weight, high concentration (GVGVP)n solutions.
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 Linear Trimer Linear from Meyer 
and Chilkoti 
2.4
   
kt (˚C) 114.5 190.8 129 
Ccr (mM) 30.0 106.4 25 
Tcr (˚C) 20.8 18.5 20.8 
Table 2-1: Fit parameters for linear and trimer constructs from molar concentration data. 
An observation from our data is that at high concentrations shorter ELP molecules, 
particularly obvious for (GVGVP)40, show a deviation from linearity in the Tt versus log 
concentration plots (Figure 2-4a). It appears that for these shorter constructs, no matter 
how high the concentration, the Tc will not decrease to Tcr. Although the cause of this 
deviation is not clear, this higher temperature plateau might be the result of chain end 
effects, which reduce the stabilizing effect of chain association and consequently increase 
the transition temperature above what is predicted by Tcr.  
2-4-4. Limitations of the Model 
As mentioned above, the critical temperature is the minimum temperature at which 
ELPs containing the same amino acid repeats will aggregate out of the solution.
2.3, 2.4
 This 
temperature is thought to be independent of the length of the ELPs and is based on the 
idea that all of the ELP constructs at high enough concentration act like high molecular 
weight ELP. Considering the results from the fits of this model, there are reasons to 
believe that the use of molar concentration in the model does not result in critical 
parameters that merit attributing this physical meaning to.  
First, the critical transition temperature for linear (GVGVP)n using molar concentration 
in this model is 20.8˚C, consistent the original reported value,2.4 and 18.5˚C for the 
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trimer. However, there has not been any report of transition temperatures of the 
(GVGVP)n system below 24˚C, which is the value at high concentration and molecular 
weight.
2.3
 
Secondly, the critical point is at a high concentration where there are significant chain-
chain interactions such that the transition temperature is no longer dependent on chain 
length, but solely the interactions of the ELP chains with each other and the solvent. One 
might expect that this temperature should also be independent of molecular configuration. 
However, using molar concentration results in a difference between the critical transition 
temperatures of linear and trimer constructs. It should be noted that it is reasonable that 
the molecular configuration may influence the length and concentration dependence of 
the transition temperature at concentrations below the critical point, where the differences 
in conformations between the branched and linear systems can affect chain-chain 
interactions. 
Finally, in the model, the critical concentration value is dependent on the choice of the 
type of concentration producing significantly different results. In fact, the critical 
parameters were originally defined by Urry on a mass concentration phase diagram of 
ELP solutions.
2.21
 So for this model to be directly comparable to Urry’s phase diagram 
the model should utilize mass concentration instead of molar concentration. Using our 
experimental data, we have found that the model indeed can be used to fit mass 
concentration data for both linear and trimer constructs resulting in different values of Tcr 
and Ccr, compared to the fit with molar concentration (Figure 2-5).  
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a       b 
 
 
Figure 2-5. Fit of experimental data to Meyer and Chilkoti model using mass-based concentration for both 
linear (a) and trimer (b). The results show different values of critical transition temperature and 
concentration in comparison to the molar-based fit for both constructs. And they both result in lower values 
of Tcr than the experimental values. 
 
2-4-5. Modification of the Model 
Because of the inconsistencies in Tcr for different molecular architectures and the 
ability to redefine the concentration unit, we sought a concentration definition that could 
provide physical meaning to the critical point. To do this, we propose to use a 
concentration based on the volume of the polypeptide coils at the transition temperature, 
specifically the ratio of the total polymer coil volume to the solution volume. We 
consider the polymer coil volume to be the equivalent hydrodynamic volume, Ve, which 
is related to the average polymer conformation, indicating the geometry of the coil and 
the degree of swelling. For a given chain conformation there is a scaling relationship 
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between the molecular weight (M) and hydrodynamic volume. Consequently for a 
polymeric chain in the solution
2.22
: 

Ve M
n ,                                                                                        (2-3) 
where, the exponent n describes the scaling relationship. For theta conditions, where the 
radius of gyration squared (Rg
2
) is proportional to M, the value of n is 3/2. 
 
The volume concentration, based on equation (2-3) becomes  

Cv Cm L
n k ,                                                                                 (2-4) 
where Cm is molar concentration and k' is a constant. At the critical point we have 
arbitrarily defined the critical volume concentration, Cv, to be equal to 1, where the total 
volume of the polymer coils is equal to the solution volume, allowing k' to be a fit 
parameter. Experimental data for both the linear and trimer constructs were fit together 
by coupling the equations 2-1 and 2-4 using a single Tcr and individual n, k', and kt values 
for the linear and trimer architectures (Figure 2-4c,d and Table 2-2).   
 Linear ELP-foldon trimer 
kt (˚C)  119 179 
k' (L.mol
n-1
.gr
-n
) 3.3×10
-4
 2.0×10
-6
 
Tcr (˚C) 23.0 23.0 
n 1.51 2.30 
Table 2-2. Fit parameters for linear and ELP-foldon trimer constructs using volumetric concentration 
 
The resulting critical transition temperature is 23.0˚C, which is higher than the fit using 
molar or mass concentration and is closer to the transition temperature observed for high 
molecular weight linear constructs.
2.21
 It is notable that a single temperature could be 
successfully fit to the data for both the linear and trimeric constructs, which was not 
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possible using either mass or molar concentrations. This suggests that using volumetric 
concentration may result in parameters that have physical meaning, where the critical 
point indicates the volumetric concentration at which significant chain-chain interactions 
occur. One interpretation could be that this is the point where ELP chains start to overlap. 
From the fit, kt values were again found to be related by a factor of 1.5 (as was 
observed with fits for all other types of concentration). The constant kt relates the 
concentration dependence of the Tc to the number of pentapeptide repeats in the ELP 
(Equations 2-1 and 2-2). The factor of 1.5 may indicate that the concentration 
dependence of Tc is more accurately related to the maximum contour length of the ELP 
(for our system the total ELP repeats is 1.5 times the ELP repeats in the contour length) 
rather than the total amount of ELP, but data on other polymer configurations would be 
needed to confirm this.   
 
2-4-6. Interpretation of Model Parameters 
The results of fitting using volumetric concentration provide additional information that 
can be used to elucidate the effect of architecture on the behavior of ELP molecules. The 
exponent n indicates how the polymer coil size scales with molecular weight and is 
similar to the exponent, a, in the Mark-Houwink-Sakurada relationship between intrinsic 
viscosity ([]) and molecular weight (M) with the constant K, 

[]K Ma ,                                                                                    (2-5) 
except since mass concentration is used for intrinsic viscosity, n = 1 + a.  The determined 
value of 1.51 for the linear construct is consistent with the polymers in a theta coil 
conformation at their transition temperature.
2.22
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Previous findings show that ELPs begin to exhibit β-secondary structure which were 
interpreted as β turns, becoming more ordered and less flexible, as they approach their 
transition temperature. 
2.23
 This structuring is a gradual process which starts well below 
and increases up to the transition temperature.
2.14
 The equilibrium between the β and 
unordered structure at the transition temperature is affected by the length and 
hydrophobicity of the chains and with unordered regions being particularly prominent for 
more hydrophobic chains including poly(GVGVP)
2.24, 2.25
. The finding that the 
(GVGVP)n  is in a random coil conformation at the transition temperature is consistent 
with this process.  
The trimer constructs on the other hand have a higher n value, about 2.3, which is 
consistent with an extended coil/rod like state. This difference in conformation can be 
explained within the accepted theory of folding and aggregation of the ELP molecules.
2.3, 
2.14
 The chains go through the transition from random coil to more ordered state when 
they approach their transition temperature.  However, neighboring chains can potentially 
stabilize these ordered chains by forming twisted filaments of three chains leading to 
aggregation and formation of a coacervate. In our trimeric system, there are three chains 
attached at one end, which provides the proper stiochiometry for twisted filaments at 
higher local concentration than the bulk solution. This could lead to an earlier and more 
stable formation of a twisted filament resulting in a non-spherical conformation of the 
trimer prior to aggregation, leading to the higher n value.   
The formation of a twisted filament conformation could also explain the larger critical 
concentrations observed for the trimer conformation. The twisted filament is a more 
compact conformation having a smaller hydrodynamic radius than comparable linear 
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constructs. The critical concentration being defined as the point of significant interactions 
of the chains is higher for the more compact conformation. As an example, the critical 
molar concentrations can be calculated from equation 2-4 using k', the length of the 
polypeptide, and the critical volume concentration. For (GVGVP)120 this results in critical 
concentration of 2.2 mM, while the comparable molecular weight trimer, (GVGVP)40-
foldon, has a critical concentration of 8.3 mM, which is nearly a factor of four larger than 
that of the linear constructs.  
We have noted that, although any form of concentration in the model can be used to 
predict the concentration and length dependence of ELPs, except for the volumetric 
concentration, they fail to correctly determine the critical transition temperature.  Despite 
the fact that most of the ELP solutions are used well below their critical point, the 
prediction of the critical transition temperature is still of importance especially when 
dealing with cross-linked networks. In these networks, no matter what the initial length of 
polypeptide, cross-linking can potentially result in an essentially infinite molecular 
weight gel and the transition temperature theoretically approaches Tcr. The precise 
prediction of this temperature can be important if such gels are considered to be used in 
sensitive application such as drug delivery in which the functioning of the system is 
dependent on the response of the gel at the designed temperature.    
2-4-7. Foldon-ELP constructs 
To further expand our results and to investigate the effect of foldon positioning in the 
construct, we made and used trimer constructs by adding foldon to the N-terminus of the 
ELP molecules. The two studied constructs were foldon-(GVGVP)20 and foldon-
(GVGVP)40. Their molecular weight and trimer formation were confirmed by SDS-
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PAGE electrophoresis and CD spectroscopy the same way that were done for other 
constructs. The transition temperatures at different protein concentrations were fit to 
equation 4 the same way as the ELP-foldon data. The critical concentration for this 
construct was also kept constant at 1 and all other parameters were fit simultaneously 
with the linear data (Figure 2-6 and Table 2-3).   
 
 Linear Foldon-ELP 
trimer 
ELP-foldon 
trimer 
kt (˚C)  119 224.5 179 
k' (L.mol
n-1
.gr
-n
) 3.6×10
-4 
3.5×10
-6 
2.0×10
-6
 
Tcr (˚C) 23 23 23.0 
n 1.48 2.6 2.30 
Table 2-3. Fit parameters for linear and foldon-ELP and ELP-foldon trimer constructs using volumetric 
concentration 
 
 
Figure 2-6. Transition temperatures versus log concentration trimer foldon-ELPs. 
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Comparing the fit parameters of foldon-ELP to that of the linear and ELP-foldon 
constructs shows an increase in n and kt. The higher n value compared to linear constructs 
is expected and can be understood based on the previous discussions. But interestingly 
the n value is even higher than that of the ELP-foldon trimers. This can be an indication 
of certain differences between the folding and aggregation of these constructs based on 
the position of the trimer forming domain. The higher n value for foldon-ELP can be an 
indication of even more extended and stiffer folded constructs.  
To better understand the conformational differences between these constructs circular 
dichroism (CD) spectroscopy was done using samples of ELP-foldon and foldon-ELP at 
the same solution concentrations and temperatures below the transition temperatures 
(Figure 2-7). ELP-foldon construct at this temperature shows the behavior fairly similar 
to that of a random coil polypeptide with a minimum around 196 nm. This minimum is 
considered to be the characteristic feature of random coil polypeptides.
2.26
 On the other 
hand, the CD spectrum for foldon-ELP shows a minimum around 217. This minimum is 
an indication of much higher population of ordered ELP construct and shows a clear 
difference between the secondary structures of these two constructs. This is in agreement 
with previous studies using coiled-coil self-assembling polypeptides at two ends of the 
ELP constructs.
2.27
 The CD spectra of different constructs will be discussed in more 
details in Chapter 6. 
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Figure 2-7. Circular dichroism spectroscopy of Foldon-(GVGVP)40 and (GVGVP)40-foldon at 10 µM 
protein concentration and 25˚C. 
 
The difference between the two constructs can be contributed to the folding process of 
the ELP chains. We suggest that the folding of ELP molecules might be a directional 
process that starts from the N-terminus of the ELPs. Adding the foldon to this end of the 
molecules and bringing the chains in a very close proximity induces the folding of the 
constructs. In case of ELP-foldon, adding the foldon domain was shown to induce the 
folding process, but as observed with foldon-ELP, it seems that the foldon at the N-
terminus has a greater effect on the folding of ELPs. 
 
2-5. Conclusion 
In this study the role of molecular architecture on the thermal transition behavior and 
the polypeptide coil structure of elastin-like polypeptides was investigated by developing 
a three-armed star ELP system using a trimer forming oligomerization domain. The 
domain was added to either N- or C-terminus of the ELP. The transition temperatures of 
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linear and trimer constructs at different concentrations were fit to a mathematical model 
using a volume-based concentration that scales with molecular weight, providing a 
physical interpretation of the critical transition temperatures for ELP constructs. This new 
fit resulted in critical transition temperatures in good agreement with experimentally 
observed critical parameters for high molecular weight constructs. This approach also 
enabled us to study the different behavior of linear and branched ELP molecules at their 
transition temperature. It was shown that the trimer goes into a more extended 
conformation at its transition temperature while the linear construct keeps a more random 
coil conformation. Between the two trimer construct, it was shown that when foldon was 
added to the N-terminus of the ELP, it had a greater effect on their folding. The results 
are consistent with the theory of twisted filament formation of ELPs above their 
transition temperature.  
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Chapter III 
Thermoreversible Micelle Formation Using a Three-Armed Star 
Elastin-like Polypeptide 
(As published with J.T. Cole and N.B. Holland, Macromolecules 2010, 43, 4340–4345) 
3-1. Abstract  
We have designed, synthesized, and purified a novel three-armed star polymer consisting 
of an elastin-like polypeptide (ELP) followed by a negatively charged trimer-forming 
oligomerization domain at the C-terminus. In low salt conditions, the water-soluble 
trimers assemble into micellar particles as small as 25 nm in diameter when heated to 
temperatures above their transition temperature. The size of these micelles can be 
controlled by adjusting salt and cosurfactant concentrations. They are stable at elevated 
temperatures but will dissociate into the individual trimers when the temperature is again 
decreased below the transition temperature. Their behavior at high temperatures is quite 
different than typical ELP constructs, which initially form large aggregates followed by 
phase separation into a coacervate and soluble fraction. The polypeptide consists of 40 
pentapeptide repeats of glycine-valine-glycine-valine-proline (GVGVP) followed by the 
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27 amino acid foldon domain. It is expressed in E. coli and purified by thermal transition 
cycling.  
3-2. Introduction 
Elastin-like polypeptides (ELP) are a part of the family of responsive polymers that 
have been studied extensively for the past two decades.
3.1-3
 These polymers consist of 
repeats of the sequence GαGβP, where α can be any of the 20 naturally occurring amino 
acids and β can be any except for proline.3.1 These polypeptides are similar to responsive 
synthetic polymers like PNIPAA in many ways. This includes the fact that both exhibit 
LCST (lower critical solution temperature) behavior by phase separating above a specific 
transition temperature.
3.1, 3.4
 When these materials are prepared as bulk hydrogels, this 
behavior results in significant volume changes when passing through the transition 
temperature. These so called responsive materials have been used for many different 
applications including drug delivery
3.5-6
, tissue engineering
3.7-8
, surface engineering
3.9-11
, 
nano sensors
3.12
, and hydrogels.
3.1, 3.13-14
 The environmental stimuli for both synthetic 
polymers and elastin-like polypeptides can be chosen based on the intended application 
and can include temperature
3.1-2
, pH
3.15-16
, ionic strength
3.16
, or light
3.17-18
.  
An area that elastin-like polypeptides have attracted much attention is the molecular 
self-assembly of ELP constructs into nano- and micro-scale constructs.
3.19-23
 Several 
different block copolymers (either AB or ABA) consisting of ELP chains with different 
hydrophobicities have been designed.
3.5, 3.24
 these constructs assemble into particles when 
triggered by external stimuli that cause one of the ELP chains of the copolymer to 
become hydrophobic, leaving the second soluble ELP block to act as a hydrophilic head 
group that stabilizes the formation of micellar or vesicular particles.  
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Drug delivery using self assembled particles
3.25-26
 is an attractive area for ELP because 
of the ability to precisely control the structure of these polypeptides
3.27
 and their natural 
biocompatibility.
3.28
 ELP constructs have demonstrated efficacy in properties desirable 
for drug delivery carriers including targeted delivery
3.29
, good loading capacity
3.30
, and 
low clearance in animals
3.31
. The most important environmental stimuli for a drug 
delivery carrier are the ones which have physiological relevance, i.e. pH difference 
between the healthy and diseased cells, temperature, concentration difference, or a 
combination of these
3.32-33
 and ELP molecules have the capacity to be designed and 
constructed to respond to any of these environmental stimuli. Another advantage of ELP 
self-assembled particles is their small size. These particles can be 100 nm or less, which 
is much smaller than typical ELP aggregates. The smaller size can be an advantage in 
vivo by decreasing antigenicity and reducing clearance.
3.24
   
Although the specifics of ELP aggregation at the molecular level are still debated, an 
early description of the process suggested that the ELP chains transition from a random 
coil conformation to a folded β-spiral which is hydrophobic.3.1, 3.34 The folded 
polypeptides are partially stabilized by forming a twisted filament of three chains and 
phase separating in the form of a coacervate.
3.35
 This process results in the measurable 
turbidity of the solution above its transition temperature. This theory has been supported 
by a number of studies, especially by using circular dichroism (CD) measurements.
3.2, 3.36
 
In a recent report, it was demonstrated that combining ELP with the trimer forming α-
helical coiled coil motif resulted in the tail ends of the ELP coming into close proximity 
above the transition temperature, further supporting this model.
3.37
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There are numerous protein folds that incorporate such a triple helix, including the 
collagen triple helix and the α-helical coiled coil motif. Another instance is in 
bacteriophage T4 fibritin protein, which forms a fibrous trimer. Unlike the collagen and 
α-helical coiled-coil, the fibritin fold is not stable alone, but requires a terminal trimer 
folding domain to stabilize it.
3.38
 This domain, called foldon, can be expressed as a 27 
amino acid peptide which forms a homotrimer in a large range of pH, with the notable 
exception of very low pH.
3.39-40
 At neutral pH, the domain is negatively charged and 
thermally stable up to 75°C.
3.38
 These features have been used to stabilize short triple 
helices of collagen for structural studies using recombinant methods to incorporate 
foldon.
3.41
 With the 27 amino acid sequence at either the N- or C-terminus, a collagen 
triple helix can be stabilized at higher temperatures and lower concentrations than one 
without the foldon sequence.
3.38
  
We report here the design and biosynthesis of a new elastin-like polypeptide construct 
that incorporates the foldon domain at its C-terminal end. We demonstrate that the foldon 
domain folds, producing a trimer resulting in a three-armed star ELP. The thermal 
transitions of this construct are compared to linear ELP at different polypeptide and salt 
concentrations. Additionally, we show that this construct behaves quite differently at low 
salt concentrations by forming nanoscale micellar aggregates at temperatures above the 
ELP transition temperature. We describe generally the conditions that lead to the 
formation of these micelles. 
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3-3. Materials and Methods 
3-3-1. Gene Design and Preparation 
The synthesis of the elastin-like polypeptide gene was based on the methods described 
by Meyer and Chilkoti.
3.27
 In short, complementary oligonucleotides (Invitrogen) 
encoding five repeats of amino acid sequence GVGVP were designed to have appropriate 
overhangs to insert into pUC19 cloning vector (Novagen) digested with EcoRI and 
HinDIII, as well as internal cut sites for restriction enzymes BglI and PflMI. These two 
oligonucleotides were annealed together by heating to 95ºC and slowly cooling in a 
thermocycler. An aliquot of pUC19 vector was double digested using EcoRI and HinDIII 
and then purified using a DNA extraction kit (GenScript). The annealed DNA was ligated 
into the double digested vector in a three to one molar ratio using Quick Ligase (New 
England Biolabs) for 15 minutes. A 10 µL aliquot of the ligation product was combined 
with 50 µL of chemically competent E. coli cells and transformed by heat shocking (30 
min at 4°C followed by 2 min at 37°C) and left overnight on solid agar plates 
supplemented by 100mg/L of ampicillin. Colonies were grown overnight and screened 
using PCR screening techniques. The sequence was ultimately confirmed by DNA 
sequencing.  
To increase the length of the ELP encoding DNA, we double digested the pUC19 
vector containing (GVGVP)5 with NdeI and PflMI restriction enzymes. A separate 
sample of the same plasmid was also double digested by using NdeI and BglI restriction 
enzymes to produce the insert. Using double digestions minimizes the number of false 
positives on the plates after transformation and does not require dephosphorylation of the 
vectors. This process resulted in DNA encoding ten GVGVP repeats. This process was 
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repeated twice more to reach (GVGVP)40. This (GVGVP)40 encoding DNA was 
transferred to a pET20b expression vector modified as described by Meyer and 
Chilkoti
3.27
 to have one SfiI recognition site that leaves an overhang that is compatible 
with the PflMI cutsite in the pUC19 construct. The (GVGVP)40 DNA resulting from the 
digestion of the pUC vector with NdeI and PflMI was inserted into the pET vector 
digested with NdeI and SfiI. The resulting gene encodes a 206 amino acid polypeptide: 
MGH(GVGVP)40GWP. 
To prepare DNA encoding the foldon domain, oligonucleotides were designed so they 
would anneal into a double stranded DNA cassette with overhangs compatible with the 
SfiI cut site, and leaving a PflMI recognition site. The codons were selected for optimal 
expression in E. coli.
3.42
 This construct was ligated into the modified pET20b vector 
described above digested with SfiI. A (GVGVP)40 encoding DNA was then inserted as 
above resulting in the 233 amino acid polypeptide that includes a C-terminal foldon 
domain sequence:  MGH(GVGVP)40GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL. 
3-3-2. Protein Expression and Purification 
Expressions were started by preparing a 5 ml overnight starter culture from frozen 
stock in LB medium supplemented with 100 μg/ml ampicillin (LBA) at 37°C. The starter 
culture was added to 1 L of LBA medium in a 2 L Erlenmeyer flask and shaken at 300 
rpm and 37°C to an OD600 of between 0.9 to 1.0, at which point expression was induced 
by adding 0.1 mM IPTG. The cells were harvested after 4 to 5 hours by centrifugation for 
30 min at 3000g. To lyse the cells they were resuspended in 20 ml of bacterial protein 
extraction reagent (B-PER, Pierce) by vortexing vigorously for several minutes. The 
lysed cells were then centrifuged at 4˚C for 20 min at 20000g to separate the soluble 
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protein from insoluble cell lysate. The soluble supernatant, which contained our 
polypeptide, was then purified using inverse transition cycling method.
3.43
 We utilized 
warm centrifugation of the protein solution for 15 min at about 40°C at 15000g to pellet 
out the aggregated proteins. The isolated pellet was resuspended by using 5 ml of chilled 
PBS buffer pH 7.4 (Fisher Scientific). The resuspended solution was then centrifuged at 
4°C for 15 min at 15000g. This process was repeated two times to purify the ELP. 
3-3-3. Protein Characterization 
Purified ELP was characterized first by using 10-20% gradient Tris-Glycerol SDS-
PAGE (Lonza) to confirm the purity and molecular weight. The samples were prepared in 
loading buffer containing 0.1% SDS and heated for 5 minutes prior to loading on the gel 
at temperatures ranging from room temperature to 100˚C. The concentration of the 
proteins was quantified using UV absorption at 280 nm on a Biomate3 (Thermo 
Scientific). The extinction coefficient used to convert absorbance to concentration was 
calculated based on the tyrosine and tryptophan content of the peptides.
3.44
 To observe the 
folding of the foldon domain, circular dichroism spectra were obtained using an Aviv 215 
CD spectropolarimeter. 
Transition temperatures of ELP solutions were determined by solution turbidity 
measured using a Cary 50 Bio UV-visible spectrophotometer equipped with a 
temperature-controlled cell (Varian). Spectra from 800 nm to 200 nm were obtained at 
0.5˚C steps with an average temperature ramp of 1°C/min. The transition temperature is 
defined as the temperature corresponding to the midpoint of the baseline and maximum 
absorbance (approximate maximum slope) of the 350 nm absorbance curve  
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Particle size measurements were performed using 90 Plus Particle Size Analyzer 
(Brookhaven Instruments), which is a fixed angle (90º) dynamic light scattering 
instrument equipped with peltier temperature control. The samples were carefully filtered 
using a 0.22 μm filter prior to loading in 1 cm x 1 cm quartz cuvettes. The measurements 
were made in 2 minute runs and repeated at least twice and were analyzed by BIC 
software (Brookhaven Instruments). The results are the mean diameter of multimodal size 
distribution (MSD), being calculated by the software based on the non-negatively 
constrained least square (NNLS) algorithm. 
3-4. Results 
ELP with and without foldon were successfully expressed and purified with yields 
between 50 and 100 mg/L of culture. The foldon sequence is expected to fold as a homo-
trimer resulting in a three-armed star polypeptide (Figure 3-1). An SDS PAGE of the 
(GVGVP)40-foldon illustrates the formation and stability of the trimer (Figure 3-2). 
Samples heated to different temperatures in loading buffer containing 0.1% SDS prior to 
loading on the gel resulted in different band patterns. Since the foldon domain is stable up 
to concentrations of 2% SDS
40
 the foldon domain in the sample which was not heated 
remained folded and the construct was observed at about 60 kD, three times the weight of 
a single polypeptide chain. By heating the sample at temperatures of 65˚C or above, the 
foldon domain was completely denatured and the individual polypeptide chains are 
observed at 20 kD. This temperature is about 10˚C lower than the reported stability of the 
foldon domain, which is reasonable considering the presence of SDS in the loading buffer 
which will destabilize it. At intermediate temperatures (e.g. 45˚C) partial unfolding is 
observed where bands appear at both 20 and 60 kD. Circular dichroism spectra of the 
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(GVGVP)40-foldon constructs further confirmed trimer formation by a peak at 228 nm 
which is characteristic of the folded foldon domain
3.38
 (Data shown in Chapter 2). 
a)                                                               b) 
   
 
 
Figure 3-1. a) Ribbon diagram of the foldon domain. This homotrimeric oligomerization domain is stable 
up to 70°C in water (PDB accession number 1RFO).3.39 Elastin-like polypeptide is added to the N-terminal 
residues to make the ELP trimer. b) The three-armed star elastin-like polypeptide (GVGVP)40-foldon 
before and after thermal transition. The foldon domain holds the three chains together below and above the 
ELP transition temperature. The contour length of the folded ELP reduces to about 20% of the unfolded 
one. The collapsed twisted filament ELP model3.35 was created using Swiss PDB viewer based on reported 
backbone dihedral angles for the β-spiral structure.34 
 
 
Figure 3-2. An SDS-PAGE gel of (GVGVP)40-
foldon with different degrees of heating prior to 
loading. The sample in lane 2 was not heated 
prior to loading on the gel and it runs around 60 
kD, which is three times the size of a single 
(GVGVP)40-foldon. The other lanes were heated for five minutes at the designated temperatures prior to 
loading on the gel. For the 45°C sample, most of the polypeptide shows up as the trimer, but a small 
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fraction of it runs as monomer (~20 kD). The samples which were heated to temperatures above 65°C 
resulted in the complete disruption of the trimers. 
The defining characteristic of the environmental response of an ELP is the transition 
temperature (Tt) above which the protein solution becomes turbid, most frequently 
measured by absorbance in a UV-visible spectrometer. Representative data for obtaining 
the Tt of ELP and ELP-foldon constructs (Figure 3-3a) show a relatively sharp change in 
the 350 nm absorbance as a function of temperature for three different constructs. A 
linear relationship is observed between the Tt values of these ELP constructs and the 
logarithm of molar concentration of GVGVP pentapeptides (Figure 3-3b). Using the 
molar concentration of pentapeptide normalizes the samples to the total amount of ELP in 
solution. This represents an equivalent molar concentrations for the (GVGVP)40-foldon 
trimer and linear (GVGVP)120, whereas the (GVGVP)40 is at three times the molar 
concentration of the others. Even at a higher molar concentration, the Tt of linear 
(GVGVP)40 is higher than that of (GVGVP)40-foldon. The transition temperature of ELP-
foldon trimer is higher than a linear ELP with the same molecular mass indicating that 
the molecular geometry affects the Tt. The similar slopes of the two samples indicate that 
the three-armed geometry results in a constant increase in Tt at equivalent concentrations. 
The linear dependence of the transition temperature on salt concentration, a well-
described phenomenon,
3.45-46
 is observed for the three-armed ELP. The transition 
temperature decreases linearly as a function of the sodium chloride concentration (Figure 
3-4). This relationship suggests the zero salt concentration transition temperature for a 
(GVGVP)40-foldon solution with 25 μM protein should be 38˚C. This is not observed. At 
salt concentrations below 50 mM, no turbidity is observed up to the temperature of the 
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foldon stability (~70˚C), well above the expected transition temperature. Even when the 
solutions are held at these temperatures for extended times no phase separation is 
observed. This is in contrast to the linear (GVGVP)40, which exhibits a Tt even at zero 
salt concentration. The near identical slopes of the curves in this figure suggest that the 
effect of salt in decreasing the transition temperature is independent of geometry and 
molecular weight of the constructs. 
 
a)        b)  
  
 
Figure 3-3. a) Determination of the ELP and ELP-foldon transition temperatures. Transition temperatures 
are characterized for 25 μM solutions of (GVGVP)40 (diamonds), (GVGVP)40-foldon (circles) and 
(GVGVP)120 (squares) in PBS by measuring UV absorbance at 350 nm as a function of temperature with a 
temperature ramp of 1˚C/min. The transition temperature is defined as the temperature at the midpoint 
between the baseline and maximum turbidity (approximately the steepest slope). For these samples, the 
transition temperatures are 41.5°C for (GVGVP)40, 34.5ºC for (GVGVP)40-foldon, and 30.0°C for 
(GVGVP)120. b) Transition temperatures of (GVGVP)40 (diamonds), (GVGVP)40-foldon (circles) and 
(GVGVP)120 (squares) as a function of molar concentration of GVGVP pentapeptides (i.e. constant ELP 
mass concentration). A linear relationship between Tt and log C is observed for each construct. Comparing 
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(GVGVP)40-foldon and (GVGVP)120, which have the same ELP molecular weight, the slopes are the same, 
but the former has higher Tt values. 
 
 
Figure 3-4.  Effect of salt on the transition temperature of (GVGVP)40 (diamonds), (GVGVP)40-foldon 
(circles), and (GVGVP)120 (squares). There is a linear relationship between salt concentration and the 
transition temperature of ELP-foldon solutions, except at low salt concentrations. At salt concentrations 
below 45 mM, a transition temperature is not observed by turbidity measurements. This contrasts the 
typical ELP, which exhibits transitions even without salt. The slopes for the three samples are equivalent, 
indicating that the geometry does not affect the salt dependency of the Tt for the ELP molecules. The 
(GVGVP)40-foldon transition temperatures for all salt concentrations fall between (GVGVP)40 and 
(GVGVP)120. 
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Figure 3-5.  Dynamic light scattering particle size determination as a function of temperature for 
(GVGVP)40 and (GVGVP)40-foldon. The solutions are in low salt concentration and the graphs show very 
clear difference between the sizes of the particles above the transition temperature. For (GVGVP)40 the 
particle size changes from below 10 nm to about 500 nm resulting in turbidity of the solution. In the case of 
(GVGVP)40-foldon, the diameter of particles does not exceed 30 nm when the salt concentration is 7 mM 
and 60 nm for a salt concentration of 20 mM. These solutions remain clear and the particle diameter does 
not change over time. This is also a reversible process as no difference in particle size as a function of 
temperature is observed when the sample is cooled. The inset is a magnification of the graph illustrating the 
region where small particles form. 
 
Dynamic light scattering particle sizing was used to further investigate aggregation, 
particularly in low salt solutions (Figure 3-5). Below the transition temperature, the linear 
(GVGVP)40 is soluble as observed by a polymer chain conformation size of less than 10 
nm. Above the transition temperature, it aggregates into particles of about 500 nm in size. 
This particle formation is consistent with the turbidy observed for these solutions. For the 
(GVGVP)40-foldon trimers, a distinctly different behavior is observed. At salt 
concentrations below 15 mM, when heated from below to above its expected transition 
temperature (based on the linear relationship to salt concentration), the size changes from 
below 10 nm to about 30 nm. The small aggregate size explains why no turbidity is 
observed by UV absorption under these conditions. For salt concentrations between 15 
mM and about 45 mM, when the solution is heated to temperatures above the transition 
temperature, the size of the particles change to about 60 nm. The formation of the small 
particles at low salt is a reversible process as is observed by cooling down the solution 
and observing no hysteresis between warming and cooling experiments. 
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a) 
 
 
  
 
b) 
 
Figure 3-6.  Dynamic light scattering of (GVGVP)40-foldon in different NaCl concentrations. Dynamic 
light scattering was performed on 10 μM polypeptide solutions at 50°C, which is above the polypeptide 
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transition temperature. The measurements show very narrow distribution of particle sizes over a wide range 
of salt concentrations (a) and that the size of the aggregates varies as a function of salt concentration (b). 
Three zones are observed. For salt concentration below 15 mM, the particles are less than 30 nm and 
below. For salt concentrations between 15 mM and 45 mM the size of the particles are in the range of 60 to 
65 nm. Increasing the salt concentration to values above 45 mM the aggregates are greater than 300 nm and 
the solution becomes visibly turbid.  
 
Further measurements demonstrate that the size of the aggregate is dependent on salt 
concentration, with three distinct regimes (Figure 3-6). In Regime I, at salt concentration 
below 15 mM, the aggregates are 30 nm or smaller and appear to linearly increase with 
salt concentration. For salt concentrations between 15 and 45 mM (Regime II), the size of 
the aggregates is approximately constant in the range of 60 to 65 nm, and in Regime III, 
for salt concentrations above 45 mM, the particles are large and turbidity is observed 
which is consistent with the UV turbidity measurements. The particle size distributions in 
all three regimes are quite narrow having peak widths less than 1% of the particle 
diameters (Figure 3-6a). 
The addition of SDS surfactant to the trimer solution generally led to a decrease in the 
stability of aggregates in both high and low salt conditions. SDS was added to two 
different (GVGVP)40-foldon solutions with different salt concentrations. In one solution, 
SDS was changed from 0 to 0.05% while the salt concentration was kept constant at 7 
mM (Figure 3-7). In this case, the particles were stable up to about 0.02% of SDS and 
then the diameter of the particles dropped sharply in to what is expected to be a random 
coil polypeptide. In the case of the second solution with about 150 mM salt (Figure 3-7), 
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the aggregates were not stable in the presence of SDS and even at SDS concentration of 
0.02% there was no turbidity.  
 
Figure 3-7.  The effect of SDS on the (GVGVP)40-foldon micelles and aggregates. At 150 mM salt (left 
axis), (GVGVP)40-foldon aggregates of several hundred nanometers form above the transition temperature. 
SDS is able to disrupt the formation of these aggregates. SDS can also disrupt polypeptide micelle 
formation in low salt conditions (right axis), but requires higher concentrations. 
 
 
3-5. Discussion 
Typical ELP chains heated above their transition temperatures go from a random coil to 
a more ordered hydrophobic state and phase separate into a coacervate containing 63% 
water and 37% polypeptide.
3.1
 Previous reports have shown that the initial formation of 
the coacervate phase is followed by aggregate growth and coalescence over time.
3.5,3.47
 
We would not expect significant differences in the behavior of the ELP when attached to 
the foldon domain, since aggregation above its transition temperature has been reported 
when ELP was used as a fusion protein for protein purification
3.43
 and in the coiled-coil 
trimer of Fujita et al.
3.37
 Like typical ELP, our data shows that the three-armed ELP in 
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moderate salt concentrations does exhibit a transition temperature that is dependent on 
salt and ELP concentrations, as well as an aggregate size that increases with time.  
However, at low salt concentrations (<45 mM), the three-armed ELP, formed by ELP-
foldon, behaves differently in comparison to linear ELP. Under these conditions, stable 
nano-scale aggregates form. Under further scrutiny, it is observed that there are two 
regimes of stable aggregates with considerably different size distributions (Figure 3-6b). 
We propose that each of these two regimes consists of stable micellar particles that do not 
coalesce over time, which is notably different from the higher salt regime. Below we 
interpret the size of these stable aggregates by considering the geometry of the ELP-
foldon and the intermolecular interactions.   
The foldon domain has a net negative charge and so can behave as a hydrophilic group 
to stabilize the coacervate aggregates formed by the ELP chains above their transition 
temperature. In essence, the ELP-foldon is a surfactant with three hydrophobic tails and a 
charged head group, which forms micelles at salt concentrations below 45 mM (Regimes 
I and II). The salt concentration plays a key role in determining the size and type of 
aggregation that occurs in charged surfactant systems. The primary effect of salt in 
solution is to moderate the electrostatic interactions between charged species; however, 
salt can also modify hydrophobic interactions as is observed by the dependence of the 
transition temperature of ELPs on salt. 
The geometry of any surfactant determines the size and shape of micellar aggregates
3.48-
49
, based on the dimensionless packing factor: 
v/a0l,        (3-1) 
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where v and l are the volume and length of the hydrophobic tails, respectively, and a0 is 
the effective area of the hydrophilic head group. If this dimensionless number is less than 
1/3, spherical micelles will form with a size such that the diameter of the micelle will be  
d = 6 v/a0.        (3-2) 
For spherical micelles, the maximum diameter of the micelles is twice the length of the 
hydrophobic tail. Based on the ELP folding into a beta-spiral and forming a triple 
strand
3.1
, the length of a (GVGVP)40-foldon in its collapsed state is around 15 nm (Figure 
3-1), corresponding to a maximum diameter of 30 nm for a spherical micelle. For 
(GVGVP)40-foldon below its transition temperature, a micelle would have a maximum 
diameter of 150 nm. Based on the micelle size as a function of salt concentration, this 
indicates that Regime I is consistent with spherical micelles with folded ELP chains. 
Regime II diameters are greater than 30 nm, which suggests that the micelles are either 
non-spherical or spherical micelles with unfolded or partially unfolded ELP chains. 
We expect that the hydrophobic tails phase separate in the interior of the micelle into 
an immiscible coacervate-like phase, as in typical ELP solutions. Since the coacervate 
contains 37% protein and 63% water
3.1
, and is slightly more dense than water, it is 
estimated that the volume occupied by the 120 pentapeptide repeats in a (GVGVP)40-
foldon trimer is approximately 200 nm
3
. This is comparable with an estimation based on 
the molecular model of the collapsed ELP conformation occupying a cylinder of diameter 
4.8 nm and length of 11 nm (Figure 3-1). Assuming a spherical micelle, this volume 
together with the micelle diameter can be used to calculate the head group areas. It is 
notable that Regime I exhibits a slight increase in diameter with increasing salt. Based on 
equation 3-2, the apparent head group diameter is between 8 and 9 nm with a slight 
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decrease as the salt concentration increases. Such a decrease in the head group size is not 
unexpected. The apparent area of the foldon domain, which has a net negative charge, 
will be affected by the electrostatic shielding of the additional salt. 
In Regime II, the micelle size remains approximately constant, corresponding to a head 
group diameter of about 5 nm if it were a spherical micelle. This value is slightly larger 
than the 2 to 3 nm diameter of the foldon domain, which suggests that they are not 
spherical micelles. Nevertheless, the constant size in this region suggests that the ion 
shielding is large enough that increasing the salt concentration does not result in any 
further reduction in head group area. This is consistent with a reduction in the Debye 
length to 2.5 nm at 15 mM NaCl. However, since the micelles are stable, the overall 
electrostatic interaction between micelles is apparently strong enough to prevent 
coalescence. As the salt concentration increases above 50 mM and we move into Regime 
III, the charge on the foldon domains is shielded to a greater extent so that large 
aggregates will form. 
The effect of increasing SDS concentration for both micellar and large aggregates of 
(GVGVP)40-foldon results in a rather sharp decrease in the particles size, but the micellar 
aggregates shows greater stability, since the large particles disaggregate at lower SDS 
concentration (Figure 3-7). These patterns give us criteria that can be used together with 
the salt dependency of the ELP-foldon micelles to predict the size of the aggregates. 
There is a limited range of salt and SDS concentration in which micelles can be made. 
The size of these particles for a (GVGVP)40-foldon can be controlled and be kept as small 
as 20 to 30 nm. It is potentially possible to have even smaller micelles using shorter ELP 
chains.   
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Several other ELP micelles have been reported, most using a diblock polymer 
configuration. In recent work by Fujita et al. a hydrophobic block of different lengths of 
ELP was combined with a C-terminal hydrophilic polyaspartic acid block resulting in 
micellar particles.
3.24
 They showed the formation of micelles only for ELP molecules 
with at least 80 pentapeptide repeats and no micelle formation was observed for 
(GVGVP)40. In another work by Dreher et al., two different ELP molecules with total 
length of 124 to 184 repeats of pentapeptide was used as the building block for micelle 
formation.
3.5
 These two ELP molecules with two different transition temperatures were 
used to make micelles in the temperature range between their transition temperatures.  
These resulted in micelles of 35 to 45 nm.   
Since our system uses a small hydrophilic head group, short ELP molecules can be 
used to make these micelles and quite small aggregates have been achieved. Additionally, 
the second hydrophilic block does not restrict the responsiveness of the micelles. In a 
very recent study it has been shown that the transition temperature of block copolymers is 
also a function of the way that polarity is arranged and distributed along the ELP 
chain.
3.50
 In an ELP block copolymer this can add to the complexity of controlling the 
transition temperature. For our system this is not an issue and we are able to control the 
characteristics of the particles in a more precise way. This study demonstrates the 
possibility of making small micellar particles without the need of using block 
copolymers. Even though this approach relies on non-physiological salt concentrations, 
there is no reason that modification of the head group cannot produce similarly small 
particles in physiologically applicable salt concentrations. This will make these particles 
appealing for applications such as targeted drug delivery. 
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3-6. Conclusions 
We have designed and constructed a new responsive three-armed star elastin-like 
polypeptides and by using a trimer forming oligomerization domain. This new construct 
exhibits typical behavior of ELP molecules, except at low salt concentrations where it 
responsively forms micellar particles above its transition temperature. The process of 
micelle formation is thermally reversible and the particles are shown to be stable at 
temperatures above the transition temperature and can be made as small as 20 to 30 nm in 
diameter. The size of these micelles is among the smallest ELP particles that have been 
reported. Salt and surfactant were observed to affect the stability and size of the micelles, 
and by adjusting these two parameters the size of these particles can be controlled. 
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Chapter IV 
Size and Shape Characterization of Thermoreversible Micelles of 
Three-armed Star Elastin-like polypeptides 
 
4-1. Abstract   
Three-armed star elastin-like polypeptides have been shown to form micelles in certain 
solution conditions. Here, a thorough study of size distribution, shape, and molecular 
weight of these micelles at different salt concentrations and pH values was done. Multi 
angle dynamic light scattering was used to study the formation, reversibility, and size of 
the micelles under different conditions. As a function of the solution salt concentration, 
two distinct regimes based on micelle size and shape, as well as a transition region 
between them, were identified. Static light scattering was done to study the molecular 
weight and anisotropy of the micelles in each regime. The anisotropic behavior and the 
elongation of the particles was then studied by polarized and depolarized dynamic light 
scattering and a model for the micelles at each regime was proposed. The size of the 
micelles were verified independently using viscosity measurements. The results of this 
study suggest that there is big jump in size and molecular weight of the micelles from the 
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first to the second regime, and the shape of the micelles transition from spherical to 
cylindrical micelles with more than 10:1 axis ratio. The micelles were then crosslinked 
into responsive nano-particles that are stable and responsive in physiological conditions.     
4-2.Introduction 
Self-assembly of macromolecules into well defined shapes and geometries has been 
studied for many years but during the past decade it has received particular attention with 
the need for developing nano-scale materials for delivering drugs, genes, or other agents 
in the rapidly growing field of nanomedicine and targeted delivery.
4.1-5
 The use of these 
well-defined self-assembling systems in minimizing premature drug release, maximizing 
drug circulation time, decreasing systemic toxicity, and increasing drug availability to the 
targeted organs have made them the focal point of many studies. Most of these nano-
scale self-assembled particles are based on either liposomes or large polymeric molecules 
in the form of polymer conjugates or polymeric micelles.
4.6
 Among these polymeric 
materials, micelles have been shown to have great potential for drug loading and 
administration.
4.7, 4.8
 They were introduced as potential drug delivery vehicles in the 
1980’s,4.9, 4.10 particularly for hydrophobic drugs with low solubility in water, they have 
superior characteristics in comparison with other nano-scale carriers based on their small 
size, relative ease of control over their shape and size, and high drug loading capacity. It 
has been shown that using micelles as drug delivery vehicles not only maintains the drug 
concentration at higher levels in the system but also gives the opportunity to modify the 
surface of the micelle with ligand binding receptors for targeted delivery.
4.6
 It has also 
been shown that micelle shape, in addition to its size has a direct effect on the drug 
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delivery efficiency,
4.11
 and so a thorough understanding of size and shape of the micelles 
in each system has practical importance in designing drug delivery systems.  
In general, the structure of polymeric micelles is based on the spontaneous self-
assembly of amphiphilic polymer molecules, called unimers, under certain solution 
conditions.
4.12
 In most cases the core of the micelle, consisting of the hydrophobic blocks, 
can act as a depot for hydrophobic molecules. The size of the micelle is usually dictated 
by the kinetic and thermodynamic stability of it based on the geometry of the unimer. 
While the block length would affect the disassembly rate of the micelles, the 
thermodynamic stability of the system is affected by the micelle interactions in solution. 
But since the thermodynamic stability of micelles are generally high above the critical 
micelle concentration (a concentration at which formation of micellar particles is 
energetically favorable), the length and chemical characteristics of blocks are usually the 
most effective parameters in determining final shape and geometry of the micelles.
4.6
 
The same concept of critical micelle concentration can apply to a solution at a constant 
concentration in which increasing the temperature would push the solution towards the 
aggregation of the monomers into micelles at a temperature called the critical micelle 
temperature (CMT).  
The critical micelle temperature for polymer micelles can be attributable to lower 
critical solution temperature (LCST) behavior observed, where in some polymeric 
systems the polymer begins to phase separate at high temperatures. One of the most well-
known polymeric systems possessing LCST behavior is poly(N-isopropylacrylamide) 
(PNIPAm) which has a LCST of 32˚C and has been used in developing many 
temperature responsive polymeric systems.
4.13-16
 It is a relatively flexible system and has 
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been shown that the blocks of the copolymers can be chosen such that PNIPAm would 
act as either core or shell of the micelle.
4.15, 4.17
  
Another approach to make responsive polymer micelle systems is by using 
environmentally responsive peptide-based polymers. The best known family of 
responsive polypeptides is elastin-like polypeptides (ELP).
4.18
 These polymers consist of 
repeats of (Val-Pro-Gly-Xxx-Gly) in which Xxx can be any of the naturally occurring 
amino acids except for proline.
4.19
 The chemical identity, length and ultimately transition 
temperature of ELP constructs can be precisely controlled from the gene level and their 
transition temperature is affected by the length, sequence, and architecture of the 
polypeptides.
4.20-22
 The fact that they can be designed to respond to many environmental 
stimuli, including temperature, pH, light, and ionic strength makes them ideal for 
developing responsive biomaterials.
4.23-25
  
Molecular self-assembly of ELP molecules to micro and nano-scale constructs has been 
an area of active research in the past few years and many research groups have tried to 
use this highly controllable system to develop medically applicable micelle systems by 
constructing di- or tri-block copolymers of hydrophobic and hydrophilic blocks.
4.26-28
  
Recently, we have designed and constructed a three-armed star ELP molecule 
consisting of a trimer forming oligomerization domain (foldon) and repeats of GVGVP 
which self-assembles into micellar particles.
4.29
 Instead of having a bulky hydrophilic 
polymer block, this system utilizes the compact charged foldon domain as the hydrophilic 
head group. This increases the fraction of the micelle consisting of the hydrophobic core. 
Micelles of this system were shown to be as small as 20 nm in diameter and the size 
could be controlled by adjusting the salt concentration in the solution. The initial 
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characterization of this system was primarily based on data from UV-vis spectroscopy 
and single-angle dynamic light scattering particle size analysis. Our results suggested the 
existence of spherical particles in salt concentrations up to 15 mM and two other regimes 
at higher salt concentrations, one between 15 to 45 mM and the third one above 45 mM.  
Although our previous study provided insight into this new system and its ability to 
form micellar particles with predictable sizes, the single angle dynamic light scattering 
did not give us enough information to characterize the shape of the particles and, at times, 
their wide distribution.
4.29
 Other limitations of our previous study were the low laser 
power and insufficient quality of the optics in the particle-sizer used and the lack of 
capability for adjusting the optical parameters of the system.  
The scope of the current study is to fully describe the size and shape of the micelles in 
each regime. We use data from multi angle dynamic light scattering to confirm the sizes 
of particles in each regime and to better understand the geometry of them. Static light 
scattering measurements along with polarized and depolarized dynamic light scattering 
were performed at different salt concentrations to study the shape of the particles and to 
determine the molecular weight of the particles in each regime. 
4-3. Materials and Methods 
4-3-1. Polypeptide Preparation  
The genes encoding (GVGVP)n-foldon were designed and constructed using standard 
molecular biology methods as previously described.
4.29
 The exact sequence encoded by 
the gene as confirmed by DNA sequencing (Cleveland Clinic) is MGH-(GVGVP)40-
GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL. The (GVGVP)40-foldon gene was 
expressed and purified with yields between 100 to 200 mg/ml as previously described.
4.21
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The purity of the sample and its molecular weight were confirmed by SDS-PAGE gel and 
ion-spray quadropole/time-of-flight mass spectroscopy (AB/Sciex), respectively.  
4-3-2. Sample Preparation 
Samples for measurement were made by diluting the PBS stock solutions in reverse 
osmosis purified water (Millipore, 18.2 MΩ-cm). Salt concentration was adjusted by 
adding NaCl solution from a 5 M stock solution to the desired concentration. The pH of 
the samples was then adjusted using 1 M NaOH solution. To make sure that pH had 
stabilized, samples were left at room temperature after initial pH adjustment for at least 
half an hour and the pH was measured again and, if necessary, adjusted to the desired pH 
value. The samples were then filtered using 0.22 μm Millipak filters (Milex-GV, 0.22 
µm, Millipore) into borosilicate glass cuvettes. The cuvettes were cleaned prior to use by 
soaking the cells for 30 minutes in concentrated sulfuric acid and then for 10 minutes in a 
strong oxidizing solution (containing 2 molar NaOH and 0.2 molar KMnO4). The cells 
were then rinsed by water and dipped into a dilute HCl solution for several times before a 
through rinse with deionized water and dried using ultra high purity Nitrogen gas 
(99.9%). For each measurement a fresh sample was loaded into a newly cleaned cuvette.   
4-3-3. Light Scattering 
Static and dynamic light scattering experiments were done using an Ar
+
 Spectra 
Physics 2017 laser with wavelength of 514.5 nm and maximum power of 2 W. The 
system was optically isolated to eliminate the background noise. A TSX-1A variable 
neutral density filter (ORIEL) and a VPH-4 optical iris (NRC) were used to control the 
power of the laser reaching the sample when necessary. The laser beam was directed to 
the sample in a BI-200SM Goniometer (Brookhaven Instruments) using a series of 
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mirrors. The sample cell was held in a decalin-filled vat and the temperature of the cell 
was controlled using a HAAKE-A81 refrigerated water bath (± 0.2ºC). Dynamic light 
scattering (DLS) experiments were carried out at scattering angles from 40º to 145º with 
a step of 5-15º. Scattered light was detected by BI-DS2 photomultiplier and analyzed 
with BI-9000 digital correlator.  
DLS analyzes fluctuations in intensity (I) of the scattered light through measured 
intensity-intensity correlation function S(q,),  
          (4-1) 
Where q is the scattering vector,  is the delay time, and T is the duration of the 
experiment. The magnitude of scattering vector is, 
          (4-2) 
Here n is the refractive index of the solvent, θ is the scattering angle and λ0 is the 
wavelength of the light in vacuum. The measured spectra S(q,t) were analyzed by line 
shape analysis method
4.30
, in which intensity correlation function is converted to a field 
correlation function g
(1)
(q,t) by Siegert relation. g
(1)
(q,t) was then fit to a sum of stretched 
exponentials using nonlinear-least-squares simplex algorithm.
4.31
 
          (4-3) 
Here N is the number of observed relaxation modes labeled by i, i is the decay 
pseudorate, i is the stretching parameter and Ai the amplitude. It was found that most of 
the data could be fit with either one or two modes. g
(1)
(q,t) can also be expressed as a 
Laplace Transform of the normalized distribution of decay rates A(),  
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          (4-4) 
The analysis of the correlation function can yield mean relaxation times (<-1>) of the 
most prominent modes. The spectral time moment analysis was applied in this study to 
determine the zeroth time moment for i
th
 mode obtaining the mean decay rate  for that 
mode.
4.31
 An apparent mean diffusion coefficient Di corresponding to each mode can then 
be calculated from each mean decay rate as 
        .                             (4-5) 
The spectral time moment analysis allows for calculation of mean diffusion coefficient 
of each mode from an accurate fit of a field correlation function. The approach considers 
the properties of each observed mode in detail to identify physical processes 
corresponding to this mode. Specific methodology, applications, and advantages of this 
method over Inverse Laplace Transform based methods are described elsewhere.
4.30, 4.32
 
Depolarized DLS measurements were done using the optical system described above 
with a Newport RSP 2T polarizer inserted between the scattering cell and PMT. The 
polarizer was rotated 90˚ between vertical and horizontal measurements. The laser light 
in the all experiments was vertically polarized and inserting the polarizer into the system 
resulted in a 3-5% decrease in the intensity of the light. 
To determine the mean translational (Dt) and rotational (θ) diffusion coefficients from 
polarized and depolarized dynamic light scattering, the measured spectra were analyzed 
using spectral time moment analysis described above to obtain the mean decay rates 
(<i>VH and <i>VV) of the correlation functions for the horizontally (VH) and vertically 
scattered light (VV). 
138 
 
The mean diffusion coefficient (Di) and mean rotational diffusion (θ) were then 
determined from plotting corresponding <Γi> vs. q
2
 from VV and VH and data using 
〈  〉       
         (4-6) 
and  
〈  〉       
       ,      (4-7) 
in which DTi is the slope and θRi is the intercept of the plot from Equation 4-7. 
In static light scattering (SLS) experiments the angular dependence of the reduced 
time-average scattering intensity, known as excess Rayleigh ratio Rvv(q) was measured. 
SLS measurements were carried out with the same optical system as DLS measurements 
but with a smaller angular step and only samples of 10 μM concentration were used. SLS 
data was analyzed in terms of Berry equation for a case of dilute solution with 
concentration C. 
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 〉    )     (4-8) 
Here, K=4n2(dn/dc)2/(NA
n is solvent refractive index, dn/dc is the differential 
refractive index increment of the solution, NA is the Avogadro number, Mw is the weight 
average molecular weight, <Rg> is z-average root mean square radius of gyration, and A2 
is the second virial coefficient. In cases of significant nonlinearity of Kc/Rvv(q), the Berry 
plot equation was used for the extrapolation. It should also be noted that the 
concentration of particles in our study was low, making A2 negligibly small, which makes 
extrapolation to zero concentration unnecessary. The extrapolation to zero scattering 
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angle yielded the apparent Mw while the fit of the angular dependence of Kc/Rvv(q) 
produced an apparent Rg. 
In order to reliably obtain a molecular weight from static light scattering measurements 
the differential refractive index increment (dn/dc) of the solutions had to be directly 
measured. Bruce-Phoenix differential refractometer with sample cell controlled by 
Thermo RTE-7 refrigerated bath/circulator was used for these measurements. The values 
of the measured dn/dc under different were then used in the calculations. 
4-3-4. Micelle Crosslinking 
To crosslink the micelles, a 5 µM solution of (GVGVP)40-foldon in 10 mM PBS 
solution and pH of about 10.2 the solution was heated up to 55˚C. Different 
concentrations of GTA solutions (2.5%, 5%, 10%) were then added to the solution drop 
by drop and the solution was stirred at 55˚C for about 18 hours. The final product was 
then filtered using 0.22 µm filters. 
4-4. Results 
4-4-1. Dynamic light scattering 
We performed single angle dynamic light scattering using a 10 μM (GVGVP)40-foldon 
solution with salt concentration of 10 mM (Figure 4-1) to confirm the temperature 
induced formation of micelles, including the reversibility of the process and 
reproducibility of the data, as previously observed
4.29
. Using the more powerful light 
scattering apparatus, significantly bimodal correlation functions were measured. The 
faster mode (with D = 5-9×10
-7
 cm
2
/s), was found to have small standard deviation and 
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no dependence of apparent diffusion coefficient on scattering angle, indicative of small 
diffusive particles with an apparent hydrodynamic radius (Rh) of about 3 to 5.5 nm in 
agreement with our previous findings
4.29
. An additional slower mode which was not seen 
previously was also observed below the transition temperature was observed. This mode, 
with a typical D of 1-10×10
-8
 cm
2
/s, was not seen previously, but had a significant 
contribution to the measured correlation function (with amplitude of 75-85%) and had a 
stretching parameter b=0.6-0.7 which indicates significant polydispersity of the 
scatterers. The estimates of apparent hydrodynamic radius for this mode (appearing on 
Figure 4-1) are somewhat misleading as this mode was found to have a strong 
dependence of D on scattering angle (atypical of center of mass diffusion of a particle). 
This mode is indicative of slower processes in the system such as relaxation of the 
unfolded trimers. It should be noted that the different angular dependence of the observed 
two modes argues against averaging the two processes into one. The faster mode (D = 5-
9× 10
-7
 cm
2
/s), was found to have smaller standard deviation and diffusive in multi-angle 
experiments showing no dependence of apparent diffusion coefficient on scattering angle.  
Above the transition temperature, only a single mode was observed for solutions with 
10 mM of salt. Using a second mode to fit measured correlation function could not be 
justified in this case as the RMS error did not change significantly with the addition of 
the second mode to the fit (see supporting information). The single observed mode was 
found to have a D which was independent of a scattering angle, corresponding to 
particles with an apparent hydrodynamic radius of 12 to 15nm.  
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Figure 4-1. Micelles radius as a function of temperature for 10 µM solution of (GVGVP)40-foldon at pH 
of 10.2 and 10 mM salt concentration. Below the transition temperature the correlation functions can be fit 
to two modes and a two-mode distribution of particle sizes was observed. Above the transition temperature 
only one population of particles with fairly narrow size distribution was observed. 
The experiments were repeated at least three times and the data points are shown to be 
in very good agreement from one experiment to another. Also, the reversibility of the 
micelle formation process was confirmed by showing formation of micelles with increase 
in temperature and disassembly of micelles with decrease of temperature. 
The pH dependency of micelle formation process was investigated by measuring the 
size of the micelles formed as a function of pH at constant salt concentration. A series of 
10 μM protein samples with 40 mM salt ranging from pH 9.6 to 11.5 were characterized 
(Figure 4-2). The results show a gradual decrease in micelle size from pH 9.6 to 10.2, 
above which a fairly constant size was observed. Based on these results all of the 
following measurements were done after adjusting the protein solutions between pH 10.2 
and 10.4. 
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Figure 4-2. Effect of pH on micelle size. The micelles were seen to only exist in pH values above 9.6. A 
gradual decrease in the size of the particles was observed from this pH value to about 10.2 and then the 
micelle sizes reach a plateau.  
The correlation functions of micelles formed above the transition temperature were 
carefully studied at different scattering angles to further investigate the size and shape of 
micelles. The experiments were performed in the range of salt concentrations from 5 to 
60 mM. At all salt concentrations at 50˚C (above the transition temperature), the 
normalized correlation functions of (GVGVP)40-foldon solutions measured at scattering 
angle of 90˚ cover two to two and half orders of decay, signifying a good quality of the 
experiments (Figure 4-3). Comparing the normalized correlations functions, it is apparent 
that the lower salt concentrations (below 20 mM) display faster decays of the correlation 
functions corresponding to particles of smaller apparent size. These correlation functions 
are comparable to each other indicating a constant apparent size in this salt regime. The 
increase of salt concentration to values above 30 mM yields a significant change in shape 
of correlation function. Higher salt data display much slower decays corresponding to 
particles with larger apparent sizes. 
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Figure 4-3. Dynamic light scattering correlation functions of 10 µM solution of (GVGVP)40-foldon at 
different salt concentrations. The two and half orders of magnitude decay of correlation function shows the 
good quality of the data. In the low salt regime (below 15 mM), all are nearly identical fast decaying 
correlation functions. A similar behavior is observed for high salt concentration regime (above 30 mM) 
except for much slower decay rate. In between the two regimes an area of transition is seen. 
The estimates of the diffusion coefficients for different salt concentrations were 
obtained in two different ways (Figure 4-4): from single angle experiments at 90˚ and 
from multi-angle measurements, in both cases using either one- or two-mode fits. For the 
single angle (90˚) measurements were analyzed with two modes, and two apparent 
diffusion coefficients are reported. For the multiple angle measurements, Figure 4-4 
reports only the diffusion coefficients of the angular-independent (diffusive) modes.  
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Figure 4-4. Diffusion coefficients as a function of salt concentration for a 10 µM solution of (GVGVP)40-
foldon. The diffusion coefficients show the two salt regimes and a transition region. The first regime with 
higher diffusion coefficients corresponds to particles with smaller diameters while above 30 mM of salt a 
clear decrease in the diffusion coefficients is observed. Fitting the correlation functions to a single mode 
(circles) or using the diffusive mode (square) of a bimodal fit result in very similar trends but some small 
differences in the diffusion coefficients. 
Plotting the diffusion coefficients above the transition temperature versus the salt 
concentration shows the two distinct regimes where micelles are formed as previously 
reported
4.29
, but with improved concentration resolution, a transition region is observed 
between them (Figure 4-4). The first regime is up to about 15 mM of salt and the second 
regime is between 30 and 60 mM salt where fairly constant diffusion coefficients are 
observed. A significant decrease in diffusion coefficients (an increase in the micelle 
sizes) is observed in the transitional region between the two regimes. The relative 
agreement between values of D for two modes of 90˚ measurements and D from angular 
measurements for low salt indicates relative monodispersity and isotropic nature of 
scatters. On the other hand at high salt, there is a significant difference not only between 
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D for the two observed modes of 90˚ measurement, but also between those and the 
angular results. This is indicative of either significant polydispersity of the sample or/and 
anisotropy of the sample. 
The calculated diffusion coefficient (D) of each apparent mode of these correlation 
functions was then used to calculate corresponding hydrodynamic radius of the particles 
Rh at each salt concentrations using Stokes-Einstein equation, 
   
  
    
         (4-9) 
where k is Boltzmann’s constant, T is temperature, and η is the solvent’s viscosity. This 
relationship assumes a suspension of dilute, spherical, monodisperse particles in a small 
molecule solvent. Our system is composed of dilute particles in a small molecule solvent. 
However, one cannot a priori assume the monodispersity of the system or the spherical 
shape of the micellar particles. Therefore, measurements at various scattering angles are 
needed to ascertain the possibility of using Equation 4-9 in the analysis. If the decay rate 
of a correlation function scales linearly with the scattering wave vector q with zero 
intercept, then the particles are considered to be spherical and Equation 4-9 can be used 
to estimate their hydrodynamic radius.   
A representative angular dependence for the first salt regime is presented as a plot of 
the decay rate as a function of scattering wave vector (Figure 4-5a). The two-mode fit of 
the correlation functions in this regime yields two linear dependences of Γ vs. q2 with 
small intercepts corresponding to apparent radii of ~9 nm and ~18 nm. The one mode fit 
also gives a linear Γ vs. q2 dependence with a small intercept corresponding to an 
apparent radius of ~14 nm. As mentioned before the addition of the second mode to the 
one-mode fit in analyzing the data does not change the RMS significantly. In addition, 
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the obtained two mode parameters have similar angular dependence to the one mode fit 
results yielding the apparent sizes that average to a value similar to a single mode fit 
radius. This indicates that the observed particles have somewhat broad distribution of 
sizes but still on average behave as spherical micelles with a radius of ~14 nm. These 
sizes are very well in agreement with our previously reported sizes for this regime
4.29
. 
The spherical shape of these particles is also confirmed by depolarized dynamic light 
scattering in which no significant signal was detected from the particles at low salt 
concentrations.  
For the transitional region the plot of Γ vs. q2 shows linear dependence of decay rate on 
scattering angle for the first mode (with a small intercept) and somewhat different 
behavior for the second mode (Figure 4-5b). In fact, for the second mode, there is some 
deviation from the linear Γ vs. q2 dependence at high angles (large q), which is an 
indication of some micelle anisotropy in this regime. The nonlinearity of the second 
mode is noticeable but not as strong as at higher salt concentrations   
For the second regime, with the single mode fits, the obtained Γ vs. q2 shows even 
more non-linearity at high angles (above 100°) (Figure 4-5c). This non-linearity increases 
with increased in salt concentration. Therefore the data at high salt concentrations had to 
be analyzed with two modes due to significant bimodality of measured correlation 
functions. The faster of the two modes is somewhat diffusive (linear Γ vs q2 with 
significant non-zero intercept) yielding micelles with apparent hydrodynamic radius of 
about 45-50 nm. This mode does not change with increasing of salt concentration (Figure 
4-4). On the other hand, the slower mode is completely non-diffusive, as seen from a lack 
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of strong angular dependence of the decay rate (Figure 4-5c) and the values of the 
stretching exponent (β=0.6-0.85). 
 
a       b   
 
c  
 
Figure 4-5. Decay rate (Γ) as a function of scattering vector (q2) from dynamic light scattering at different 
incident angles. For low salt regime at 10 mM salt concentration (a), the single-mode fit or bimodal fit 
result in linear dependencies. The two-mode fit results in two ranges of radii which can be averaged to the 
radius from a single mode fit and based on the RMS values, a single-mode fit seems to be sufficient for this 
region. For the transition region at 20 mM salt concentration (b), the two-mode fit results in a non-linear 
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deviation in the slow mode at high angles that might be the effect of some anisotropy in the particles shape. 
The high salt regime at 40 mM salt concentration (c), shows a non-diffusive slow mode from the two-mode 
fit which can be an indication of significantly elongated particles. 
4-4-2. Static Light Scattering (SLS) Measurements 
To further investigate the size and shape and molecular weight of the micelles a series 
of static light scattering (SLS) measurements were done at different salt concentrations. 
The average intensity of scattered light (I) was measured at a wide range of angles and 
compared with the solvent scattering under identical conditions. The angular dependence 
of the reduced intensity I was analyzed (Figure 4-6), and the radius of gyration, Rg, was 
obtained from the Berry fits of the data.  
The dependence of I
-1
 vs. q
2
 above the transition shows very little (if any) angular 
dependence at low salt (below 20 mM) which indicates that particles present under those 
conditions are too small (< λ/20) to diffract light. Both in transitional region and in the 
second salt concentration regime the angular dependence is strong indicating the presence 
of large particles.   
The radius of gyration of micelles was calculated using the Berry formula (Equation 4-
8) due to significant curvature seen in I
-1
 vs. q
2
 dependence at higher salts. The obtained 
values for Rg are listed in the Table 4-1. The salt concentration dependence of Rg is 
similar to salt concentration dependence of Rh. Both apparent sizes slightly increase with 
salt concentration up to 15 mM, change fourfold in the transition region (15<C<30mM), 
continue to slightly increase with concentration in the second concentration regime, and 
show significant increase in size above 45 mM. The ratio of Rg to Rh was also calculated 
for different salt concentrations. The ratio Rg/Rh overall increased from 1 at low salts to 
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1.45 at high salt indicating some elongation of the observed particles. However, this 
result has to be taken with caution as most of the analyzed DLS data was bimodal 
yielding two values for Rh while SLS data produced one value of Rg.  
 
 
Table 4-1. Rg and Rg/Rh at different salt concentrations for (GVGVP)40-foldon in 10 µM solution 
Extrapolation to zero scattering angle, measurement of the scattering by the standard 
(toluene), and the direct measurement of the differential refractive index increment 
(dn/dc) of the solutions permits the calculation of the molecular weight, Mw, of the 
micelles (Figure 4-7). Mw reveals a salt concentration dependence reverse that of the salt 
concentration dependence of D (Figure4-7). Namely, in the first concentration regime, 
Mw increases slightly from 4,500 to 6,500 kDa with salt concentration increase. In the 
transitional region, Mw increases to about 70,000 kDa. In the second concentration 
regime, Mw is relatively constant up to 45 mM of salt. 
 
Salt(mM) Rg for 90˚ angle Rg/Rh for 90˚ angle  
5 14.5 
 
1.06897 
10 15.4 1.11688 
15 16.1 1.03727 
20 20.6 0.99029 
25 36.4 1.31044 
30 63.5 0.99213 
35 67.2 0.98512 
40 67 1.00746 
45 72 1.22222 
50 83.6 1.26435 
60 82 1.42805 
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Figure 4-6. Average intensity of scattered light as a function of scattering vector at different angles. At low 
salt concentrations (10 mM) no angular dependency is observed which indicates the presence of very small 
particles. At high salt concentration an obvious and somewhat non-linear angular dependence points toward 
more elongated particles. 
 
Figure 4-7. Molecular weight as a function of salt concentration. The same two high and low salt 
concentration regimes and the transition region are observed from both Zimm and Berry plots. In the low 
salt regime a fairly constant molecular weight distribution around 3000 to 4,000 kDa is measured while 
above 30 mM of salt a considerable increase in the molecular weight is measured. There is also a jump in 
the high molecular weight region above the 45 mM salt concentration. 
151 
 
4-4-3. Polarized and Depolarized Dynamic Light Scattering 
Polarized (VV) and depolarized (VH) dynamic light scattering experiments were 
carried out to study the extent of elongation of the micelles in each salt regime under the 
same conditions that unpolarized dynamic light scattering experiments were carried out. 
In general, VV showed a much greater intensity than VH measurements with the same 
optical settings yielding depolarization ratio of 0.01 or lower. This means that the entire 
unpolarized DLS scattering, which consists of VH and VV components was in essence 
due to VV scattering. Still VH signal was strong enough for reliably measuring 
correlation functions (Figure 4-8). The relationship between Γ and q2 for both VH and 
VV scattering was studied and showed a linear dependence with a similar slope in both 
cases. The slopes of VV and VH decay rates and the intercept of VH decay rate were 
used to calculate transitional and rotational diffusion coefficients of the micelles based on 
Equations 4-6 and 4-7 (Figure 4-9). 
 
Figure 4-8. Correlation functions from depolarized light scattering at different angles. The two orders of 
magnitude decay shows good quality of the data while the obvious angular dependence of the correlation 
functions points towards the elongation of the particles. 
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Figure 4-9. Decay rate (Γ) as a function of scattering vector (q2) from polarized and depolarized dynamic 
light scattering. The two lines are appeared to be parallel. The polarized light data set (squares) have zero 
intercept while depolarized light data (circles) has a positive intercept corresponding to the rotational 
diffusion coefficient. 
4-4-4. Viscosity Measurements 
Based on the viscosity measurements done of (GVGVP)40-foldon solutions in a range 
of concentrations from 200 µM to 600µM at 40˚C, the intrinsic viscosity is calculated to 
be 1.92×10
-4
 µM
-1
. (Data from Sumit Kambow Master’s thesis, Cleveland State 
University, 2012)  
4-5. Discussion 
4-5-1. Effect of pH 
Micelles of (GVGVP)40-foldon are observed to form only above pH 9.6. This is above 
the pKa of a typical N-terminal amine (about pH 9), and it is presumes that at lower pH 
values, the positive charges on the ELP tails are sufficient to disrupt micelle formation by 
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giving a net charge to the ELP core. By neutralizing a higher fraction of the N-termini at 
higher pH values, the phase separation of the ELP in the core of the micelle becomes 
energetically favorable. 
The mechanism with which pH changes affect the micelle size is not clear but one 
explanation might be the effect of end charges preventing the three arms from folding 
together which then results in more extended chains of ELP in the micelle core. It should 
be noted that the size of the micelle reaches a minimum at about pH 10.2 when the 
majority of N-terminal amines are deporotonated. At a pH of the pKa, about 50% of all 
the N-terminal amines are deprotonated and so there are still considerable charged N-
terminal amines but above pH of about 10, we expect most the N-terminal amines to be 
neutralized.  
4-5-2. Micelle Formation and Characterization 
Based on our findings from the dynamic and static light scattering in this work and our 
previously reported data
4.29
, the micelle formation in this system can be studied in 
different regimes based on the total salt concentration of the solutions. Here a thorough 
study of the micelles size and shape in each regime is presented. 
4-5-2-1. Regime I. This regime occurs in solutions with up to15 mM salt, where a fairly 
constant diffusion coefficient is observed above the transition temperature (Figure 4-4). 
Below the transition temperature in this salt concentration regime DSL reveals two 
distinguishable modes. The diffusive mode was found to correspond to particles with 
hydrodynamic radius (Rh) of about 3 to 5.5 nm. This mode corresponds to (GVGVP)40-
foldon trimers in the form of random coils. The second mode observed below the 
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transition was found to be non-diffusive and corresponded to a much slower process in 
the system such as relaxation of the unfolded trimers.  
The single mode observed for the 10 mM salt above transition (or the average of the 
two similar diffusive modes) was found to be diffusive (Figure 4-5a) and corresponds to 
particles with an apparent hydrodynamic radius of 12-15 nm, which is corresponds to 
micelles formed from folded (GVGVP)40-foldon trimers.  
To better understand the geometry of the micelles at each regime static and dynamic 
light scattering measurements should considered together. In the first concentration 
regime (up to 15 mM) a slightly increasing molecular weight from about 3000 to 4000 
kDa was measured from static light scattering. Although the protein content of these 
micelles cannot be measured directly, if we consider that the aggregation in the micelles 
is the same process as the bulk aggregation, there should be about 37% protein in the 
micelles.
4.18
 That translates to about 20 to 24 trimers in each micelle at the low salt 
concentration considering that (GVGVP)40-foldon trimer has a molecular weight of about 
60.4 kDa. If we consider 3500 kDa as the average molecular weight of the micelles in 
this salt regime, the density of the spherical micelle of such molecular weight and a 30 
nm diameter can be calculated to be 0.42 g/cm
3
. This value is of course much less than 
the approximate density of pure ELP which is estimated to be about 1.1 to 1.2 g/cm
3
 and 
so there should be considerable amount of water associated with the micelle that is 
moving along with the particle and is measured in DLS as a part of the micelle size but is 
not measured in SLS and so is not included in the molecular weight. 
The actual hard core sphere of the micelles and the extent of water shell can be 
calculated based on the ELP mass in each micelle. The mass of the average number of 
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trimers, 24 of (GVGVP)40 with monomer mass of 17 kDa is calculated to be 2.08×10
-18
g. 
Considering that the ELP specific gravity of about 1.1, the volume of this mass of ELP is 
about 2290 nm
3
. Since the core of the micelle should only contain about 37% protein, the 
total volume would be about 6020 nm
3
. The radius of a sphere with such volume is then 
calculated to be 11.3 nm. This is the core of the micelle which consists of aggregated 
ELP chains only and the foldon head groups should be added to this sphere to calculate 
the actual size of the micelles. From protein data base, foldon in its folded state is a 
globular protein which has about 3.1 nm in diameter and so the radius of the micelle 
should be about 14.4 nm. This is very close to 15 nm from DLS measurements and the 
difference can be contributed to the outside water shell on the surface of the micelles. We 
believe this water shell is closely organized around the micelles outer surface and is 
behaving differently from the bulk water in that it can move along with the particles so it 
is measured in correlation functions of DLS measurements yet the nature of this water is 
is not tightly associated to the protein like the water trapped inside the micelle, and so it 
cannot be seen from SLS measurements (Figure 4-10). 
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Figure 4-10. Schematic of the spherical micelles at low salt regime. The coacervate core interior 
hydrophobic sphere of the micelle which consists of folded ELP trimers is calculated to be close to 11.3 nm 
in radius. Foldon head group is about 3.1 nm in diameter which gives a total of about 14.4 nm in radius to 
the micelle. There is a small water shell surrounding the micelle that makes it to appear slightly larger in 
dynamic light scattering. 
Viscosity measurement data was used to independently verify molecular weight and 
size of the micelles in the first salt regime. The intrinsic viscosity of (GVGVP)40-foldon 
at 40˚C was measured to be 1.92×10-4 µM-1. Using this value and Einstein equation,   
      
  
     
[ ]
         (4-10) 
the density of the micelles is calculated to be 0.262 g/cm
3
 with ±10% error. This density, 
together with the volume of a spherical micelle with 30 nm in diameter, results in 
3.71×10
-18
 g, as the total protein mass (ELP, foldon, and water) in each micelle. This 
mass, translates to 73 ELP molecules or about 24 trimers in each micelle. This number is 
essentially the same as what was calculated based on light scattering data analysis and 
confirms the micelle core size. 
To further study the consistency of the results from different measurements in our 
experiments including molecular weight from SLS, hydrodynamic radius from DLS, and 
density of micelles from viscosity measurements, each of these values can be calculated 
using the other two measured values. Comparison between these values shows fairly 
good agreement between calculated and measured values (Table 4-2) 
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 experimental calculated 
Mw (g/mole) 3482-3603 1707-4182 
Rh (nm) 12-15 12.41-13.56 
ρ (g/cm3) 0.236-0.296 0.409-0.827 
Table4-2. Comparison of measured and calculated values of Mw, Rh, ρ at low salt regime. 
 
This spherical shape at low salt is also consistent with the molecular geometry based on 
theory that ELP assume a more ordered structure of β-spirals above their transition 
temperature.
4.19
 The β-spiral of the (GVGVP)40 polypeptides, which acts as the 
hydrophobic tail of the construct is considered to have the maximum length of about 15 
nm. Since the maximum radius of a spherical micelle cannot exceed the length of the 
hydrophobic tail, micelles of up to about 15 nm in radius are expected. This is consistent 
with the size that is observed in this regime and we speculate that these folded trimers are 
the unimers of these spherical micelles at these low salt concentrations. It is noticeable 
that the micelle core size is observed to be somehow smaller than the expected length of 
15 nm and we speculate that the actual folded construct of ELPs in the micelles are in a 
more compact form than what was calculated based on the molecular model. 
4-5-2-2. Transitional region. The transition region starts around 15 mM salt, where the 
micelles begin to gradually increase in size, and continues to about 30 mM salt when the 
size plateaus (Figures 4-3 and 4-4). The decay rates of correlation functions in this 
regime are slower than in the first regime and the correlation functions can be fit to two 
distinct modes. This region was not observed previously using single angle particle size 
analyzer and above 15 mM salt concentration a jump in the micelle size was reported.
4.29
 
The depolarized dynamic light scattering measurements for samples in this region did not 
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result in meaningful and reproducible data which might be an indication of unstable and 
transitional particles that are constantly changing in size and shape. SLS experiments in 
this region shows significant linear angular dependence indicating that scattering species 
are big enough to diffract light and that, on average, there is no significant anisotropy in 
the system. In this region, the particles get larger and the molecular weight increases up 
to about 70,000 kDa which is the start of the second regime (Figure 4-7). 
We think inconsistencies between the new results and our previous study can be 
explained by the fact that our previous data was based on single angle measurements and 
the results were compiled and analyzed by the instrument that had no ability to assess 
possible non-spherical nature of the particles. Here we have expanded our experiments to 
multi angle light scattering done with more powerful laser and better optics that allowed 
us to actually probe the entire breadth of particulates in tested solutions, their apparent 
size and their shape.  
4-5-2-3. Regime II. This regime starts from about 30 mM salt concentration and very 
similar decay rate of correlation functions from one salt concentration to another is 
observed (Figure 4-3). But these decay rates are much slower in comparison to regime I. 
The slower decays for the correlation functions correspond to bigger particles. This is in 
general agreement with our previous findings but more accurate results are obtained by 
fitting the correlation functions to a two-mode model. Based on the two-mode fit 
analysis, the slow mode is consistently present in our analysis in this concentration 
regime and constitutes about 50-60% of correlation function. The presence of this mode 
either indicates significant anisotropy of micelles or is a probe of other slower processes 
in a sample such as diffusion of random coils. In the case of this salt regime the two 
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modes should not be averaged as they exhibit a very different nature as apparent from 
different angular dependences. The anisotropy of the micelles in this regime can be seen 
from significant and somewhat non-linear angular dependence of I
-1
 which is an 
indication of bigger and possibly elongated particles (Figure 4-6). 
The huge increase in the molecular weight in this regime is in agreement with 
observations of particle becoming anisotropic in the high salt regime. In the regime of 
highest salt concentrations the apparent molecular weight was found to increase 
somewhat with salt concentration but an average of about 70,000 to 80,000 kDa can be 
observed. 
We believe that at higher salts the head groups of the trimers, which consist of 
negatively charged foldon domain, become smaller. The shape of the micelles is directly 
affected by the packing factor 
      ,    (4-11) 
Where V is the volume and l is the length of the hydrophobic tail and a0 is the surface 
area of the head group. So the smaller head group means a larger packing factor, and 
when it becomes larger than 1/3, the micelles begin to become non-spherical.
4.12
 
Consequently in our system higher salt concentrations push the system towards non-
spherical particles that can accommodate many more of the trimeric monomers leading to 
the much higher molecular weight. These conclusions are in agreement with our SLS and 
DLS data and especially polarized DLS data in which non-zero VH signal indicates that 
the micelles in the second regime are elongated and anisotropic. It is possible that these 
particles have distribution of different lengths of elongated micelles and consequently a 
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distribution of different molecular weights because one can expect very little energy 
barrier between lengths of elongated particles.  
There is also a jump in the size deduced from the second mode in this regime around 
45 mM of salt, which is consistent with where the start of the third regime was reported 
previously.
4.29
 This might be attributed to the fact that at these higher salt concentrations 
the micelle head group is very small and bigger aggregates start to grow. 
4-5-3. Study of the Particles Elongation 
The polarized and depolarized dynamic light scattering at different salt concentrations 
provided us the best tool to study the shape of the micelles under these conditions and the 
non-zero VH signal in the second salt regime proved the existence of anisotropic particles 
in this regime. The correlation function from VH measurements showed some angular 
dependency (Figure 4-8) and the Γ vs. q2 plot of VV and VH resulted in linear 
dependency for both of the measurements, while VH measurements resulted in an 
intercept and the two lines are observed to be parallel (Figure 4-9). This is in agreement 
with what is expected from equations 4-8 and 4-9, in which the slope of this linear 
dependence should be identical and can be used to calculate the rotational diffusion 
coefficient. The intercept from VH measurement is related to the translational diffusion 
coefficient. Based on the data from this plot, we fit the data to cylindrical models to 
calculate the elongation of the particles in each salt concentration. In this system we 
considered a cylinder with radius r which is equivalent to the maximum radius of the 
spherical micelles and length of L and calculated DT and θR using the Broersma 
equations: 
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where k is the Boltzmann constant, T is the temperature and λ is the viscosity. 
By fitting the data from our DLS and polarized and depolarized light scattering 
experiments to this model the extent of elongation of the particles in each regime was 
calculated (Figure 4-11). 
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Figure 11. The extent of elongation of particles as a function of salt concentration from dynamic light 
scattering and polarized and depolarized dynamic light scattering. The data from dynamic light scattering 
was fit to ellipsoidal model and up to about 20 mM the particles are consistently spherical (squares). The 
result of this fit for data above 20 mM results in particles with a much more elongated nature (spheres). The 
polarized and depolarized light scattering data in the second regime results in elongated ellipsoidal particles 
as well (triangles) which can be as long as 800 nm to 1000nm in length. 
Based on this model, the two regimes and the transition region can still be identified. 
The micelles in the first regime are shown to be spheres of about 30 nm in diameter 
which is again consistent with all other measurements and analysis so far and give us the 
final piece of data as a proof of the existence of spherical micelles in low salt 
concentrations. But interestingly the micelles at the second regime which starts around 30 
mM salt concentration show very large elongation up to about 300 to 350 nm. This can 
explain the very different behavior of these particles from DLS and SLS measurements. 
We also used an ellipsoidal model to fit the data and quite similar results were obtained 
which is expected considering the large length to diameter ratio of the micelles which 
makes the ellipsoidal model very close to the cylindrical one. 
Considering the elongated particles at higher salt concentrations with a diameter around 
30 nm and lengths of 300 to 350 nm, the number of trimers that are housed in these 
micelles is calculated to be about 1000 to 1200. From SLS measurements molecular 
weights of micelles in this regime are calculated to be around 70,000 to 80,000 kDa and 
considering about 60 kDa as the molecular weight of each trimer, the number of trimers 
is calculated to be about 500 to 600 in each micelle. The difference between the two 
calculations can be attributed to the fact that the DLS measurements result in Z-averaged 
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values which means a higher than actual lengths for the elongation particles might be 
observed.   
4-5-4. Crosslinking of Micelles and Responsive Particle Formation 
Up to this point we studied the micelle formation of ELP-foldon constructs at low salt 
and high pH conditions. Although responsive micelles have been used in different 
applications as discussed in the first chapter of this manuscript, it is always an advantage 
to have environmentally responsive particles which are stable in any salt or pH conditions 
so that they can be utilized especially in physiological conditions. For that reason many 
efforts have been made in crosslinking micelles into particles using different techniques 
such as UV irradiation
4.33
, chemical reaction with bifunctional crosslinking agents such as 
carbidiimide coupling 
4.34
, 1,2-bis (2′-iodoethoxyl) ethane (BIEE)4.35, Glutaraldehyde4.36 
activated esters
4.37
, disulfide-based crosslinkers
4.38
, and many other techniques.
4.39
 
In our system, since the micelles are formed in non-physiological conditions, it would 
be necessary to crosslink them especially if they are to be potentially considered as drug 
delivery or theronostic particles. 
The first attempt to crosslink these micelles was done by our collaborators in Technical 
University of Munich by using radioactive source and irradiation of a 10 µM sample of 
(GVGVP)40-foldon in 10 mM PBS solution for an hour. The results were mixed and 
although some potentially crosslinked particles were observed by atomic force 
measurement (AFM) imaging, there was not enough evidence to convince us that the 
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particles are still responsive and they can go through a change in their size by passing the 
transition temperature (data not shown). 
The next approach was to do chemical crosslinking of the micelles by using the 
available amines on the N-terminal of the ELP constructs. Dimethyl 3,3-
dithiobispropionimidate (DTBP) is a homobifunctional imidoester that contains 
imidoester group at both ends and can react to the amine groups in the pH range of about 
7 to 10 and produces amidine linkages between them.
4.40
 
 
The crosslinking was done by reacting 10 µM solution of (GVGVP)40-foldon (3 mM 
PBS and pH 9.5) for 2 hours at 55˚C using 300µM DTBP. The reaction was quenched by 
adding 50 mM Tris.HCl. The solution was then dialyzed against 3 mM PBS to remove 
reactants and reduce the pH. The resultant solution was dried on a mica surface covered 
with ZnCl and was then imaged at room temperature by AFM (tapping mode) at room 
temperature. The results show the existence of the particles with diameter around 30 to 
40 nm which is in agreement with the expected size of the micelles in this salt 
concentration (Figure 4-12). This experiment was a proof of concept that we were able to 
crosslink the micelles into particles which are stable at room temperature. 
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Figure 4-12. AFM image of crosslinked particles at room temperature. The micelles were made from a 10 
µM solution of (GVGVP)40-foldon at 10 mM salt concentration and pH of above 10. The micelles were 
then dried on a mica surface and AFM images were obtained in tapping mode. The size of the micelles 
seem to be consistent with the measured size from light scattering. 
 
Glutaraldehyde (GTA) is the most commonly used homobifunctional crosslinker and 
the reaction of this molecule with amines proceed through the formation of Schiff bases 
while subsequent reactions with some reducers results in stable secondary amines.
4.40
 
Although GTA can be polymerized in either acidic or basic conditions, it has been shown 
that the polymerization and subsequently crosslinking is usually most effective in higher 
pH values. That in fact makes it a good candidate for our system in which micelles are 
formed only in alkaline conditions.  
With all the three different GTA concentrations reasonable size particles were observed 
by single angle dynamic light scattering although the best results were obtained using 
higher concentrations of GTA. The particles were shown to be stable at room temperature 
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and had a mean diameter of about 60 to 65 nm. When heated, the size of the particles was 
observed to become smaller with mean diameter of around 45 to 50 nm in diameter 
(Figure 4-13) with narrower size distribution. These crosslinked particles were salt and 
pH independent and unlike their micelle counterparts they kept all of their characteristics 
when the solution conditions were changed to physiological conditions (PBS). 
In addition to temperature responsive particles, other constructs with pH sensitivity 
were constructed and crosslinked. One such construct was ((GVGVG)6(GHGVP))4-
foldon. In this construct four of the Valine residues are substituted with Histidines to give 
the construct pH responsiveness. The crosslinked particles from this construct were 
shown to shrink and expand by changing the pH below and above the pKa of Histidine. 
 
Figure 4-13. Particle size distribution of crosslinked (GVGVP)40-foldon micelles above and below the 
transition temperature. The particles are generally swelled at temperatures below the transition temperature 
but by going through the transition a shift in the size distribution of particles is observed and the mean 
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diameter of particles decreases from around 65 nm to below 50 nm which is close to 50% change in the 
volume. 
4-6. Conclusions  
In this work, which is a complementary study to our previously reported data, the 
geometry and size of thermoresponsive micelles made from three-armed star elastin-like 
polypeptides were investigated as a function of temperature, pH, and salt concentration. 
The studies were mainly based on using different light scattering techniques and were 
also verified by viscosity measurements. The temperature was shown to effectively drive 
the reversible micelle formation above the transition temperature of ELP. The solution 
pH was shown not only to be essential in micelle formation, with the micelles only 
forming at pH values above 9.6, but also has a measurable effect on the size of the 
particles, which reach to a constant, minimum size above pH 10.2. Increasing the salt 
concentration affected the size and shape of the micelles, which exhibited different 
behaviors in a low salt regime (below 15 mM) and a high salt regime (above 30 mM) 
with a transitional region between them. The micelles in the low salt regime are spherical 
and consist of about 24 unimers while the micelles in the high salt regime are elongated 
cylindrical particles with high molecular weights. The intrinsic viscosity was measured at 
temperatures above the transition temperature to independently verify total mass and 
volume of the micelles. We also were successful in crosslinking the spherical micelles 
into responsive nano-particles which are responsive in the physiological conditions and 
stable for a long time at room temperature.     
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Chapter V 
Mixtures of Elastin-like Polypeptides with Different Architectures 
(Part of this chapter was modified from publication with N.B. Holland, Biomacromolecules 2011, 12, 4022-
4029)    
5-1. Introduction 
We have shown previously that ELP systems can be designed such that they self-
assemble into micellar aggregates above the transition temperature,
5.1
 but the size of these 
micelles could only be controlled at certain plateaus. Although these micellar particles 
have great potentials for further applications, a more defined control over their size such 
that micelles with any size would be achievable is very desirable. Mixtures of elastin-like 
polypeptides of different lengths and chemical identities with other polypeptides and with 
each other have been studied especially for protein purification purposes,
5.2
 or for making 
micro-scale particles with different properties.
5.3
 It has been reported that mixing 
solutions of ELP molecules with different lengths and molecular weights, but the same 
amino acid sequence repeats, results in a single population of aggregates and a single 
transition temperature.
5.3
 Additionally, it has been shown that a single transition would 
take place for mixtures of ELP and ELP fusion proteins when the ELP component of 
each has the same molecular weight and sequence.
5.4
 Therefore, if different architectures 
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of the ELP molecules (e.g. making trimer constructs) behave similar to the linear 
molecules, i.e. the foldon is just acting as a fusion protein for these new construct and not 
affecting the folding and aggregation of ELP molecules, a single transition temperature 
for their mixtures would be expected. In addition, we hypothesize that, for a mixture of 
linear and non-linear ELP molecules in conditions similar to that of the micelle 
formation, the aggregates of the linear ELPs can be stabilized by ELP-foldon trimers 
forming micelles with different sizes and that by adjusting the ratio of linear to trimer 
constructs virtually any size of the micelles could be achievable. This would give us 
higher flexibility in controlling the size and shape of these micelles and we would be able 
to tailor the ELP molecules and force them to make micelles with a specific size and 
shape. To test these hypotheses, we performed a series of experiments with linear and 
trimer mixtures at different ratios and concentrations and characterized them using UV-
vis spectrometer and particle size analyzer. 
5-2. Materials and Methods 
(GVGVP)40 and (GVGVP)40-foldon were expressed and purified as described 
previously.
5.1, 5.5
 The mixtures were made either in PBS or by diluting the samples in pure 
water and then adjusting the salt to the desired concentration. The UV absorbance 
measurements were performed at 350 nm on a Shimatzu 1800 spectrophotometer 
equipped with a temperature-controller sample holder unit. The spectra were obtained 
with a temperature ramp of 1˚C collecting data at 0.1˚C steps. 
Particle size measurements were performed using a 90 Plus particle size analyzer 
(Brookhaven Instruments) equipped with temperature control unit at 90˚ fixed angle. All 
the samples were filtered prior to light scattering measurements (Millex 0.22 µm, 
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Millipore). The measurements were made in 2 to 5 minutes runs and were repeated at 
least twice. Analysis of the data was done by the instrument using BIC software 
(Brookhaven Instruments) and the results are the reported as the mean diameter of 
multimodal distribution.  
5-3. Results and Discussion 
To test the differences between transition of pure ELP solutions and mixtures of ELP 
constructs with different architecture, mixtures of (GVGVP)40 and (GVGVP)40-foldon in 
a ratio of 20 to 1 were examined over a wide range of dilutions. The UV absorbance of 
these mixtures exhibit two distinct behaviors depending on the total concentrations 
(Figure 5-1a). At high concentrations, a single transition, similar to the pure species, is 
observed. However, at lower concentrations two distinct transitions are observed. The 
temperature of the first transition is very similar to the transition temperature 
corresponding to the concentration of the pure (GVGVP)40-foldon (Figure 5-1b). This is 
interesting considering the fact that the presence of linear molecules at much greater 
concentration, does not affect the trimer Tc. The trimers presumeably aggregate 
independently at first, however, the linear molecules may to some extent become 
incorporated prior to the second transition since the turbidity is greater there than for the 
pure trimer solution. This dual transition phenomenon is only observed at lower 
concentrations while at higher concentrations a single transition is observed at 
temperatures below both the pure (GVGVP)40 and (GVGVP)40-foldon solutions (Figure 
5-1c).   
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a       b 
 
  c 
 
Figure 5-1. Turbidity measurements for mixtures of (GVGVP)40 and (GVGVP)40-foldon at constant ratio 
of 20:1. a) UV absorbance at 350 nm was measured for each solution mixture, labeled by concentration of 
the (GVGVP)40 component. At high concentrations a single transition is observed, while at lower 
concentrations two transitions are observed. b) The mixture of linear (GVGVP)40 at 25 µM and the trimer 
(GVGVP)40-foldon at 1.25 µM concentrations (20:1 ratio) results in two transition temperatures, where the 
first transition occurs at the same temperature as the pure 25 µM ELP trimer solution. c) For the UV 
absorbance of the mixture of (GVGVP)40 and (GVGVP)40-foldon at higher concentration (400 µM and 20 
µM, respectively) only a single transition was observed, which is at a lower temperature than the pure 
solution of either component. 
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The transition temperatures of the mixtures have been plotted together with the 
corresponding transition temperatures for the pure components (Figure 5-2). The 
transition temperatures of the pure components cross each other because of the difference 
in their concentration dependence. This clearly illustrates that the transition temperatures 
of the mixture at high concentrations are lower than those of either of the pure 
components.   
 
Figure 5-2. The comparison between the transition temperatures of pure (GVGVP)40 and (GVGVP)40-
foldon and their 20:1 mixtures as a function of mixture concentration. The mixture at high concentrations 
shows a single transition temperature that is lower than the transition temperature of pure linear ELP. In 
this region pure linear ELP (solid line) has a lower transition temperature than that of the trimer (dashed 
line). But at lower concentrations, where the pure ELP-foldon has a lower transition temperature, two 
transition temperatures are observed.  The first one is the same as the pure ELP-foldon transition 
temperature and the second one approaches that of the linear ELP.   
 
At lower concentrations, where the mixture exhibits two transition temperatures, the 
lower transition temperature follows the transition temperature of a pure (GVGVP)40-
foldon construct while the second transition temperatures approaches that of the pure 
(GVGVP)40. It appears that if the concentrations of the linear and trimer constructs are 
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such that they have a minimum of 2˚C difference between the transition temperatures of 
their pure solutions, two transition temperatures are observed in the mixture.  
The dual transition behavior of ELP and ELP-foldon can be explained by the difference 
in the nature of the folding and aggregation of the two constructs, which is contributed to 
the difference in their architecture. For either of these constructs the folding of individual 
chains would proceed by the maturation step
5.6
 in which a few of the folded chains come 
together and to stabilize the more hydrophobic conformation. The concentration 
dependence arises because this step needs a sufficiently high concentration of folded 
polypeptide chains to proceed. The architecture of ELP-foldon may modify this 
maturation process. When temperature rises, the three ELP chains that are connected by 
the foldon domain, will associate with each other first because of their local proximity, 
enhancing the maturation process. Consequently in a mixture of linear and trimer 
constructs, the maturation of trimer constructs occur at some lower temperature in 
comparison to the linear ones which leads to the independent aggregation of the trimers. 
In the case when linear constructs have a lower transition temperature than the pure 
trimer in the mixture, there is no preference for the folded linear polypeptide to aggregate 
with itself compared to the trimer, so both linear and trimer molecules aggregate together 
at a temperature below the transition temperature of the pure linear ELP. These data 
suggest that folding and aggregation occur differently for the trimer constructs than for 
the linear constructs. Further experimentation will be necessary to fully elucidate the 
differences.  
The micelles that form from ELP-foldon constructs grow in size by transitioning from 
spherical to nonshperical shapes, as was discussed in detail in Chapter 4 of this 
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dissertation. At low salt concentrations (below 15 mM NaCl) there is a fairly constant 
size distribution of particles in the solution, attributed to the length of the folded ELP 
portion of the construct. Although this is an important finding that can be used in 
preparing small responsive particles, it might be interesting to have a system in which the 
size of the particles can be changed to any desirable size without the need of changing the 
structure of the molecules (i.e. changing the molecules to longer or shorter ELPs). In fact 
the reason for having a range of salt concentrations in which a constant size distribution 
of particles is achieved can be contributed to the fact that the particles in the system do 
not attain different sizes unless a change in geometry occurs (based on their packing 
factor) and as we have shown in previous chapter, this geometrical change can push the 
particles to go from very small particles to large micelles with different geometries and 
much higher molecular weight. We have shown that this transition from one regime to 
another happens in a fairly narrow transition region and the particle sizes show some kind 
of a plateau at each salt concentration  
To overcome this limitation, we modified the system by making mixture of linear and 
trimer ELP molecules with different linear to trimer ratios with the intent that the interior 
of the micelles can be filled with more ELP molecules and gradually expand to any size 
for a given salt concentration and instead of transitioning to other geometries keep their 
spherical shape. The mixtures were made based on the fact that ELP-foldon and ELP 
molecules can either go through the transition independently or simultaneously 
depending on the mixing ratios as discussed in this chapter.  
Based on the results from Figure 5-2 the experiments can be done in two different 
regimes. If the mixture ratio is below the crossing point of the pure linear and trimer 
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transition temperatures, we expect to have two transitions in which the trimers form the 
micelles prior to the aggregation of linear constructs which means we should expect two 
transition temperatures and consequently two populations of particles. This was studied 
by a mixture of (GVGVP)40 and (GVGVP)40-foldon with 20:1 ratio in which the trimer 
had much lower concentration than the linear construct. The results from particle size 
analyzer confirm the existence of two different sizes based on the temperature at which 
the measurements were done (Figure 5-3). The first transition was shown to be above the 
transition temperature of the trimer construct and the second transition just above that of 
the linear. But interestingly there was not two populations of particles above the second 
transition temperature and the size of the particles were smaller than what is expected 
from aggregation of the linear ELP molecules which is in the range of 500 to 800 nm. 
  
Figure 5-3. Micelle formation at different salt concentration for a mixture of (GVGVP)40 and (GVGVP)40-
foldon at a ratio of 20:1 at total concentration of 10 µM. The two transitions show a two-step particle 
formation in which the trimer first goes into particles but above the second transition temperature a single 
population of particles with sizes well below the expected aggregates of linear ELP is observed. 
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The smaller size of the aggregates can be attributed to the stabilization of aggregates 
during the growth period of the particles by ELP-foldon construct. The fact that only a 
single population of particles are observed in the mixture at any temperature also can 
indicate that in fact the linear ELPs start to separate into the already formed micelles of 
ELP-foldon. This makes sense especially for higher salt concentrations in which the ELP-
foldon micelles are less stable in their spherical form and start to transition to elongated 
micelles. But the presence of linear ELP molecules above their transition temperature 
which can be housed in the core of these micelles would provide enough core volume to 
maintain their spherical geometry and remain relatively small. 
 
5-4. Conclusion 
The effect of architecture on the behavior of ELP transition was studied by using 
mixtures of ELP and ELP-foldon constructs. It was shown that the existence of the trimer 
changes the aggregation behavior of ELP molecules such that these molecules can in fact 
aggregate independent of the linear constructs in certain concentrations. The conditions in 
which this independent aggregation can happen were investigated by UV-vis 
spectroscopy. 
The mixtures of linear and trimer ELPs were also studied with the aim of controlling 
the size of the ELP-based micelles in a practical way. It was shown that the mixtures can 
be made such that they go through two transitions but in each transition only a single 
population of particles was observed. The first transition is attributed to the trimer 
transition with particles of small sizes as it was expected from a pure trimer solution but 
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the second transition is considered to be the aggregation of linear ELPs into the ELP-
foldon micelles or decoration of ELP aggregates by ELP foldon constructs.  
Although this study on its own is not yet conclusive enough to give us a complete map 
of different sizes of ELP-based particles at any given mixing ratio, it demonstrates that 
the very good control over the size and shape of these ELP-based micelles can be 
achieved by this method. Further investigation of micelle formation at different salt 
concentration and mixing ratios are necessary to complete this study. 
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Chapter VI 
Study of ELP Folding and Aggregation Using Different Molecular 
Architectures 
6-1. Introduction 
Understanding how molecules assemble into supramolecular architectures requires 
careful consideration of the inter- and intra-molecular interactions which control the 
molecular associations. This is also true for the self-assembly of elastin-like polypeptides 
and their derivatives but as discussed in the first chapter of this dissertation,  the theory of 
aggregation of elastin-like polypeptides is still debated and there are different points of 
view as to how these molecules assemble and come out of solution above their transition 
temperature. Understanding the aggregation process of these molecules and ultimately 
controlling this process at the molecular level would give us insight into how to design 
them for a desired measurable response. 
There are at least four different suggested pathways for the molecular transition of ELP 
constructs from below to above the transition temperature and each of them are supported 
by a number of experimental or theoretical studies. Here an overview of these theories is 
presented and later based on our experimental data, our theory of folding and aggregation 
of ELPs will be discussed.  
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Pathway of no order to homogeneous order through folding and association 
This is the most discussed and the most widely accepted pathway suggested by Urry 
three decades ago as discussed in the first chapter. 
6.1
 Based on this theory, which is 
supported by a number of circular dichroism, NMR, and dielectric relaxation studies, 
mostly below the transition temperature, the ELP chains are in random coil conformation 
when they are well below the transition temperature and by increasing the temperature 
they start to go into more internally ordered structures consisting of β-turns. 6.2, 6.3 A few 
of these molecules then come together and make a “matured” intermediate construct 
which has some exposed hydrophobic residue. 
6.4
 These intermediate molecular units then 
come together to form more stable and energetically favorable aggregates which is the 
macroscopic outcome of the transition process. In this theory there are in fact three 
different stages involved in the process of aggregation including a conformational 
change, an association step and finally the aggregation. 
6.4
 The first step is shown to be 
gradual but the next two are supposed to be happening at the same time when the solution 
gets to the transition temperature especially because the result of the maturation process 
is small aggregates of a few molecules (perhaps a triple helix
6.1
) with exposed 
hydrophobic surface.  
Pathway of no order to homogeneous order without well-defined chain associations 
The difference between this theory and the last one is that here no association step is 
proposed and although the constructs go through some internal ordering, they aggregate 
out of solution with no intermediate folded unit.  
Based on molecular simulation of (VPGVG)3, Krukau et al. suggested the existence of 
some structured elements on the peptide chains close to and even above the transition 
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temperature but could not conclude the existence of specific folding pattern. 
6.5
 Li et al. 
molecular simulations showed that above Tt the ELP monomer can be described as a 
compact and amorphous structure which contains disordered β strands. They suggested 
some ordering in each of the chains but a random aggregation overall. 
6.6
 
Based on this theory the aggregation is a continuous process which starts at lower 
temperature by some internal ordering of the chains and finishes at the transition 
temperature by random aggregation of these chains. 
Pathway of no order to heterogeneous order 
Ohgo et al. suggested a simultaneous presence of different conformations at the 
transition temperature of ELP constructs. 
6.7
 These conformations include type II β-turns, 
type I β-turns and unordered structure which makes the ELP a structurally heterogeneous 
biopolymer. Using TEM they also observed twisted-rope aggregates which might be in 
agreement to the Urry’s theory. 
Kumashiro et al. did NMR studies on the ELP constructs and concluded that the best 
describing scenario for these polypeptides is a “conformational ensemble” which includes 
a number of different conformations including type II β-turn and type I β-turn structures 
at the same time. 
6.8
 This heterogeneity in conformation was also reported by Ahmed et 
al. using CD, UV and Raman spectroscopy for cyclic polypeptides in which populations 
of unordered, type II β-turns and type III β-turns were reported along with noticeable 
increase in type II β-turns at temperatures above the transition temperature. 6.9 
Based on this theory increasing the temperature would increase the ordering of the 
chains but there are different conformations that the chains fold into and so a 
heterogeneous ensemble of conformations is expected. This theory would not necessarily 
184 
 
be in contradiction to Urry’s twisted filament theory but it suggests no clear pathway to 
folding and aggregation of the chains. 
Pathway of no order to no order  
Based on this theory, regardless of the chemical identity and length of ELP constructs 
they are always unordered and there is no folding, ordering or intermediate state between 
the chains at low temperature and the ones or above the transition temperature. This 
theory is almost solely backed by molecular simulations and not much experimental 
results. 
6.10, 6.11
  
Comparing these four different pathways, it is clear that in all of them except for the 
last one some kind of chain ordering or folding is expected when the temperature of the 
solution changes from below up to the transition temperature. But these theories are very 
different when it comes to predicting the intermediate stages between random chains and 
ordered aggregated ones. 
Developing a new method to study the transition pathway 
In this study we probed the existence and stability of the intermediate steps by making 
constructs that should increase the stability of a folded stage while still far from 
aggregation. This can give us a tool to understand the aggregation process and the theory 
behind it. If Urry’s theory of folding and aggregation is valid, it should be possible to 
design ELP constructs such that the matured constructs would stay stable at temperatures 
below the transition temperature of ELP. To examine this we expanded our investigation 
of new architectures of ELP molecules by capping N-, C- or both termini of the trimer 
constructs and also designed molecules such that the exposed surface of them after 
folding according to the Urry model would consist of hydrophilic residues, stabilizing 
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them in the solution without aggregation. These different architectures were investigated 
using mainly UV-vis and CD spectroscopy to probe their molecular behavior and the 
relationship between their microscopic and macroscopic transitions.      
 
6-2. Materials and methods 
All the genes were constructed with the same molecular biology techniques that were 
described previously. 
6.12, 6.13
 A complete list of all different constructs which were made 
for this research can be found in appendix A but the genes which are discussed here are 
(GVGVP)40, (GVGVP)40-foldon, foldon-(GVGVP)40, foldon-(GVGVP)40-foldon, and 
foldon-(GLGVPGQGVPGQGVP)12-foldon. The exact amino acid sequence of these 
constructs are reported in Appendix A. 
 Protein expression was in general similar to what described in previous chapters. One 
notable difference was  for the purification of the constructs with foldon on both ends 
because with the standard method of heat and cold cycling which is used for other ELP 
constructs most of the protein ended up staying in the pellet from the first cold 
centrifugation. To overcome this problem,  after the first cold centrifuge of the disrupted 
cells, the pellet was brought back up into the solution by adding PBS and keeping the 
solution at 4˚C for 3 to 4 days. This solution was centrifuged at 4˚C again and the 
supernatant was then heated up in the presence of 1 molar NaCl and the pellet was then 
resuspended again by adding cold PBS and was left at 4˚C for another 3 to 4 days. The 
solution was vortexed a few times each day. The solution was then centrifuged at 4˚C and 
the supernatant was separated and the cycle was repeated again if necessary. 
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Characterization of the constructs were done using SDS-PAGE gel electrophoresis to 
confirm their molecular weight and purity and UV-vis spectroscopy (Shimatzu 1800) was 
used to measure the transition temperatures. Circular dichroism (CD) spectroscopy (Aviv 
215) was used extensively for this study in order to study the conformational changes in 
each of the constructs at different temperatures. The CD samples were prepared the same 
way as the UV samples by diluting a PBS stock solution either in PBS or water. The 
samples were loaded in either 1 mm or 0.1 mm pathway cuvettes, depending on the 
concentration of the sample and the salt concentration, and the spectra were measured 
from 190 nm to 250 nm. 
  
6-3. Results and discussion 
Our goal in this study was to modify the architecture and surface decoration of ELP 
molecules such that it becomes energetically favorable for them to stay in the matured or 
folded state if such intermediate step actually exists. Here the results of characterization 
of each of the constructs are discussed separately and then they will be compared. 
(GVGVP)40 
This construct was used as our reference molecule. It is linear and is very well 
characterized both in the literature and in our lab.
6.13
 Turbidity measurements of solutions 
of this ELP molecule with many different ranges of concentrations were studied and 
discussed in detail in previous works.
6.13
 UV absorbance curves from these solutions as a 
function of temperature at have a  sharp  absorbance maxima of around 1 (except for very 
low protein concentrations)(Figure 6-1).  
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Figure 6-1. UV-absorbance of (GVGVP)40 at 25µM protein concentration dissolved in PBS (square) and 
zero salt concentrations (diamond). The behavior is very similar in both salt concentrations except for the 
different transition temperatures. 
 
The circular dichroism (CD) spectroscopy of (GVGVP)40 in PBS shows gradual 
changes in the conformation (Figure 6-2). The low temperature spectra have the well-
known characteristic minimum of a random coil around 195 accompanied with a weaker 
one at 220. These minimums then start to become less negative by increasing the 
temperature. The decrease is accompanied by a slight red shift of the bands which is an 
indication of the presence of at least some β-turn structures at higher temperatures. The 
third peak at 212 nm is fairly constant and can be considered as the isodichroic point. The 
presence of this point is an indication of the presence of two main conformational states 
at the same time and the fact that one changes to the other by changing the 
temperature.
6.14, 6.15
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Figure 6-2. CD spectroscopy of (GVGVP)40 (a) at 10 µM protein concentration in PBS from below to 
above transition temperature and (b) at 25 µM protein concentration in water from below to above 
transition temperature 
   
An important aspect of this spectrum is the lack of an expected positive band between 
200 and 210 nm which is also a characteristic of type II β-turn. This can be explained by 
the strong presence of random coils even at higher temperatures. But it appears that the 
construct starts to become more ordered and shifts towards a combination of random coil 
and type II β-turn structure. This is in agreement with previously reported CD spectra of 
different ELP constructs. 
6.14, 6.16
 Above the transition temperature, the aggregation causes 
the loss of the signal for this construct. 
The CD spectrum of the same polypeptide diluted in water (low salt) also exhibits 
similar general behavior, but it appears that the 212 nm peak does not behave as an 
isodichroic point anymore as it shifts to higher values with increasing temperature. This 
might be an indication of tendency towards β-turn structure and less random coil in the 
solutions at higher temperatures. But nevertheless there is still a considerable amount of 
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random coil conformations at or close to the transition temperature together with this 
ordered structure.  
 
(GVGVP)40-foldon 
As shown in previous studies
6.12
, this construct is a three-armed star elastin-like 
polypeptide which also has different aggregation properties than linear ELP. However, 
the measurable response of these molecules, when studied in PBS, was shown to be 
similar to the linear ones, with a sharp change in UV absorbance at the transition 
temperature and similar features at low or high salt concentrations.   
a)                                               b)  
 
Figure 6-3. UV absorbance (a) and CD spectrum (b) of (GVGVP)40-foldon at 100 µM protein solution in 
PBS using 1mm pathway cuvette for CD measurement and 10 mm pathway cuvette for UV measurements.  
 
UV spectroscopy of a 100 µM solution of (GVGVP)40-foldon in PBS shows a sharp 
transition below 30˚C (Figure 6-3a). But without losing the signal, the CD spectrum of 
the same sample at 30˚C shows clear sign of more ordered structure above the transition 
temperature (Figure 6-3b). In general the behavior of the ELP-foldon molecules in PBS at 
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low temperatures is similar to that of the linear ELP, but seems to show more order close 
to the transition temperature. This can be an indication of the effect of foldon on inducing 
order in the ELP molecules especially when the solution is close to the transition 
temperature. 
Foldon-(GVGVP)40  
This construct has very similar geometry to (GVGVP)40-foldon but instead of having 
the foldon on the C-terminus of the ELP, it is located on the N-terminus. It has been 
shown previously that ELP conformation can be affected by adding a self-assembling 
domain to either of the two termini and that there is a difference between adding this 
domain to C- or N-terminus,
6.17
 so we believe there could be molecular and 
conformational differences between adding the foldon to the ELP N- or C- terminus.  
UV-absorbance was used to measure the transition temperatures of foldon-(GVGVP)40 
as a function of concentration and the results were compared to the (GVGVP)40-foldon 
(Figure 6-4). The two curves have very similar slopes but foldon-ELP transition 
temperatures appear to be consistently about 3˚C lower than the ELP-foldon constructs at 
the same concentrations. This is interesting considering the similar geometry of the two 
constructs. It is possible that foldon-ELP trimers fold into their matured stage (with the 
assumption that such stage actually exists) at lower temperatures compared to the ELP-
fodon constructs and this causes them to aggregate out of the solution at lower 
temperatures. This is a clear sign of different molecular behavior of these two constructs. 
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Figure 6-4. Transition temperature as a function of concentration for (GVGVP)40-foldon (squares) and fol-
(GVGVP)40 (diamonds). The foldon-ELP construct shows the same linear dependency between the 
transition temperature and logarithm of concentration but is about 3˚C lower in transition temperature 
compared to the same concentration of ELP-foldon construct.   
 
 
Figure 6-5. CD spectra of fol-(GVGVP)40 at 100 µM in PBS and different temperatures. The spectra show 
similar behavior as linear or ELP-foldon at low temperatures but above the transition temperature (33˚C) a 
red shift at 210 nm peak and decrease in random coil conformation is observed. 
 
To study the conformational changes of these two constructs, the CD spectra of fol-
ELP (Figure 6-5) were compared to those of the ELP-foldon (Figure 6-3b).  The spectra 
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in general show similar behavior at low temperatures as linear or ELP-foldon but at 35˚C, 
which is above the transition temperature, the signal is not lost in contrast to the linear 
construct and conformational ordering is observed. Also interestingly, for foldon-ELP, 
there is not a considerable change in the CD signal even at 30˚C which is above the 
transition temperature for the 100µM solution while for ELP-foldon the 197 nm 
minimum is lost at the transition temperature. Another interesting difference between 
trimer constructs and the linear ones is the absolute value of the CD signal. For a 25 µM 
linear (GVGVP)40, the 195 minimum is about -25 deg cm
2 
dm
-1
 at 10˚C while for a 100 
µM solution of ELP-foldon this signal is only -18 deg cm
2 
dm
-1
 and for 100 µM fol-ELP 
the signal is at -16 deg cm
2 
dm
-1
. If the three construct contained the same amount of 
random coil constructs we would expect to see a much higher negative value for ELP-
foldon and foldon-ELP at concentrations 10 times the linear. The fact that the peak is in 
fact less negative, is a good indication of much less random conformation in the solution 
even at low temperatures. We believe this is the orientation of the chains as a result of 
adding the foldon domain. Between the two trimer constructs, foldon-ELP exhibits less 
random coil content as well. This can be an indication that folding of the ELP molecules 
may preferentially start from the N-terminal and holding a few of the ELP chains together 
from this end, gives them better chance to come together even at low temperatures.  
To further investigate the conformation of trimer ELPs in different environments, the 
CD spectra of foldon-ELP was studied in low salt solutions. The CD spectra of fol-
(GVGVP)40 in water show very different behavior compared to that of the linear 
construct (Figure 6-6). There is no 195 nm minimum even at very low temperatures and 
instead there is a minimum at 218 nm which becomes more visible at higher temperatures 
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and close to transition temperature shifts to about 220 nm. This spectrum has the 
characteristics of protein with high population of β structure especially at wavelengths 
above 205. 
6.18
 But for it to be all β a positive maximum around 197 is expected. The 
reason for not observing this peak could be the presence of random segments in the 
conformation of the polypeptides even at high temperatures. This specially might be the 
case for segments of ELP far from the foldon domain that might not be affected by the 
foldon or have less ordered conformations in the presence of C-terminal ends of the other 
chains. At higher temperatures (45˚C) a weak positive peak at 210 nm is observed. This 
band together with negative band around 220 nm is an indication of the existence of type 
II β-turns. The small red shift in the two peaks in comparison to the expected type II β-
turn spectrum might be an indication of existence of other types of β turn in the 
conformation.
6.19
 Regardless of the exact conformation of this construct, the fact that a 
noticeable difference between the conformation of this construct and linear ELP is a good 
reason to believe that the architecture of these molecules actually affects their 
conformation and that there is in fact a folding process occurring prior to aggregation.  
The reason for not having the same type of behavior for fol-ELP when it is in PBS is not 
completely clear but it might be attributed to the salting-out effect of NaCl.  
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Figure 6-6. CD spectra of fol-(GVGVP)40 at 25 µM in water. The spectra show ordered structure at low 
temperature. Increasing the temperature results in more β-like conformations.  
 
Up to this point we at least partially answered the question of whether or not the ELP 
molecules fold (or have the potential to fold) into more ordered structures and if this 
ordered structure can be stabilized independently from the aggregation process. To 
continue our investigation, we synthesized new constructs which are capped at both ends. 
Our goal was to induce the folding into a homogenous population at any environmental 
condition. By capping both ends of the ELP trimer we would avoid random folding or 
aggregation of free chains and answer the question of if ELP aggregation is inherently 
heterogeneous or can be forced to be a homogeneous population. 
Foldon-(GVGVP)40-foldon 
This construct is very similar to the ones just described except that both ends of it are 
capped by foldon domain. The UV spectra of this construct at different protein 
concentration show some different general behavior in comparison to other linear or 
trimer ELP constructs (Figure 6-7). 
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Figure 6-7. UV absorbance of (a) foldon-(GVGVP)40-foldon and (b) (GVGVP)40 at different total protein 
concentrations in PBS. The construct with both ends capped shows different transitional behavior than the 
linear construct 
It is noticeable that the concentration change of one order of magnitude (from 25 µM to 
250 µM) changes the transition temperature only by less than 2˚C (Figure 6-7a). This is 
of course very different from linear ELP constructs in which a change of about 8˚C for 
the same change in the concentration is observed (Figure 6-7b). The smaller change in 
the transition temperature can be attributed to smaller concentration dependency of this 
construct. From a molecular point of view this might be the result of matured trimers that 
are made in a more orderly process. For a typical ELP, the chains are randomly 
distributed and it is expected that they also find other chains randomly and so each chain 
might associate with a number of different chains as the temperature start to rise and that 
means the process of aggregation is more dependent on the number of available chains in 
the solution which is directly proportional to the solution concentration. But for foldon-
ELP-foldon construct the three chains are already in close proximity and the maturation 
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process is less dependent on the solution concentration and more related to the chemical 
identity of the ELP and the hydrophobicity of the folded trimer.  
The CD spectra of foldon-(GVGVP)40-foldon in PBS is also interestingly different 
from the other ELP constructs (Figure 6-8). At very low temperatures two minima, one at 
205 nm and the other around 217 nm are observed. This spectrum can be interpreted as 
the existence of high population of β-structured proteins especially that a weak positive 
maximum around 197 nm to 200 nm is also observed in the spectrum even at low 
temperatures. 
6.18
 In fact by increasing the temperature to the transition temperature of 
this solution, which is somewhere between 30 to 35˚C, the shift towards a stronger 
positive peak at that range can be observed. The other way to interpret the data at low 
temperature is a slightly red-shifted α-helical conformation. But it has been shown that 
type II β-turn conformations from polypeptides containing “Pro-Xxx” might show similar 
CD spectra as helical structures and since there is no reason to believe these constructs 
make α-helical conformations, the best possible way of describing their spectra would be 
by assigning β structure conformation to them.6.20 In general there seems to be a high 
content of β-turn conformation at low temperatures which then change to more β strand 
conformation at or around transition temperature (Figure 6-8 dotted spectrum). 
6.21
 
Another interesting aspect of the spectra is that above the transition temperature the 
foldon peak starts to diminish while the positive peak at the 197 nm gets stronger and the 
minimum at 217 nm is not affected. This is a different behavior from all the other 
previously studied ELPs for which above the transition temperature the aggregation 
causes the loss or weakening of the whole spectrum. This might be an indication that in 
this case, the aggregation is not a random process among many different folded chains 
197 
 
and in fact the orderly folded chains start to aggregate into the β strand-like conformation 
above the transition temperature.   
 
Figure 6-8. CD spectra of foldon-(GVGVP)40-foldon at 10 µM solution concentration in PBS. The spectra 
below the transition temperature (up to 35˚C) shows signs of high β-turn content which then shifted 
towards more β strands conformation above the transition temperature.  
 
Modifying geometry and chemical identity of ELP molecules 
Up to this point we have shown that different molecular geometries modify the folding 
and aggregation of the ELP molecules. The next question is if the chemical identity of the 
construct can also affect the folding process, especially if it is combined with proper 
geometric design and also, if this can actually help the stabilization of the folded 
constructs. To answer this question we made a number of different constructs with the 
idea of giving the surface of the folded trimer more hydrophilic characteristics and 
burying the hydrophobic residues inside the folded trimer. To accomplish this goal, the 
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valines in the ELP sequences for each different architecture (linear, trimer or both ends-
capped trimer) were substituted in a pattern to more hydrophilic or hydrophobic residues 
based on the molecular model of the folded ELP (Figure 6-9). 
 
Figure 6-9. Molecular model of modified ELP trimer from unfolded to folded. The chemical identity of the 
folded trimer can be controlled by changing Valine residues which are going to be exposed to water (or 
hidden inside the folded trimer). 
 
Foldon-(GLGVPGQGVGPGQGVP)12-foldon.    
Of the constructs synthesized with changed amino acid residues, most of the ones with 
only one end capped behaved more or less similarly to the previously described trimers, 
but the ones with both end capped showed some interesting characteristics. One of the 
most promising one is a construct that consists of 36 repeats of GαGβP in which α and β 
were substituted with valine, glutamine, and leucine and the arrangement was chosen to 
have the glutamine residues in contact with water after the folding of the trimer. The 
folding model was chosen to be β-spiral with repeating β-turns. 
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The UV spectrum of this ELP solution has an interesting feature that it shows much 
lower absorbance compared to other ELP solutions (Figure 6-10). This lower UV 
absorbance could be the result of less aggregation which might be a result of stable 
folded trimers that are energetically stable in their folded (matured) state without the need 
to aggregate out of the solution. 
 
Figure 6-10. UV absorbance of foldon-(GLGVPGQGVGPGQGVP)12-foldon in PBS at 50 µM 
concentration. The absorbance is close to one third of what is usually expected from a 50 µM ELP solution.   
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Figure 6-11. CD spectra of foldon-(GLGVPGQGVGPGQGVP)12-foldon at 50 µM in PBS at different 
temperatures. The spectra seem to be very similar from below to above the transition temperature.  At high 
temperatures the strong positive peak around 190 nm might be an indication of β-strand structure while 
below transition temperature more β-turn structure is observed. 
 
To study the conformation of this construct at different temperature, CD spectra of the 
same sample at different temperatures were measured (Figure 6-11). The spectra are in 
general similar to the ones for foldon-(GVGVP)40-foldon (Figure 6-8) but they show 
stronger β-turn content below the transition temperature. The signal is weaker than the 
other spectra which is a result of using cuvettes with 0.1 mm pathway instead of 1 mm. 
Above the transition temperature β-strand conformations are observed. In general, the 
construct above and below the transition temperature do not appear to be very different 
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and definitely no random coil conformation is observed. There is no loss of CD signal 
above the transition temperature. 
It appears that this construct in fact is stabilized in its folded conformation and 
apparently it goes into this folded conformation at temperatures well below the transition 
temperature. But above the transition temperature there are some rearrangements of these 
folded units but not all of these folded constructs go into aggregates. This is very 
interesting because it shows that aggregation is not an inevitable result of folding or 
maturation of the ELP chains and they can be designed such that they stay soluble and 
stable even above their predicted transition temperature. 
 
6-4. Conclusion 
We have studied the folding and aggregation theories of ELPs by synthesizing different 
geometries and chemical identities of these molecules with the aim to gain better 
understanding of the process of folding. We have shown that depending on the geometry 
of the ELP molecules and the environment that they are studied at, their folding can be 
affected. We believe that there is definitely some kind of ordering of chains when the 
solution approaches its transition temperature but the folding starts at temperatures well 
below the transition temperature and it is a gradual process. It appeared to us that folding 
of the ELP chains starts most efficiently from their N-termini and constructs with their N-
terminal capped show the ordering towards what can be interpreted as β conformations at 
lower temperatures but it is also observed that capping only one end of the ELP construct 
cannot induce the folding especially at higher salt concentrations. On the other hand, by 
capping both ends of ELP constructs into a trimer, well-defined conformations of β-turns 
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were observed at temperatures below the transition temperature. These β-rich constructs 
appeared to pack into some kind of β-strand conformation at temperatures above the 
transition temperature. Also, we have shown that the chemical identity of the chains can 
be designed together with the geometry, to result in a system of stably folded trimers. 
These trimers are the first ELP constructs to show clear folding without aggregation.  
Based on these results, we believe that ELP molecules in fact fold into more ordered 
structures as the temperature rises to their transition temperature. But their final 
conformation is not a universal conformation, which means that depending on their 
molecular architecture, their chemical identity, and their environment they might take 
different conformations. It is possible to design them such that a separate folding and 
aggregation occur. It additionally seems that folding is necessary for the constructs to 
aggregate, but aggregation is not the inevitable fate of the folded constructs. This is 
especially interesting for the potential of utilizing these folded but not aggregated 
molecules for NMR structural studies and for certain applications in which a folded 
construct might be used as the modular unit to make responsive biomaterials. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
203 
 
6-5. References 
 
6.1  Cook, W. J.; Einspahr, H.; Trapane, T. L.; Urry, D. W.; Bugg, C. E. Journal of the 
American Chemical Society, 102, 5502,(1980). 
6.2  Urry, D. W.; Trapane, T. L.; Iqbal, M.; Venkatachalam, C. M.; Prasad, K. U. 
Biochemistry, 24, 5182,(1985). 
6.3  Urry, D. W.; Trapane, T. L.; Prasad, K. U. Biopolymers, 24, 2345,(1985). 
6.4  Yamaoka, T.; Tamura, T.; Seto, Y.; Tada, T.; Kunugi, S.; Tirrell, D. A. 
Biomacromolecules, 4, 1680,(2003). 
6.5  Krukau, A.; Brovchenko, I.; Geiger, A. Biomacromolecules, 8, 2196,(2007). 
6.6  Li, B.; Alonso, D. O. V.; Daggett, V. Journal of Molecular Biology, 305, 581,(2001). 
6.7  Ohgo, K.; Niemczura, W. P.; Ashida, J.; Okonogi, M.; Asakura, T.; Kumashiro, K. 
K. Biomacromolecules, 7, 3306,(2006). 
6.8  Kumashiro, K. K.; Ohgo, K.; Niemczura, W. P.; Onizuka, A. K.; Asakura, T. 
Biopolymers, 89, 668,(2008). 
6.9  Ahmed, Z.; Scaffidi, J. P.; Asher, S. A. Biopolymers, 91, 52,(2009). 
6.10  Gross, P. C.; Possart, W.; Zeppezauer, M. Zeitschrift Fur Naturforschung C-a 
Journal of Biosciences, 58, 873,(2003). 
6.11  Li, B.; Alonso, D. O. V.; Bennion, B. J.; Daggett, V. Journal of the American 
Chemical Society, 123, 11991,(2001). 
6.12  Ghoorchian, A.; Cole, J. T.; Holland, N. B. Macromolecules, 43, 4340,(2010). 
6.13  Ghoorchian, A.; Holland, N. B. Biomacromolecules, 12, 4022,(2011). 
6.14  Nicolini, C.; Ravindra, R.; Ludolph, B.; Winter, R. Biophysical Journal, 86, 
1385,(2004). 
204 
 
6.15  Urry, D. W.; Shaw, R. G.; Prasad, K. U. Biochemical and Biophysical Research 
Communications, 130, 50,(1985). 
6.16  Cho, Y.; Sagle, L. B.; Iimura, S.; Zhang, Y. J.; Kherb, J.; Chilkoti, A.; Scholtz, J. 
M.; Cremer, P. S. Journal of the American Chemical Society, 131, 15188,(2009). 
6.17  Dai, M.; Haghpanah, J.; Singh, N.; Roth, E. W.; Liang, A.; Tu, R. S.; Montclare, J. 
K. Biomacromolecules, 12, 4240,(2011). 
6.18  Venyaminov, S. Y.; Vassilenko, K. S. Analytical Biochemistry, 222, 176,(1994). 
6.19  Perczel, A.; Hollosi, M.; Sandor, P.; Fasman, G. D. International Journal of Peptide 
and Protein Research, 41, 223,(1993). 
6.20  Ananthanarayanan, V. S.; Shyamasundar, N. Biochemical and Biophysical 
Research Communications, 102, 295,(1981). 
6.21  Bazzi, M. D.; Woody, R. W. Biophysical Journal, 48, 957,(1985). 
205 
 
Chapter VII 
 
Concluding Remarks 
 
Elastin-like polypeptides have been shown to be an interesting class of environmentally 
responsive biomaterials and their molecular behavior and macroscopic response have 
been subject to many studies but the pathway of molecules from soluble to insoluble has 
not yet been clearly understood and also the effect of molecular architecture on their 
transitional behavior has not been explored. The aggregation of ELP molecules is 
concentration dependent and our hypothesis was to induce the folding of the chains at 
temperatures lower than the transition temperature by physically keeping them in close 
proximity. Our approach was to make use of a trimer forming oligomerization domain 
called foldon at N-, C- or both termini of the chains and essentially make new geometries 
of ELP molecules and study their behavior and also decorate the ELP chains by 
hydrophobic and hydrophilic residues in a way to increase the stability of the folded 
constructs. 
 The three-armed star ELP molecules are shown to fold into more extended rod-like 
structures at the transition temperature while the linear ELP keeps its random coil 
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conformation all the way to the transition temperature. A mathematical model was 
developed to enable us predict the critical transition temperature as well as understanding 
the molecular conformation at the transition temperature. Based on this model we predict 
that the ELP molecules, which are confined at their N-termini can fold into more 
extended conformation at the transition temperature compared to the linear or the ones 
which are capped at their C-temini. We also showed for the first time that capping both 
ends of the ELP molecules together with proper choice of amino acids in the chain induce 
stable folding of the trimers to β-rich conformations without aggregation even at 
temperatures above the transition temperature.   
Using these new architectures and exploiting the slight negative charge on the foldon 
domain, we developed responsive micellar systems in which micelles are formed at 
certain salt and pH concentrations and their size can also be controlled from as low as 20 
nm to few hundred nano meters by adjusting salt, pH and mixture ratios of linear and 
trimer constructs. We fully characterized these micelles at different salt regimes by 
dynamic and static light scattering. It appears that changing salt from below 15 mM to 
above 30 mM induce drastic changes in the size as well as the shape of the micelles. At 
low salt concentration, the trimers pack into spherical micelles of about 30 nm in 
diameter while at higher salt concentrations they start to expand and elongate into 
cylindrical micelles with lengths of about 10 times longer than the micelles diameter. 
This size increase is accompanied by a big jump in the molecular weight of the micelles. 
We were also able to crosslink these self-assembled construct to responsive nano-
particles that are responsive and stable at physiologic conditions    
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With these constructs we have shown how the design of new architectures can not only 
help us  better understand the theory of folding and aggregation but it also give us a 
robust tool in developing self-assembling ELP systems.  
The better understanding of the folding and aggregation of the ELP chains and the fact 
that we are able to have better control over the chain-chain interactions, together with 
self-assembling capabilities of these constructs give us the tools to design molecules in 
the future that can be used in applications such as responsive fibers in which a controlled 
directional response is desired.  
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Appendix A 
 
List of synthesized constructs 
This is a list of the constructs that were made during the course of this research. 
 
MGH(GVGVP)5GWP 
MGH(GVGVP)10GWP 
MGH(GVGVP)20GWP 
MGH(GVGVP)40GWP 
MGH(GVGVP)40GWPC 
MGH(GVGVP)60GWPC 
MGH(GVGVP)80GWPC 
MGH((GVGVP)6(GKGVP))4GWP 
MGH((GVGVP)6(GKGVP))8GWP 
MGH((GVGVP)6(GKGVP))4(GVGVP)20GWP 
MGH(((GVGVP)6(GKGVP))4(GVGVP)20)2GWP 
MGH(GVGVP)3(GVGVPGHGVP)6GWP 
MGH((GVGVP)3(GVGVPGHGVP)6)2GWP 
MGH(GLGVPGVGVPGQGVP)12GWP 
MGH(GLGQPGQGQPGQGLP)12GWP 
MGH((GLGQPGQGQPGQGLP)3(GVGVP)20)2GWP 
MGH(GLGQPGQGQPGQGLP)6(GVGVP)40GWP 
MGH(GVGVP)20(GVGVPGCGVPGVGVP)(GVGVP)20GWP 
MGH(GVGVP)40(GVGVPGCGVPGVGVP)(GVGVP)20GWP 
MGH((GVGVP)6(GEGVP))2GWP 
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MGH((GVGVP)6(GEGVP))4GWP 
(MGHGVGWTSTGPQSSNDGNPDTSGQNNVP (GVGVP)20)8-
MGHGVGWTSTGPQSSNDGNPDTSGQNNVPGWP 
MGH(GVGVP)20-GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGH(GVGVP)40- GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGH(GVGVPGEGVP)(GVGVP)21 GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGH(GVGVPGEGVP)(GVGVP)41 GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGHGVGYIPEAPRDGQAYVRKDGEWVLLSTFL(GVGVP)40GWP 
MGHGVGYIPEAPRDGQAYVRKDGEWVLLSTFL(GVGVP)20GWP 
MGH((GVGVP)6(GKGVP))4 GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGHGVGYIPEAPRDGQAYVRKDGEWVLLSTFL((GVGVP)6GKGVP)4- 
GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGHGVGYIPEAPRDGQAYVRKDGEWVLLSTFL(GVGVP)40-GWPC 
MGHGVGYIPEAPRDGQAYVRKDGEWVLLSTFL(GVGVP)40 
GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGHGVGYIPEAPRDGQAYVRKDGEWVLLSTFL(GVGVP)40 
GWPGYIPEAPRDGQAYVRKDGEWVLLSTFLC 
MGH(GPP)8-(GVGVP)40 GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
(GLGVPGVGVPGQGVP)12GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGHGVGYIPEAPRDGQAYVRKDGEWVLLSTFL-(GLGVPGVGVPGQGVP)12 
GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
MGH((GVGVP)6(GKGVP))4(GVGVP)20 GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
(GLGQPGQGQPGQGLP)12GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
((GVGVP)3(GVGVPGHGVP)6)2GWPGYIPEAPRDGQAYVRKDGEWVLLSTFL 
 
 
